Expanding contraceptive options in South Africa : knowledge, attitudes, and practices surrounding the intrauterine device (IUD) by Gutin, Sarah Anne
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
Expanding Contraceptive Options in South Africa: Knowledge, 
Attitudes, and Practices Surrounding the Intrauterine Device (IUD) 
By 
Sarah Anne Gutin 
GTNSAROOl 
SUBMITTED TO THE UNIVERSITY OF CAPE TOWN 
In partial fulfillment of the requirements for the degree 
M Sc Public Health 
Faculty of Health Sciences 
UNIVERSITY OF CAPE TOWN 
Submitted 20 February 2007 
Revised 18 May 2007 
Supervisor: Dr. Chelsea Morroni 
School of Public Health and Family Medicine 
University of Cape Town 
I 
The copyright of this thesis vests in the author. No 
quotation from it or information derived from it is to be 
published without full acknowledgement of the source. 
The thesis is to be used for private study or non-
commercial research purposes only. 
Published by the University of Cape Town (UCT) in terms 
of the non-exclusive license granted to UCT by the author. 
Un
ive
rsi
ty 
f C
ap
e T
ow
n
FR01 : We.bC i ty-Hardsof t FAX l'O. :25641256539 May. 18 2007 02: 34PM P2 
•.: · 
~-·· ··- _. 
: : 
·..r-· ·:·.ao ~ 
DECLARATION 
. 
. 
· l , Sarah Anne Gutin, hereby declare that tll.e work on which th.is dissertation is based 
is my original work (except where acknowledgements indicate otherwise) and that 
neither the whole work nor any part of it has been , is being, or is to be submitted for 
another degree in this or any other universit)' . 
I empower the univer..ity to reproduce for the purpose of research either tl1e whole or 
any portion of the content, in an~ manner whatsoever. 
SignabH~ .. A. .... ~;._ 
Date: ·:/£ .... ff.la.y···p.(£}../J.=1.-. .. ... . 
·-
2 
PROJECT TITLE 
Expanding Contraceptive Options in South Africa: Knowledge, Attitudes. and 
Practices Surrounding the Intrauterine Device (IUD) 
Principle Investigator 
Dr. Chelsea Morroni, Senior Researcher 
Women's Health Research Unit 
School of Public Health and Family Medicine 
University of Cape Town, South Africa 
Co-Jnyestigators 
Sarah Gutin, MPH Candidate 
Women's Health Research Unit 
School of Public Health and Family Medicine 
University of Cape Town, South Africa 
Regina Mlobeli, Researcher 
Women's Health Research Unit 
School of Public Health and Family Medicine 
University of Cape Town, South Africa 
3 
TABLE OF CONTENTS 
DECLARATION ......... ....... .. .. .... ........ ........... .. .... ..... ......... ..... ................ ... ...... ................... 2 
PROJ ECT TIT LE .. ...... ...... ............... ....... ..... .......... ..... ..... ... ............ .......... ... .......... .. ... .. ..... . 3 
TABLE OF CONTENTS ... ........ ...... .... ... .. ... .... ....... .... ..... ... ....... ............ ........ ........ ........ ..... 4 
ABSTRACT ...... .. .......... ... ...... ......... ............. ............... ..... .. ..................... .......... ...... ... ......... 6 
BACKGROUN D ........ .... ..... ...... ...... ...... ...... .... ... ........... .... ..... .. .... ......... ..... .... .......... .......... 8 
Types of IUDs ... ........ .... ............ .. ...... .... ... ... .. ......... .. ... .. .... ............ ... ... ... ......... ..... .. ... ...... 8 
Mechanisms of Action .... ........ ... ..... ... ... ........ .............. ... ....... ....... .... ... ............ ........ .... .... 9 
Efficacy of the IUD .. ...... ... .......... ........ ..... .... ........... ..... .. ........ ... ........ ... ..... ... ...... .. ..... .... 10 
Major and Minor Side Effects .. ........... .... ......... ..... .... ....... .................... ......... .... .... ....... . I 1 
Safety Issues .. ........... .... ........... .. ........ .. .. ........ ... ... ............. .... .............. ..... .... .. .... .... .... .... 11 
Advantages and Disadvantages of the IUD .. .... ... ... .. ... .. ... ........ ............ .. ... .......... ........ . 14 
IUD Candidate Selection: Indications and Contraindications .. .... ..... .... .................... ... 16 
Insertion and Removal Issues ... ... ........ .. ... .... .... ..... .... .. .. .. .. ... .. .... .... ...... ..... ... ...... ....... .... 17 
Common Myths and Misperceptions ..... ....................... ....... ....... .... .... ...... ........ ... .. ....... 18 
What is the current use of the IUD around the world? ............ ......... ... ....... ..... ......... .... 19 
Barr iers to Use .. ... .... ................ ........... .............. ... ........... ... .................. .......... ..... .... ... .... 2 1 
The Prevalence of IUD Usage in South Africa .. ..... ..... ... ....... ... ........ ................ .... ........ 23 
The Case for Expanding Use of the IUD in South Africa ... ... ...... ..... ... .. ....... ..... ... ..... ... 23 
STUDY AIMS .... ........... ...... .. ... ..... .. .. ....... .... ........ .... ..... ..... ....... ..... ... ..... ...................... .... 26 
SETTJNG .... ..... ... ... ... .. ..... .. ...... .... ... ..... ....... ... .... ... ....... ... ... ..... ... ... .... .... ... ... .... ......... ... ... ... 26 
STUDY DESIGN AND METHODOLOGY .. ..... ... .. ............ ... ...... .... ....... ... ... ... ....... .... .. .. 27 
Study population ..... ........... ......................... ........ ... ..... ... .. .......... ..... ..... ........ ........ .. ..... .. 28 
Sampling strategy ... ...... .. ..... ... ..... ........... ..... ..................... ......... .......... ....... .......... ...... .. . 28 
Data Collection .... ... ....... .. ...... ................. .. ............. ....... .... ...... ..... ....... .. ..... .... ...... .... ...... 28 
DATA MANAGEMENT AND ANALYSIS ..... ...... ... .... ..... ... ....... ........ .......... ....... ....... .. 29 
ETHICAL CONSIDERATIONS ..... ..................... .... .......... ............. ...... .. ......................... 29 
Institutional approvals ...... ........ .... .... .. ........ .... ...... .... ..... ... .. ..... ...... .... .......... .. ... ...... ..... .. 29 
Consent procedures ... ... .. .. ....... ......... .. .... ... ...... .. ... .... ...... ..... .. ...... ... ..... ...... ..... .. ... ...... .... 30 
Data Collection/Interview procedure ....... .. ..... ..... ....... ... ... ... .. ...... .. .... ... .... .... ... ... .......... 30 
Protection of privacy and confidentiality .... .......... ... ... ... ... ............ ... .... .......... ... ..... .... ... 30 
Risks and benefits of participation ....... .. ... ..... .. ... ... ..... .. ............ .... ... ............... .. ............ 30 
TIMEFRAME ...... .. ... ... .... .... ... ........... ....... .......... ... ....... .. .... .... ... ...... .. ....... ... ..... .... .. ... .. .. ... 30 
RESULTS - CLIENT DAT A ...... ............ .. ... .. .... ........ ... ... ..... ...................... ..... ......... .... ... 31 
Client Characteristics .... ... ... .. ......... .... .......... ....... ........... .... ..... ... ....... ... ... .. .......... .. ..... ... 31 
Awareness, Knowledge, and Use of the IUD ....... .. .... .. ............ ........ ... ....... .. ... .. ..... .. .... 33 
Attitudes towards and Perceptions of the IUD method ....... .. ... ........ .... .......... ...... .... .. ... 33 
Factors associated with awareness of the IUD method ... ... ... .... ... .. .. ....... ..... ... ...... .... .... 34 
Factors associated with ever using the IUD .. .... .. .......... ... ... .......... ........ ... ...... .. .. ....... ... . 35 
Factors associated with positive attitudes towards the IUD .. ...... .... .... ..... .... ... .. .. .... ... ... 35 
Factors associated with considering use of the IUD ...... ... ......... ... .. ........... ... .. ... ....... ... . 36 
Logistic Regression Models ........ ..... ........ ............ .... ... ..... ............. ...... ..... .... ........... .. .. .. 37 
RESULTS - PROVIDER DA TA ... ... ... ................. ... ..... ...... .. ......... ....... .. ... ....... ... ..... ....... 37 
Provider Characteristics ..... ........... .............. ..... ... ... ..... .............. .... .. .... ..... ..... ....... ... .... .. 37 
IUD Knowledge .. ............. .......... ..... .... ....... .. ....... ...... .. ... .. ................ .. ... .... ........... ......... 38 
IUD Practices ........ .. ..... .... .............. .... .... ... .. ... ..... .. ... ..... ...... ... .. .. .. ........ .... .... ..... ..... ..... .. 39 
JUD Attitudes and Perceptions .... ......... .. ......... ... ... ............ ... .... ...... ..... ..... .. .. ... .... ..... .... 39 
Training needs ... ........ ........ .............. ............ ...... ......... .... ...... ...... .... .......... ... ... .... .. ......... 40 
DJSCUSSION ..... ...... ..... ..... ...... ........... ... .... ......... .. .... ...... ..... .... ..... ............... ... ... .......... ... . 41 
ACKNOWLEDGEMENT .. .......... ... ........ ..... .. .. .... ..... ...... .... ..... ... .......... ...... .. ....... .... ....... . 48 
REFERENCES ........ .. .. ............. ........ ...... ..... ...... .. .. .... ..... ........... ... .... ....... .. ... ..... ... ..... .. ...... 49 
OTHER RESOURCES ........... ......... ................. .... .... ........ .... .... ..... .. ........ .. ... ..... ..... ... .... ... 53 
APPENDICES ....... .... .. .... ..... .... ......... ... ... ....... ........... ... ......... ... .... .... .... .. ... ... ..... ..... ...... .... 54 
Appendix 1 - Client Questionnaire .... ..... ... ..... ..... ... ... ....... .... .... .. .... ..... .. ................ ..... .. 54 
Appendix 2 - Provider Questionnaire .. .... ... .. ....... .... ........ ..... .... .... ..... ... ........ .. ... .. .. .... ... 64 
Appendix 3A - Participant consent form ...... .... .... ............ .... ..... ....... .. ..... ... ... ..... ......... . 74 
Appendix 3B - Provider consent form ......... .... .... ....... ...... .. .. ... .... .. .. ...... .. ... ..... ......... ... 76 
Appendix 4 - Project Timeline ......... ........................................ .. .. ........ .... ...... ... ... .. ..... . 78 
Appendix 5 - Tables of Results ........ ........ ........ ..... .... ..... .... .... ... .. ..... .. ...... ... .... ...... ....... 79 
Table 5 .1: Total number of clinics and participants ............ .. ... ... ..... ... ............ ... ....... 79 
Table 5.2: Client Socio-demographic characteristics .... ..................... ....... ... ..... .. .. .. .. 80 
Table 5 .3: Sexual and Reproductive characteristics of Clients .. .. ..... ..... ... .. .. ... ...... ... 81 
Table 5.4 : Contraceptive characteri stics of Cl ients .. ... ... .... ........... .. ..... .... ........ ........ . 84 
Table 5 .5: Client Awareness, Know led ge and Use of the IUD ........... ..... .......... ...... 86 
Table 5.6 : Client ' s attitudes towards the IUD method .. ...... .......... ........ ...... ... ......... .. 88 
Table 5 .7: Awareness of IUD by clini c .... ..................... ......... ....... ..... ....................... 90 
Table 5 .8: Client Characteristics Associated with Awareness of JUD ................ .. ... 9 1 
Table 5 .9: Client Characteristics Associated wi th Ever Use of IUlJ ....... ................ . 92 
Table 5 .10: C lient Characteristics Associated w ith Positive Attitudes about IUD ... 93 
Table 5 .11 : Client Characteristics Associated with Considerin g IUD use in the 
Future .. ............... ........ ... ....... ..... .. ............. .............. ... .. ....... .......... ................ .... .... .. .. . 95 
Table 5.12 : Respondent ' s feelings about whether the IUD is eas ier or harder to use 
than other contracepti ve methods ...... ........ ...... ................... .. ..... ........... ........ ....... .... .. 96 
Table 5 .13 : Logistic regression model for factors associated w ith awareness of IUD 
.. ................ ..... ... ..... ... .. .... .. ... .. ...... .. .... .... ..... ... ... .... ..... ..... ..... ....... ........ ... ...... ... ... ...... .. 97 
Table 5.14: Logistic regression model for factors associated with positi ve attitudes 
towards the IUD .................. ... ....... .. ... .. ......... ....... ........ .. ............. ....... .. .... ............. .... 98 
Table 5.15: Logistic regression model for factors associated w ith cons idering IUD 
use in the future .. .. .. .... .. ........... ..... ...... ... .. .. ... .. ....... .... ..... ... ....... ....... ......... .... ... ........ .. 99 
Table 5.16: Provider Characteri stics ..................... ...... .... .... .... .. .... ........ .. ..... ....... .... 100 
Table 5 .17 : Provider Knowledge about the IUD ..... ...... ... .. .. .......... ......... ... ...... ..... . 101 
Table 5 .18 : Provider practices related to the IUD method ... ........ ...... ... ...... ........ .... I 04 
Table 5.19: Provider attitudes related to the IUD method ......... ... ... ........... ... ...... ... 106 
Table 5.20 : Provider perceptions of the IUD ......... .. ... .... .. .... ... ...... ... ... .. ........ ....... .. 108 
5 
ABSTRACT 
The intrauterine device (IUD) is a safe, effective, convenient, reliable, inexpensive, and 
cost effective form of reversible contraception. It rivals female sterilization, injectables, 
and implants with respect to effectiveness in pregnancy prevention . Once inserted, IUDs 
are nearly maintenance free; some IUDs can even be used for over a decade. In many 
settings however, the utilization of this form of contraception is poor and a number of 
barriers to usage exist. These barriers often relate to lack of knowledge and 
misperceptions among both potential users and healthcare providers. 
The IUD is a reliable option that may be an ideal form of contraception for many women 
in South Africa. In order to make this method available on a wider scale, it is necessary to 
provide correct information to women and health care professionals and to increase the 
availability and use of this highly effective method. 
We conducted a cross-sectional descriptive study designed to assess the current 
knowledge, attitudes, and practices of potential users and health care providers with 
respect to the IUD. We recruited 205 women between 15 to 49 years of age who were 
attending family planning and ST! care services at four primary level public clinics (two 
in the more urban Western Cape Province and two in the rural Eastern Cape Province in 
South Africa). In addition, we interviewed 32 providers from 12 clinics (six clinics per 
province). Ethical approval for this research was obtained from both the University of 
Cape Town and Walter Sisulu University (formerly the University of the Transkei). 
Permission was also given by the local and provincial health services. 
Among clients, knowledge of the IUD was poor. About 26% of women had heard of the 
IUD. After the method was explained to them, 89.7% of women believed that there were 
advantages to using the IUD and 72. 7% of ,vomen said that they would consider using 
the JUD in the future. Also, women thought the IUD was an easier contraceptive method 
to use than oral contraceptive pills, injectables, male and female condoms, and female 
steri I ization . 
Logistic regression modeling showed that, after adjusting for level of education, being 
from the Western Cape, older age, and having heard of emergency contraception all 
independently predicted awareness of the IUD method. 
For the most part, providers knew how the IUD worked to prevent pregnancy; however 
providers were lacking in more detailed knowledge about the method and had 
misinformation about the IUD. Almost all (93 .6%) of providers recognized their need for 
more information and training about the IUD. Providers reported that barriers to IUD 
usage in South Africa were lack of knowledge of the method on the part of providers 
(84.4%), a lack of trained providers to insert or remove the IUD (62.5%), limited 
availability of the device at health facilities (56.3%), and a lack of knowledge on the part 
of potential users (46.9%). Despite these barriers, 81 % of providers believed women 
would be interested in the IUD if they knew about it and 73.3% believed the IUD should 
be promoted in South Africa. 
Our results suggest that the IUD vvould be a welcome addition to the contraceptive 
method mix in South Africa and that both clients and providers would be interested in 
this method. It is clear that awareness campaigns among women seeking contraception 
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would be necessary for building support and publicizing the IUD. It will also be 
necessary to train and educate providers, focusing on up to date information, dispelling 
myths, and proper insertion and removal techniques. South Africa could re-introduce the 
IUD into the contraceptive method mix and increase women's choice by adding this 
valuable, viable, and sustainable option to the contraceptive method mix. The findings of 
this study, which was requested by the provincial health services, will be used to inform 
policy and as a starting point for assessing the feasibility and acceptability of a greater 
role for the IUD in the contraceptive method mix in South Africa. 
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BACKGROUND 
Types of IUDs 
IUDs can be classified as being either inert and unmedicated, or medicated, with 
either copper or hormones added. The first modern IUDs appeared in the 1960s and 
were made of polyethylene, an inert plastic. At that time. models such as the Lippes 
Loop, Marguiles Spiral, Saf-T-Coil , and others were on the market [1]. The Lippes 
Loop was the most widely used unmedicated IUD at the time [2) . 
It was later found that adding copper to the plastic produced an IUD that was more 
effective at preventing pregnancy and caused fewer bleeding problems [I]. The first 
generation of Copper IUDs, the Cu-7 and the TCu-200 had fewer side effects, less 
bleeding and were just as effective as earlier models at preventing pregnancy. These 
IUDs were only effective for two to three years and so the second generation of 
copper IUDs was developed to provide longer pregnancy protection than their 
predecessors. The vertical and horizontal arms of these second generation 1UDs 
contain copper. Some currently available copper IUDs are the Copper T3 80A (TCu 
380A), Multiload-375, TCu-220C, and the Nova-T. The TCu 380A is the most 
frequently used IUD in the world (See Figure 1) [3]. A variation on the tradition 
copper T model is the frameless IUD (FlexiGard), which is a single monofilament 
polypropylene string, knotted at both ends, with six copper bands surrounding the 
thread [ 4]. Although this design may be better suited to nulliparous women and those 
with a smaller uterine cavity, the cumulative expulsion rate for the FlexiGard is 
significantly higher at all intervals when compared to the Copper T380A [5]. This 
model is not widely used. 
Figure I: Copper T380A (TCu 380A). 
ai 
-I 
Hormone-releasing IUDs constantly release sma11 amounts of steroid hormone into 
the uterus. The levonorgestrel-releasing IUD, marketed under the name Mirena, was 
first available in 1990 and delivers 20 ug of the progestin levonorgestrel per day over 
5 years although data support its effectiveness for as long as 7 years (see Figure 2) 
[3,6]. 
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Figure 2: The levonorgestrel-releasing IUD (Mirena). 
Mechanisms of Action 
The IUD is a small device that is inserted by a trained health care provider. It is 
inserted via the cervix into a woman's uterine cavity to prevent pregnancy. Different 
IUDs work as a contraceptive through varied mechanisms yet all IUDs make 
fertilisation very unlikely. 
The older and more commonly available copper containing IUDs are spermicidal and 
inhibit sperm transport, mobility, and viability. These IUDs work by preventing 
fertilization rather than inlt:rft:ring with implantation. The copper ions released from 
the device are toxic to sperm and interfere with sperm movement, inhibit sperm 
penetration into the egg, change the transport speed of the ovum and damage it, and 
create a foreign body inflammatory reaction that results in a spermicidal endometrium 
[7]. The contraceptive efficacy of copper IUDs is directly correlated to the surface 
area of copper in the endometrial cavity [8]. These preferlilisalion effects constitute 
the primary mechanism of action for pregnancy prevention in the copper IUD. In this 
way, copper IUDs are mainly contraceptive and not abortifacient. 
The main mechanisms of action of the newer and less commonly available 
progesterone-releasing IUD (Levonorgestrel) is to change and thicken the cervical 
mucus and render it impenetrable to sperm while the plastic IUD frame induces a 
foreign body inflammatory response in the endometrium, although to a lesser degree 
than the copper IUD (see Figure 3). The endometrium is converted to be insensitive to 
ovarian estradiol and there are only limited effects on the pituitary [9]. The levels of 
progesterone in the device are insufficient to affect ovulation [10]. 
Figure 3: An internal view of the Mirena IUD and how it works as a contraceptive. 
th n,-,l"'l) 01 tr: ll"T:J 
of mt u:erLs 
Source: Berlex-Mirena US, www.mirena-us.com 
spe.rrn 111: 01:rnenl 
t·u::~er r;i ol : • 
cervical nu, cus 
For all IUD types, the return to full fertility is rapid after the removal of the device. 
The median time to planned pregnancy following removal of the copper IUD is about 
three months [10]. In a study of 810 women who requested IUD removal for planned 
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pregnancy, 361 (44%) conceived within 5 months and 671 (86%) conceived within 
one year of removal [11]. Younger women have been found to have a faster and more 
complete return to fertility, but after controlling for age, the duration of use has not 
been found to have an impact on the time to return to fertility [ 1 O]. 
Efficacy of the IUD 
IUDs are very efficacious with respect to pregnancy prevention. The pregnancy rate 
for all major IUD types is Jess than one per 100 women per year [2] . IUDs are just as 
effective as hormone implants, injectable contraceptives, and voluntary male and 
female sterilization [2]. The TCu 380A and the levonorgestrel-releasing IUD have 
been shown respectively, in clinical trials, to be 99.2% and 98% effective at 
preventing pregnancy in one year of typical use [12]. Another study found that after 
tubal ligation, the Jevonorgestrel IUD and the TCu 380A were the second and third 
most effective contraceptive options [13]. Modem IUDs prevent pregnancy so well 
that they avert deaths that would have been due to pregnancy-related causes [2]. 
Studies have consistently shown copper IUDs to be very efficacious. In a large study, 
less than one woman per 100 became pregnant in the first year of use and in another 
study only 2.1 per 100 became pregnant in ten years of use [2]. ln a large randomized 
trial. the copper IUD was found to have a failure rate of 1.26 per 100 woman-years 
and was associated with a rate of ectopic pregnancy of 0.25 per 100 woman-years . 
Although the device is approved for use up to ten years, data support high efficacy 
rates as long as 12 years [3]. In a recent study, no pregnancy was observed in 366 
woman-years of observation beyond ten years of use and the authors found no 
evidence that the TCu 380A IUD loses its effectiveness after IO years of use [14]. 
The levonorgestrel releasing IUD may be the most effective IUD with just 0.3 
pregnancies per 100 women after five years of use [2, 10, 15]. However, another 
study has shown that levonorgestrel IUDs are no more effective than copper IUDs, 
such as the TCu 380A, which use more than 250mm2 of copper. For the 
levonorgestrel system, the failure rate has been found to be 0.09 and the ectopic 
pregnancy rate is 0.02 per 100 woman-years [16]. 
Due to their high efficacy rates, IUDs tend to be used longer than any other reversible 
contraceptive method (2, 17] . Women who use the IUD report high levels of 
satisfaction across many settings (18, 10, 20, 21, 22]. Continuation rates for both the 
copper and Jevonorgestrel IUDs are similar. At one year, continuation rates for the 
IUD are high at around 80% while they are between 38 to 50% after five years of use 
[20, 23]. One study in Kenya comparing the IUD, the injectable, and oral 
contraceptive pills found that the IUD had the lowest rate of discontinuation with 20% 
of users as compared to 80% for pills and 39% for the injectable after one year [19]. 
A study in Turkey found that mean duration of use was 5.8 years [17]. 
After IUD insertion, uterine contractions can sometimes push the IUD downwards 
leading to either partial or complete expulsions of the device. Most expulsions occur 
in the first year and especially within the first three months after insertion [2, 9, 23]. 
Expulsion rates vary from less than one to more than 7 per 100 women in the first 
year of use [2]. Another study found that between 2% and 10% of IUD users 
spontaneously expels their IUD within the first year [16]. However, failure rates for 
the IUD shortly after insertion also seem to decrease with the experience of the 
provider. One study showed that doctors with limited experience had twice the failure 
rate of experienced doctors and those doctors who were inexperienced had three times 
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the failure rate [24]. Partial or complete expulsions can lead to unplanned 
pregnancies. Among copper IUD users, partial expulsions outnumber complete 
expulsions by more than a factor of three [ 1 O]. Younger women, women who have 
never given birth before, and women with heavy periods or severe dysmenorrhoea are 
more likely to expel their IUDs [12, 16]. Correct insertion of the IUD placed high up 
in the fundus is thought to reduce the chance or expulsion [ 10, 12, 25]. 
Major and Minor Side Effects 
In general, women report fewer side effects with the IUD than with oral, implantable, 
or injectable contraceptives [23]. However, as with most other methods of 
contraception, the most commonly cited reason for discontinuation of both the copper 
and hormone-releasing IUDs are side effects [17, 19, 23]. Most of these side effects 
relate to changes in bleeding patterns or menstrual problems such as amenorrhoea, 
spotting or irregular bleeding, or increased menstrual bleeding [9]. The cumulative 5-
year termination rate because of bleeding problems is up to 20% for the copper IUD, 
which can increase blood loss by about 50 to 75%, and up to 14% for the 
levonorgestrel system [9, 16]. For copper IUDs, commonly reported side effects are 
heavier and increased menstrual bleeding for the first 3 to 6 months after inse11ion, 
dysmenorrhoea, and cramping, pain, or spotting after insertion [22 , 26]. 
For the levonorgestrel IUD, the side effects are similar to those of other hormonal 
contraceptives. These include acne, dizziness, headaches, nausea, depression, breast 
tenderness, vomiting, weight gain and ovarian cysts [l 5] . As compared to copper 
containing IUDs, hormone releasing IUDs are more likely to induce amenorrhoea or 
irregular spotting [ 10, 12, 15]. Most women with the levonorgestrel IUD ovulate 
normally but experience diminished menstrual bleeding because the levonorgestrel 
released by the IUD concentrates in the endometrium, decreases the thickness of the 
endometrium, and reduces the amount of endometrial shedding [9, 25 , 27]. In a large 
trial comparing the levonorgestrel system with the copper IUD, one third of women 
using the levonorgestrel system immediately, and 70% of women by the end of two 
years, developed oligomenorrhea (no more than one episode of bleeding in a 90 day 
period) or amenorrhoea [27]. The number of bleeding days as well as the amount of 
bleeding decreases compared to a normal menstrual flow with use of the 
levonorgestrel IUD and so the device has been used successfully to treat menorrhagia 
(excessive menstrual flow) [3, 9, 27]. 
Safety Issues 
The IUD is one of the safest and best tolerated methods of contraception available [I]. 
Serious morbidity from IUD use is rare but there are certain risks related to the 
method such as intrauterine pregnancy or spontaneous abortion, uterine perforation, 
pelvic inflammatory disease and related infertility, ectopic pregnancy, and mortality 
[28]. Some risks also relate to insertion and removal. Please see the insertion and 
removal section for more detail. 
• The Risk of Intrauterine Pregnancy While an JUD is Inserted 
Although it is a very rare occurrence given the high efficacy of the IUD method, 
spontaneous abortion is the most frequent complication of pregnancy with an IUD in 
place. Greater than 50% of uterine pregnancies spontaneously abort if the IUD is not 
removed and more than half of those occur in the second trimester [2, 8]. If pregnancy 
is confirmed in an IUD user, the IUD should be removed as soon as possible. 
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Removing the IUD immediately reduces the risk of spontaneous and septic abortions 
to the same level faced by other women [2] . An IUD that is left in place however 
during pregnancy increases the risk of premature delivery by about four- fold although 
it does not increase the chance of other complications such as birth defects, genetic 
abnormalities, or molar pregnancy [2, 8]. 
• The Risk of Uterine Perforation 
In a very small proportion of cases, an IUD, particularly if not correctly inserted, can 
perforate the wall of the uterus. Perforation of the uterus happens when the IUD, the 
inserter tube, the uterine sound (a tool used to determine the depth of the uterine 
cav_ity), or another gynaecologic instrument used during insertion, pierces the uterine 
muscle wall. Perforations can be partial, with just part of the IUD piercing the uterine 
wall or cervix, or complete, with the IUD passing through the uterine wall into the 
abdominal cavity [2]. A partial perforation of the uterus often heals quickly with no 
treatment required. By using careful and contemporary insertion techniques, in which 
the IUD is placed high in the fundus , the risk of uterine perforation approaches zero 
[ 1 O]. In large clinical trials, perforations have been rare with no more than 1.3 per 
1000 insertions [2] . However, perforations may go unnoticed at the time of insertion. 
• The Risk of Pelvic Inflammatory Disease (PID) Associated with 1he IUD 
Early studies on the IUD suggested a causal association between use of the method 
and an increased risk of PIO. This association has subsequently been disproved. 
Concern about a causal association between IUDs and PIO has been a major barrier to 
the increased use of the method. 
PID is a broad term for any infection ascending from the cervix into the uterus, 
fallopian tubes, and ovaries. PID can be caused by either sexually transmitted 
infections or the introduction into the uterus of bacteria from the vagina or outside 
contamination [29] . Among women who have active STls, it is hypothesized that 
when an IUD is inserted, sexually transmitted microorganisms that may be present in 
the endocervical canal could be transported into the uterine cavity [30) . For all 
women, not just IUD users, the complications of PID can be severe with a single 
episode permanently damaging the lining of the fallopian tubes. This can partially or 
totally block one or both tubes and lead to a higher risk of ectopic pregnancy or 
infertility [2]. PID, and not the IUD, is the cause of infertility. In a case control study, 
the odds ratio for tubal occlusion associated with previous use of a copper IUD was 
1.0 showing that there was no association between IUD use and infertility [31]. Tubal 
infertility was also not associated with the duration of IUD use. 
The risk of upper genital tract infection associated with IUDs is temporarily linked to 
insertion. Research has shown that the risk of PIO after the first month following 
insertion of an IUD is small [32]. The first large cohort study done in the USA in the 
1960' s found that the risk of PID was inversely related to the time since IUD inse1tion 
[32]. PIO infections due to IUD use are concentrated in the 20 days following 
insertion and are caused by poor infection prevention techniques at insertion [2]. The 
absolute risk for PID in the 20 days following insertion has been found to be about 
1% [10) . Additionally, in 22,908 IUD insertions, investigators found a risk of PIO 
after 20 days of 1.4 cases per 1,000 woman-years of use, compared with 9.7 cases per 
1,000 woman-years in the first 20 days following IUD insertion [27] . Therefore, PIO 
is an uncommon event in IUD users both before and after the first 20 days following 
insertion. 
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The risk of infection with IUD use is related to a woman's underlying risk of 
acquiring sexually transmitted infections. In settings where STis are uncommon, IUD 
related PID is rare. In a large WHO report, 403 I women in China had IUDs inserted 
but no participant developed PID during 9197 woman years of observation. However, 
in Africa, where STis are more prevalent, there were eight cases of PID that occurred 
during 1292 woman-years of follow-up [27, 32]. Any woman with a cervical 
infection, particularly gonorrhoea or chlamydia, is at a greater risk for developing PIO 
than an uninfected woman [33, 34]. If an IUD is inserted in the presence of 
gonorrhoea or chlamydia, the risk of symptomatic PID ranges from 3.1 to 5.3% [33]. 
Even HIV infection does not increase the risk of PID related to the IUD while 
gonorrhoea and chlamydia do [32]. If no sexually transmitted bacteria are present at 
the time of IUD insertion, none can be pushed up into the uterus and there is no risk 
of IUD-related PID. Therefore, the IUD is very safe in situations where it is possible 
to determine if women are free of infection at the time of inse1tion [29]. The greatest 
risk factor then for PID in IUD users is multiple sexual partners and the associated 
higher exposure to STis [IO] . In another study, among a population with an STI 
prevalence of 10%, the risk of PID attributable to IUD insertion was 0.15%, less than 
1 in 600 women [33]. The absolute risk of PIO among women with STis at the time 
of IUD insertion is low [30]. 
It has also been established that copper JUD use is not associated with an increased 
risk of infertility due to PJD in nulliparous women at low risk of STis [27]. To 
counter the effect of possible STis and related PIO, it has been suggested that using 
antibiotic prophylaxis before IUD insertion might decrease the subsequent risk of PID 
but meta-analyses have concluded that such prophylactic antibiotics confer little 
benefit [27]. If a woman does develop an STI or PJD while using an JUD, the WHO 
has determined that it is possible for the woman to continue using the IUD while the 
infection is treated with appropriate antibiotics since removal of the IUD does not 
affect the clinical course of PID [35, 36]. 
The risk of PID among IUD users is low and any increased risk among IUD users 
relates to a higher background prevalence of STis. Thus, health care providers need to 
have the ability to identify pre-existing cervical infections, treat them, and insure 
aseptic conditions for insertion. When these criteria are met, IUD users are not at a 
greater risk for PID related infertility than non-users [29, 30]. 
• The Risk of Ectopic Pregnancies 
A recent meta-analysis of 16 case-control studies concluded that IUDs do not increase 
the risk of ectopic pregnancy compared to non-IUD users [27]. The copper IUD has 
been shown to reduce the risk of ectopic pregnancy significantly when compared with 
the risk in women using no method [10, 25]. Although the IUD reduces a woman's 
baseline risk of tubal pregnancy, it does not protect against ectopic pregnancy as well 
as it protects against intrauterine pregnancy [1 O]. If pregnancy does occur while an 
IUD is in place, it is more likely to be ectopic and such an implantation must be ruled 
out [27, 37]. Studies have suggested that in the rare event of a woman becoming 
pregnant while using the IUD, the risk of ectopic pregnancy ranges from 5 to 20% 
[I 0, I 6]. US cohort data with both the TCu 380A and the levonorgestrel intrauterine 
system have shown an ectopic pregnancy rate of O to 0.5 per 1000 woman years, 
compared with an ectopic pregnancy rate of 3.25 to 5.25 per 1000 woman-years 
among women who do not use contraception [27]. Due to this low risk, concerns 
about ectopic pregnancy should not be a reason for discouraging JUD use. 
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• Mortality Rate 
With respect to mortality, use of a contraceptive method is generally far safer than 
pregnancy. Although it ranges, one in 8,700 women die due to pregnancy yearly 
while it is estimated that there are about one to two deaths per 100,000 IUD users per 
year [38]. When they occur, these deaths are usually as a result of infection, ectopic 
pregnancy, or second trimester septic abortions [2, 4]. In every 5-year age group, from 
15 to 44, the IUD has the lowest estimated mortality rates of any contraceptive except 
for vasectomy [2]. 
Advantages and Disadvantages of the IUD 
The IUD has many advantages over other contraceptive methods. It is safe, highly 
effective, long-acting, convenient, and private. The method is especially easy to use 
because no constant re-supply is necessary for compliance. For that reason, few 
women using the IUD present with unintended pregnancy [39]. It can be inserted at 
any time in a woman's menstrual cycle, immediately after delivery or following an 
abortion. It does not interfere with sexual intercourse or any type of medication and 
women report that the IUD has a positive impact on their sex life [I , 7, 22]. It has a 
long life span and requires fewer visits to health providers than other methods, which 
means less expenditure of money, time, and effort for users and the health service. 
Once the IUD is inserted, it is immediately effective and no additional contraceptive 
protection is needed [1]. In addition, it requires little maintenance or action on the part 
of the user. The IUD has fewer adherence issues than other methods since women 
need not adhere to a daily regimen of pills or intermittent injections. Once the IUD is 
in place, the user does not have to do anything to maintain contraceptive protection 
for I to IO years unless the device is expelled, which is a rare occurrence. 
The IUD is an ideal option for certain groups of women for whom other long-term 
methods may not be fully appropriate or desirable. The IUD is a method that can be 
used by breastfeeding women since the copper IUD has no known effects on 
breastfeeding or the volume or composition of breast milk as hormonal contraceptives 
do. Once an IUD is removed, full fertility returns quickly and so it is a good method 
for those who want to space births. Women who use IUDs for long periods of time 
conceive just as rapidly as short-term users of the method [2]. 
As a reversible contraceptive method, the IUD is an appropriate option for women 
who do not want to have more children but who do not want to opt for sterilization. 
Some women who undergo sterilization later express regret. One study found that in 
14 years post-sterilization, the characteristics most associated with regret were being 
30 years of age or younger (20.3%), African American (21.7%), or unman-ied 
(20.4%) [ 40]. The IUD would be a much better idea than sterilization for certain 
women who still might want to have children in the future. 
The levonorgestrel device has particular advantages for women with heavy menstrual 
flow because it tends to reduce the amount and duration of bleeding. Hormone 
releasing IUDs can be used as part of hormone replacement therapy and can be used 
to treat menorrhagia, anaemia, and can even be used as an alternative to hysterectomy 
for women with bleeding problems [3]. Progestin-releasing devices also reduce the 
amount of bleeding from uterine fibroids but do not reduce the size of fibroids. 
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The IUD can be used as a form of emergency contraception and can be retained for 
continued long-term contraception. Inse11ion of an IUD as a form of emergency 
contraception within 5 days of intercourse has been shown to be safe and effective at 
preventing pregnancy 98 to 99% of the time [ 1, 37] . A recent study of 1013 women 
who underwent insertion of a copper IUD for postcoital contraception, including 170 
nulliparous women, found a pregnancy rate of 0.2% [27]. 
The IUD also has many non-contraceptive health benefits. For example, six out of 
seven studies suggest that the copper IUD has a protective effect against endometrial 
cancer (2, 3, 34]. Although the evidence was not strong, two studies have also 
suggested modest protection against cervical cancer [2, 32]. 
There are also disadvantages to IUD use. IUDs offer no protection from STis and so 
women must always be counselled about condoms and dual protection if they use this 
method. IUDs can occasionally be expelled without the knowledge of the user. With 
copper IUDs, the number of bleeding days is slightly higher than normal and there 
may be somewhat increased menstrual cramping, especially during the first 3 to 6 
months of use (l]. Also, since copper IUDs can increase menstrual blood loss and 
since excessive menstrual blood loss is the most common cause of anaemia in fe11ile 
women, this may be a concern for women in developing countries where poor 
nutrition or diseases may contribute to iron-deficiency (9]. For users of the 
levonorgestrel IUD, amenorrhoea may also be a concern. IUD users may be more 
likely to develop non-specific vaginitis [2]. Lastly, the device must be inserted and 
removed by a trained provider and this has financial and resource implications for its 
users. Also, since women who have an IUD inserted do not have to come in regularly 
for check-ups, it is possible that some clients may lose contact with the health care 
system. 
• Long Term Cost effectiveness of the JUD 
Contraceptives save health care resources by preventing the substantial costs related 
to unintended pregnancies. Over time, the IUD is a cost effective option for both 
family planning programmes and users. It is a very economical option for the health 
care system since government procurement and service delivery costs of the IUD are 
low compared to other contraceptive options and it is inexpensive to produce [I]. The 
average annual cost of the IUD decreases over time when compared to other methods. 
After about 3 years, the IUD works out to be cheaper than 39 cycles of oral 
contraceptives [16]. The levonorgestrel intrauterine system was shown to be the most 
cost-effective reversible method of contraception after 5 years of continuous use 
while the copper IUD has been shown to be the most cost-effective method after just 
two years of use [27]. Another study showed that after accounting for all costs, the 
least expensive contraceptive methods were the levonorgestrel IUD and then the 
CopperT 380A IUD at a five-year cost of $1646 and $1678 respectively [13]. 
Another study showed that over 5 years, the Copper-T IUD saved $14,122 in medical 
costs when compared to using no method [ 41]. In just two years of use, the Copper-T 
IUD is less costly than the injectable (41]. Although IUDs can have high costs for the 
actual device, they have lower total method costs and better effectiveness when 
compared with hormonal and barrier contraceptive methods [13]. Overall, when all 
program costs are taken into account (staff time, follow-up visits) the JUD is the most 
cost effective method a health care system can offer [42]. However, although the 
long-term costs of the IUD are low, the up front costs of the device and its insertion 
may be prohibitive for clients living in countries where healtncare services are not 
free. In the South African public sector however, clients are not charged for 
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contraceptives and so this barrier would not exist. Therefore, in South Africa, making 
the IUD available would increase contraceptive choice without any financial burden 
to the client. 
IUD Candidate Selection: Indications and Contraindications 
Women of any reproductive age or parity can use an IUD as long as they have no 
health conditions that preclude IUD use [2, l O] . Women who have an active ST! , 
unexplained abnormal vaginal bleeding that may suggest a serious medical problem, a 
severely distorted uterine cavity that precludes proper IUD insertion, cervical , 
endometrial, or ovarian cancer that is awaiting treatment, are currently pregnant, or 
have pelvic tuberculosis should not use IUDs [43]. 
• Parity 
Both parous and nulliparous women can use the IUD method. The ideal candidate for 
IUD insertion is a parous woman with no history of PID who desires long-term 
reversible contraception and who is in a stable, mutually monogamous relationship 
(therefore putting her at low risk for STis). Women who are nulliparous can also 
safely use the IUD. However, IUD insertion through a cervix that has not been 
previously dilated may be more challenging and expulsion and failure rates are 
slightly higher for nulliparous women because the uterine cavity is smaller in women 
who have not had a vaginal delivery [24] . 
• STI Risk 
Having an active STI, or having had an STI within the last three months, is a 
contraindication for IUD insertion. Women who have had PID more than three 
months ago, with or without a subsequent pregnancy, may use IUDs. IUDs should not 
be used in women who have an active case of PIO or in women who have had PID 
within the last three months [27, 43]. 
• HIV infection 
HIV-positive women have a critical need for safe and effective contraception to avoid 
unwanted pregnancy and vertical transmission of the virus. Recent research has 
suggested that the IUD is a safe and acceptable contraceptive method for 
appropriately selected HIV-infected women with continuing access to medical 
services [34]. The IUD is not associated with any increase in the risk of HIV infection 
[36, 44]. Although hormonal contraceptives have been associated with an increased 
prevalence of cervical shedding of HIV-1 DNA among infected women, no evidence 
exists that suggests that IUD use increases an HIV-positive woman' s risk of 
transmitting the virus to a sexual partner [35, 36]. In one study, the insertion of an 
IUD did not significantly alter the prevalence of cervical shedding of HIV-] infected 
cells [ 45]. A recent study also found no relationship between HIV-infection status and 
risk of overall IUD complications or infection-related complications [ 46]. Yet another 
study found that HIV-infected and non-infected women were at similar risk for 
overall IUD complications [ 4 7]. Although cervical infections may be more common 
among HIV-infected women as compared to non-infected individuals, it should be 
cervical infection, rather than HIV status, that precludes use of the IUD method. In 
the face of this new data, the WHO medical eligibility criteria for the IUD states that 
women at high risk of HIV and women infected with HIV can safely initiate and 
continue use of the IUD. They further recommend that should a woman who is HIV-
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positive develop AIDS, an already inserted IUD need not be removed. However, they 
suggest that women who did not have an JUD prior to developing AIDS should not 
initiate use. Women who are taking ARV therapy and are clinically stable can either 
initiate IUD use or continue using the method [35]. 
Use of the IUD may be acceptable in addition to condoms as an appropriate method 
of contraception for HIV infected women from the potential infectivity to the male 
partner [45]. Although the IUD may be an appropriate contraceptive option for HIV-
infected women, it does not protect women from contracting or passing along STis 
and so it is necessary to promote this method within the context of dual protection 
where the importance of condoms will continue to be stressed. 
Insertion and Removal Issues 
• Insertion 
Inserting an IUD is a simple outpatient procedure that can be preformed by 
appropriately trained primary health care providers. The IUD can be inserted any time 
in a woman's menstrual cycle when it is reasonably certain that she is not pregnant 
[26]. However, expulsion rates for the first three post-insertion cycles were reduced 
by more than 30% when insertion was delayed until the end of menses [IO]. The 
optimal time for insertion is at the time of ovulation when the cervical canal is 
maximally dilated. Proper IUD insertion reduces the risks of pregnancy and of all 
major side effects such as expulsion, bleeding, pain, perforation, and infection. 
Access to a sterile environment and proper equipment are necessary. 
Although IUDs require only one office visit for insertion, a follow-up visit should be 
planned for 3 to 6 weeks after insertion (after the next menses) to address any adverse 
events such as expulsion or insertion related infection. Further routine visits are not 
required and are not effective at reducing the risk of method related side effects [48]. 
Women should be encouraged however to return any time they have problems, 
questions, concerns, cannot feel their strings, or wish to have the device removed. 
Complications at the time of IUD insertion are very rare. However, difficulties that 
may occur at the time of insertion include vasovagal reaction, the need for cervical 
dilation, severe pain, inability to insert the IUD, and uterine perforation (27]. Uterine 
perforation, the complication of greatest concern, is estimated to occur in 
approximately I in 1000 insertions although this risk appears to decrease with the 
increasing experience of the practitioner (10, 24, 27]. 
• A special case: Postpartum I Post-abortion insertion 
Since the l 960's, it has become popular to insert IUDs in the postpartum period. Most 
data that is currently available suggests that insertion immediately postpartum has 
better outcomes than delayed insertions. One study found that the six-month 
cumulative expulsion rates were lower in immediate insertions (those within JO 
minutes of delivery of the placenta) as opposed to delayed insertions (within 72 hours 
of placental expulsion) [ 49]. In one study by <;elen et al., it was found that the Copper 
T380A IUD, when inserted within 10 minutes of placental expulsion in both vaginal 
and caesarean deliveries, had a one year cumulative expulsion rate of 12.3% [50]. 
This was regarded as a standard expulsion rate for immediate post-placental insertion. 
Immediate postpartum insertions are associated with a low risk of uterine perforation 
and expulsion. 
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The major disadvantage of postpartum insertion is the chance of a higher expulsion 
rate following delivery as opposed to any other time for insertion [50]. The IUD is 
more easily expelled if inserted soon after childbirth because the uterus is contracting 
and the cervix is dilated [2]. Expulsion rates are lowest when the IUD is inserted 
within IO minutes of placental delivery, when a copper IUD is used rather than other 
models, and when the provider is skilled and experienced and places the IUD high in 
the fundus [2]. The difference in expulsion levels may be due to the fact that 
immediate placement of the IUD high in the fund us after placental expulsion is easier 
than at a later time [ 49]. Insertions can also take place after a caesarean delivery and 
this procedure has also been found to be safe and expulsion rates are low [2] . 
There are many advantages to postpartum IUD insertion. Women are known not to be 
pregnant at the time of insertion. The cervix is already dilated, therefore making 
insertion of the device easier and potentially less painful. Also, women receive 
immediate protection against pregnancy that does not interfere with breastfeeding. 
This is a good option for women with limited access to medical care where deliveries 
provide an important chance to address the need for contraception. Also, providing 
family planning at the time of childbirth as opposed to at a subsequent clinic Yisits, 
makes postpartum IUD inse11ion a cost saving opportunity for both clients and the 
health care system. 
IUDs can also be safely inserted in women who have had a spontaneous or induced 
abortion except when they have pelvic infections or septic abortions [2]. 
• Removal 
IUD removal is normally a routine and uncomplicated process that can be done by an 
appropriately trained health care provider in an outpatient setting at any point in the 
menstrual cycle. To remove an IUD, the clinician grasps the strings close to the 
cervical os with forceps and pulls slowly and gently. An IUD should be removed 
when it expires, when a woman no longer qualifies for IUD use, or when the woman 
requests removal. Reasons for removal are often side effects related to IUD use and 
the desire to become pregnant [ I 7] . 
An international multicentre study found that less than 2% of attempted IUD 
removals prove to be difficult [2]. One common reason for difficult removal of an 
IUD can be if the strings are "missing". In most cases, the strings have slipped into 
the cervical canal and can be drawn out using forceps. A less common reason for a 
difficult removal is when an IUD has partially or completely perforated the uterus or 
become embedded in the uterine wall [2] . 
Although a great deal of information does not exist, research suggests that women 
who do not return to have their IUDs removed do not become pregnant. There is no 
evidence that the method loses its effectiveness over 10 years of use [14]. 
Common Myths and Misperceptions 
Around the world, many women and health care providers hold incorrect notions or 
negative impressions of the IUD that are based on fear or motivated by rumours and 
myths. One common misperception is that the IUD can travel from the woman's 
uterus to distant parts of her body such as the heart or brain [2, 34]. In general, the 
IUD stays in the uterus and only if there is a perforation can the IUD enter the 
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abdominal cavity. However, the IUD will never go any further or travel to remote 
parts of the body. 
A number of common myths surround the IUD as it relates to sex, pregnancy, and 
fertility. Some believe that the IUD string can become hooked onto or wrapped 
around a man' s penis during intercourse or that having sex can dislodge the IUD [2 , 
18, 51 ]. Others believe that if a woman gets pregnant, the baby will be born with the 
IUD in its head or that the strings of the IUD will strangle the fetus [18, 52]. It is also 
a common belief that the IUD will delay or impair fertility or that it may cause 
infections [52]. Although misguided concerns that the IUD ,,.,,orks as an abortifacient 
have been disproved and shown to be erroneous, such ideas have seriously limited 
IUD use by many women and have prevented many providers from offering IUDs [ 4, 
18, 25]. In the past, IUDs have also been linked to any number of negative health 
outcomes. These associations have been disproved. A common belief is that the IUD 
causes cancer although there is no evidence to suggest this [18] . It is paradoxical that 
most women who do not use the IUD have negative perceptions of it while women 
who are users tend to view the method positively [ 18]. Despite the many myths and 
misperceptions, the IUD has been proven to be a safe contraceptive method. 
What is the current use of the IUD around the world? 
Worldwide, over 160 million women in 100 countries use the IUD making it the most 
frequently used method of reversible contraception [ 10, 16, 34, 53]. However, the 
method ' s prevalence varies greatly around the globe with some countries reporting 
high usage while others have almost none. The highest IUD prevalence is in China 
where 40% of women using contraception use the IUD [27]. In China, many women 
accept and like the IUD for its long life span, reversibility, high effectiveness, and 
because insertion is free. However, this high prevalence of IUD usage in China could 
be due to a limited range contraceptive method choices and the governments' "one 
child" policy. In Vietnam, the IUD accounts for almost two-thirds of all contraceptive 
use [2]. It is also a widely used method in Indonesia and Taiwan. 
IUD use is also common in parts of Europe and the Middle East. In Scandinavia, the 
IUD accounts for 18.2% of contraceptive usage. In Norway, 40% of women of 
reproductive age use the IUD [2, 25, 27]. In the United Kingdom, the prevalence of 
IUD use is 5%, in Switzerland and Germany it is 6%, and in France it is 21 % [28, 54] . 
In Western Europe, rates range from 7% to 19% while in Eastern Europe, rates are as 
high as 23% [17, 54]. The prevalence of IUD use is 11.6% in the Middle East and 
North Africa. In Egypt, Jordan, and Tunisia, 15%, 17%, and 18% of women prefer the 
IUD respectively [17]. It is the most widely used modem contraceptive in Turkey 
[ 17]. 
In Latin America and the Caribbean, the IUD is used by 8% of contraceptive users 
[54]. In Mexico, where the contraceptive prevalence rate is 70%, IUDs account for 
about 20% of the contraceptive method mix over the last 15 years [34]. Of the women 
using IUDs in Mexico, 55% adopted the method postpartum and the continuation rate 
at 1 year was 75% [34]. High acceptance of the IUD in Mexico has also been part of a 
concerted effort to reduce medical barriers to service delivery in family planning. 
In the United States and Canada, the IUD is used by a very small proportion of 
women [16] . Although approximately 11 % of women using contraception in the 
United States were IUD users at the height of its popularity in the l 970 ' s, now, Jess 
that 1 % of married women currently using contraceptives use the IUD [10, 27]. Much 
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of this is due to negative publicity relating to one particular IUD, the Dalkon Shield, 
which raised many questions about the safety of IUDs in the 1970' s. Despite the fact 
that modem IUDs are shown to be safe and effective in studies, US physicians tend 
not to recommend the method because of remaining liability concerns, Jack of 
knowledge about the device, and lack of IUD insertion skills . 
In sub-Saharan Africa, where access to all forms of contraception is generally low and 
there are a limited number of trained providers, levels of IUD use are generally the 
lowest in the world, with only about 1 % of married women using the method [2, 54]. 
In Kenya, where government facilities provide reproductive health services to over 
half of the population, staff lack the training that is necessary to insert an IUD and 
few functional referral services are in place. The wide variation of IUD use reflects 
different patterns of availability, health care provider and client perceptions, and 
cultural values. 
Figure 4: Contraceptive use among married women, late 1990s 
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Barriers to Use 
A number of barriers may limit the expanded use of the IUD; some of these relate to 
potential users and some to providers. Misinformation and myths can be one of the 
biggest barriers to JUD promotion. Many unfavourable attitudes towards the IUD are 
due to a lack of accurate knowledge among providers and potential users. To help 
make the IUD more acceptable, providers will need training and clarification on 
misperceptions. Only then will providers be able to counsel women appropriately to 
help combat and dispel rumours and myths about the IUD. 
A study in Kenya found that barriers to IUD use included poor product image, 
difficulty in shifting client preferences for particular methods, poor quality of care, 
provider bias or preference for particular methods, and most health providers saw the 
IUD as time-consuming to provide and requiring a high level of skill , concentration, 
and cleanliness [51]. There is also fear of HIV acquisition and transmission. Overall, 
not enough attention is given to the IUD method because most healthcare providers 
do not take the time to fully explain contraceptive options to patients and instead, 
promote the method that is the quickest and easiest to dispense. Since the IUD method 
is sensitive to variations in quality of care, when providers are misinformed, poorly 
motivated, and overworked, the IUD method suffers. A US study found that one of 
the top reasons that providers did not recommend the IUD was the belief that the IUD 
was not medically safe and they restricted IUD candidates very tightly on the basis of 
monogamy and history of PIO [55]. 
If IUD use is to increase, program planners will need to understand the factors 
influencing client's motivations to use the method as well provider's motivations to 
encourage the method [18] . A study in Nicaragua found that provider education 
programs are not enough to generate interest amongst clients [56]. Since health care 
providers are inserting few IUDs, educational programs need to highlight the safety of 
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the IUD and how it is possible to expand IUD use, perhaps through less restrictive 
and conservative criteria for selecting IUD candidates. Mass communication efforts 
may be needed to raise awareness among providers, clients, and the general public 
[57]. 
• Health Systems Barriers 
When considering a more prominent role for the IUD in the contraceptive method 
mix, it is necessary to address the obstacles within the health system which may 
preclude its expanded use. Especially in developing countries, many providers lack 
sufficient training, equipment, and supplies to insert IUDs. 
One key barrier is that insertion and removal of the IUD requires that providers have a 
greater level of training and skill as compared to providing other contraceptive 
methods. Relatively few health care providers have learned proper IUD insertion and 
removal techniques and there is currently a deficit of health care providers who are 
trained to offer this primary care service [ 16] . In a study that looked at provider and 
client attitudes towards the IUD, many providers reported that although they have 
preformed IUD insertions, they did not feel that they had enough practical experience 
[ 18]. A study in the United States among 811 practicing obstetricians-gynaecologists 
found that although 80% of respondents reported inserting IUDs in the past year, 79% 
had only inserted 10 or less [55]. The WHO recommends that health care providers 
need to perform at least 50 to 60 pelvic examinations and 10 to 15 IUD insertions 
under supervision before they have the skill and self-confidence to do the procedure 
alone [2]. Therefore, practical clinical training for healthcare providers is necessary 
and providers need to insert and remove IUDs regularly to maintain this skill. The 
healthcare providers' training and experience, particularly with insertion technique, 
are especially important and may make more of a difference to IUD performance than 
the design of the IUD [2]. 
The health systems ability to provide the IUD is also affected by the amount of 
counselling that women require before the device can be inserted. The IUD is meant 
to be a long term method that stays in place and provides pregnancy protection for a 
number of years. Women need to be counselled before the IUD can be inserted. First, 
in terms of patient load, providers and facilities may not feel that they can devote the 
necessary time to counselling potential users about the method. Ideally, a full 
reproductive history should be taken, women should be asked about their sexual 
practices, and the IUD method, including the insertion process, how it works, and 
possible side effects, should be discussed . When women are well informed about the 
method, they may be less likely to return for early removal. 
Another issue complicating IUD provision within health services is that it requires 
more stringent screening before insertion as compared to other methods. If a woman 
comes to a clinic for oral contraceptive pills or the injectable, the provider can quickly 
assess if the woman is able to use that method and can provide it without trouble. 
Providing the IUD is more involved since a gynaecologic exam needs to be preformed 
prior to insertion. The provider needs to be sure that the woman is not pregnant and 
also needs to rule out the possibility of any STI infections that might cause a problem 
if the IUD was to be inserted. This who le IUD screening process takes more time than 
that of other methods and requires a greater degree of skill on the part of the provider. 
If insertion or removal of the IUD is to take place, the facility needs to have the 
correct equipment and supplies for such procedures and needs to be able to ensure 
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that the insertion or removal process will take place within a sterile environment. Not 
all health facilities have the correct equipment and may struggle, especially in rural 
areas to create sterile conditions for insertion. Therefore, if health services were to 
offer \he IUD, many facilities would need to be upgraded so that they could offer the 
IUD in a clean and responsible way. Also, facilities would need to have the IUD in 
stock and this would mean that health systems need to spend money procuring the 
IUD. The IUD has a higher product cost than other contraceptive methods that are 
available but in the long term, it turns out to be more cost effective than shorter term 
family planning methods since there are no re-supply issues and this translates into 
fewer health centre visits [ 13 , 27, 42]. 
The Prevalence ofIUD Usage in South Africa 
Compared to the rest of sub-Saharan Africa where contraceptive prevalence is low 
with less than 20% of women of childbearing age practicing family planning, South 
Africa has a high level of availability and use of contraceptive methods [19]. The state 
is the main provider of contraceptive services and contraceptives are provided free of 
charge in the public sector. At the national level , three-quarters of all women of 
reproductive age in South Africa have used contraception [58]. The Western Cape 
Province records the highest current use of contraceptive methods with a prevalence 
of 74% while only 60% prevalence was recorded for the Eastern Cape [58]. However, 
the range of methods offered by public sector health services remains limited. 
Contraceptive knowledge and use in South Africa is generally high but only two 
methods, the injectable and the pill, tend to be promoted at public clinics, with far 
more African women using injectables. Seventy-five percent of women report having 
used a contraceptive method and the injectable was the most commonly used method 
[58]. 
Current usage of the IUD in South Africa is low. Although the IUD is a valuable and 
important component of a sustainable contraceptive method mix, IUDs are under-
utilised. This is mostly because there is a lack of trained staff to insert the IUD and a 
lack of suitable facilities. In the public sector health services, where 80% of 
contraception in South Africa is provided, IUDs are usually only offered in urban 
centres as a referral method (i.e., they are not available at all clinics and require a 
referral to a clinic that can provide them). Only the Copper T IUD is available at 
public sector clinics while other IUDs, including the Mirena, are available in the 
private sector. The South African Demographic and Health Survey (SADHS) found 
that over 75% of married and sexually active women in South Africa reported 
knowing about -the IUD while only 8.5% reported ever using it. Older age groups 
reported the highest use of the method with 15 .2o/2_among 35-39 year olds, 20.6% 
among 40-44 year olds, and 17.4% among 45-49 year olds [58]. Only 1.2% said they 
were currently using the method and of that number, the private sector was the supply 
source for almost half (46%) of IUD users. Also, only 4% of women who had ever 
used the IUD reported using the IUD as their first contraceptive method [58]. 
The Case for Expanding Use of the IUD in South Africa 
The IUD has the potential to fill an important niche in South Africa because it may be 
a method that suits the needs of women better than what is currently available. Almost 
44% of currently married women in South Africa do not want more children. More 
than half of the currently married women would like to stop childbearing altogether or 
delay the next birth for two years or more [58]. The SADHS also reported that 
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sterilization is the most popular method of contraception for women over the age of 
35 [58]. Some of these women may not have wanted to be sterilised but other forms 
of highly effective long-term contraception were not available. There is specifically a 
great deal of unmet family planning need among women under 25 and also in the 45-
49 age group. These are women who want family planning for spacing or stopping 
and are in need of more options. In South Africa, women also reported that 53-75% of 
their pregnancies were mistimed, unplanned, or unwanted [58) . Use of the IUD could 
help to decrease this unintended pregnancy rate. The IUD can be appropriate for 
young women who are not ready to have children yet and is also a good option for 
women who are HIV-positive since it provides high quality contraceptive coverage 
with only a l % pregnancy rate per year, it does not have any interactions with 
medications, and it has been shown that IUD use does not increase an HIV-positive 
woman's risk of transmitting the virus to a sexual partner [2, 35, 36) . 
In South Africa, the most commonly used contraceptive option is the injectable. 
Although this method is quick and easy to supply to clients, many women do not 
return for follow-up injections on time. As a result, there are times at which women 
have no protection against pregnancies. With the IUD, unless it has been expelled, 
there are no unintentional discontinuation issues and women do not need to adhere to 
any daily regimen in order to protect themselves from unintended pregnancies. 
The IUD also has few side effects as compared to common hormonal methods of 
contraception, such as the injectable. The injectable often leads to less frequent 
menstruation, a side effect of the method which not all women are fond of. 
Perceptions of menstruation vary according to culture and religion and women ' s 
attitudes towards changes in bleeding patterns due to contraceptives vary widely. A 
study which examined patient choices and perceptions surrounding menstruation, 
found that among all the women surveyed, only black women in Africa (South Africa 
and Nigeria) liked having periods [59). This is an important issue to consider when 
recommending the IUD in the South African setting since the copper IUD will allow 
women to continue to have regular periods while hormone releasing IUDs often 
induce oligomenorrhea. 
Another benefit is that since the IUD can be used safely and effectively for a long 
time, clients need not return for regular clinic visits for the device to be effective. 
Clients do not need to return to the clinic unless there is a problem or they want their 
IUD removed. This puts less stress and strain on the healthcare system and also makes 
the IUD a less expensive option for clients than pills or the injectable since, in the 
long run, less time and money will be spent on returning to doctors for refills or 
injections. Also, for women who live far away from health services, the IUD can be a 
good contraceptive choice since the need for frequent clinic visits for family planning 
can be a barrier to effective use. The IUD itself is also an incredibly cost effective 
option, as was discussed earlier. When this quality method is delivered with good 
services, it is an important option for many women. 
Although the IUD does not offer protection against STis, this is no different from 
other commonly used contraceptive methods such as the injectable, oral 
contraceptives, or sterilization. It will always be necessary, when providing the IUD 
in South Africa, to also counsel for dual protection and current National 
Contraceptive Service Delivery Guidelines stipulate this [7]. Since the STI rate in 
parts of South Africa are high, it will also be necessary to carefully screen patients for 
STis before IUD insertion so that PIO can be avoided. The integration of family 
planning and STI services will help facilitate this process. 
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Providers will need to be trained to insert the IUD but also to encourage clients to 
consider it as an option [ 18]. Prm·iders wi II need to be regularly updated and receive 
accurate IUD information. They will also need to do better counselling and managing 
of side effects while addressing myths and fears . To promote the IUD among 
potential users, it will be necessary to identify key positive messages about the 
method and to disseminate information (through pamphlets, billboards, newspapers, 
and radio) about where IUDs are available for potential users. When women come for 
IUDs, they will need to be correctly informed about the method, the possible side 
effects, including menstrual changes, and the need for dual method use. Services will 
also need to be improved by making IUDs available at more clinics (including mobile 
clinics) and making referrals to skilled providers easier. Lastly, if clients request the 
removal of an IUD, whether for personal or medical reasons, providers must not delay 
or refuse removal [7] . 
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STUDY AIMS 
Although the IUD may be a particularly good method for South African women, 
current use of the IUD in South Africa is low. In order to increase IUD usage, it is 
necessary to understand the current knowledge, attitudes, and practices of potential 
users and healthcare providers so that it will be possible to increase both the 
availability and use of the IUD in South Africa. 
Therefore, the primary aim of this study was to assess the knowledge, attitudes, and 
practices of women attending sexual health, family planning, and STI care services as 
well as health care providers working at these facilities. 
The specific objectives of this study were: 
1. To describe the IUD related knowledge of female clients attending public 
sector healthcare services. 
2. To describe the IUD related attitudes of female clients attending public sector 
healthcare services. 
3. To describe the IUD related practices of female clients attending public sector 
healthcare services 
4. To identify factors associated with IUD knowledge, use, and positive attitudes 
towards future IUD use. 
5. To describe the knowledge, attitudes, and practices of health care providers 
with regard to IUD use, feasibility of introduction, and service delivery. 
6. To describe the basic socio-demographic, reproductive, contraceptive, sexual 
and partnership characteristics of those surveyed. 
SETTING 
This research study took place in two separate areas in South Africa: an urban setting 
in Cape Town, Western Cape, and a rural setting near Umtata (Mthatha) in the former 
Transkei region of the Eastern Cape (see Figure 6 below). 
South Africa is divided into 9 provinces, each with its own provincial Department of 
Health. The Western Cape Province has a fairly well-developed health infrastructure 
compared to much of the rest of sub-Saharan Africa, especially in the coloured and 
white communities of the Cape Town area. The Eastern Cape, a neighbouring 
province, is widely regarded as South Africa's poorest province and most of the 
Eastern Cape's population lives in scattered rural communities. The Eastern Cape has 
the least developed health infrastructure in South Africa, with very poor reproductive 
health indicators [58]. In order to gain a more complete understanding of the 
possibility for a reintroduction of the IUD into the contraceptive method mix in South 
Africa, sites in both the Western Cape and Eastern Cape Provinces were selected. 
This approach allowed for an exploration of the key research questions in two very 
different health care systems, each facing unique challenges. 
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Figure 6: Map of South Africa showing all provmces including the Western and 
Eastern Cape. 
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The majority of family planning clients in South Africa utilise public sector facilities 
and therefore study sites at public clinics and health centres in the Western Cape and 
Eastern Cape were selected. In each region, two primary level public sector clinics 
were selected for client interviews. Six clinics were selected for provider interviews. 
The clinics provided a range of primary care services, including STI diagnosis and 
treatment, HIV care, and family planning. For this research, participants were 
recruited from the family planning and STJ care services. 
In the Western Cape (the greater Cape Tovv11 area), the study clinics were the Langa, 
Weltevreden, Phumlani, Vuyani, Guguletu, and Matthew Goniwe Clinics (operated 
by the local health authority). Client interviews were conducted at Langa and 
Weltevreden. 
In the Eastern Cape (the greater Umtata area), the study clinics were the Gateway, 
Mhlakulo, Ngangelizwe, Mbekweni , Sidwadwni, and Gungululu Clinics (operated by 
the local health authority). Client interviews were conducted at Mhlakulo and 
Mbekweni. 
These facilities were selected in consultation with provincial and local health care 
officials based on the following criteria: (a) the degree to which they were typical of 
primary care clinics in the area, (b) the preference of provincial officials to avoid 
over-researched facilities, and (c) adequate client volumes to ensure efficient data 
collection. 
STUDY DESIGN AND METHODOLOGY 
This was a cross-sectional descriptive study with an analytic component. This 
research was a sub-study couched within a larger study on contraception and 
reproductive decision-making. 
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Study population 
Clients: The study population was women between the ages of 15-49 years attending 
public sector clinics and primary level family planning and STI care services in Cape 
Town, Western Cape and in and around Umtata (Mthatha) in the Eastern Cape. 
Providers: Those providers who participated in the study were all providing family 
planning services at one of the 12 participating public clinics in either the Eastern or 
Western Cape. 
Sampling strategy 
Clients: Structured quantitative interviews were conducted with women attending 
family planning and STI care services at four of the participating clinics. In total we 
had 205 participants (105 participants in the Western Cape and I 00 participants in the 
Eastern Cape). Participants were selected consecutively as they exited the clinic and a 
log was used to record the proportion of participants who did not participate. 
Participants recruited from HIV care services included those receiving antiretroviral 
therapy as well as individuals not receiving treatment. 
All men, and women who were younger than 14 years and older than 50 years, were 
excluded from the study. 
Providers: Semi-structured interviews were conducted with health care providers 
working at six clinics in each province. Within each facility, a minimum of two health 
care providers who provide any fan1ily planning services were selected to participate. 
At some facilities, more than three providers were eligible for this and all were 
selected to participate. In this survey, "providers" include doctors as well as both 
senior and junior nursing grades and enrolled nursing assistants. Across all the 
facilities, a total of 32 health care providers, 15 in the Western Cape and 17 in the 
Eastern Cape, took part in the study. 
Data Collection 
Client interviews were structured and lasted approximately 30 minutes. The 
interviews were conducted by one of two trained female interviewers. All interviews 
took place in the participant's preferred language in private rooms at the facility. 
Participants were reimbursed for the cost of transport to attend the interview (RI 5.00 
per participant). 
The instruments used for the client interviews with underwent pilot-testing prior to 
finalisation (see Appendix 1 for final Client Questionnaire). 
Health care provider interviews lasted approximately 45 minutes and were 
administered in a private room at each facility by the study coordinator in the 
provider' s preferred language. An interview guide was used to ensure that key 
research questions were investigated with appropriate probing (see Appendix 2 for 
final Provider Questionnaire). 
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Summary of data collection methods 
Quantitatin inten·iews with female clients from FP/STI services 
Cape Town 
Langa Clinic 52 interviews 
Weltevreden Clinic 53 interviews 
Umtata 
Mhlakulo Clinic 50 interviews 
Mbekweni Clinic 50 interviews 
Total client i11terviews 205 
Semi-structured interviews with health care providers 
Cape Town 
Langa Clinic 3 interviews 
Weltevreden Clinic 3 interviews 
Phumlani Clinic 2 interviews 
Vuyani Clinic 3 interviews 
Guguletu Clinic 2 interviews 
Matthew Goniwe Clinic 2 interviews 
Umtata 
Gateway Clinic 3 interviews 
Mhlakulo Clinic 3 interviews 
Ngangelizwe Clinic 3 interviews 
Mbekweni Clinic 3 interviews 
Sidwadwni Clinic 2 interviews 
Gung,ululu Clinic 3 interviews 
Tntal nrovider illlerviews 32 
-
DATA MANAGEMENT AND ANALYSIS 
All the data was entered into a custom-designed Microsoft Access database by a data 
entry clerk. 
All quantitative data analysis was conducted using the statistical programme STAT A9 
(Stata Corporation, College Station, TX. USA). Descriptive statistics were employed 
for basic characterization of variables and to assist in data cleaning. Data analysis 
began with univariate inspection of the data. 
Our variables of interest were as follows: having heard of the IUD, having ever used 
the IUD, having positive attitudes about the IUD, and considering use of the IUD in 
the future. Bivariate associations between participant characteristics and these 
variables were described using student's T-tests (for means), chi-square tests (for 
proportions), and Wilcoxon rank-sum tests (for medians), as appropriate. Variables 
that demonstrated significant bivariate associations ( defined as p<0.05) were entered 
into logistic regression models to assess independent effects. One model was 
developed for having heard of the IUD, one for having positive attitudes about the 
IUD, and one for considering use of the IUD in the future. Variables were retained in 
the final logistic regression models if they demonstrated significant independent 
associations with the outcomes of interest, or if their removal altered the association 
between other covariates and the outcomes of interest [ 60]. 
ETHICAL CONSIDERATIONS 
Institutional approvals 
Institutional ethical approvals were obtained from the research ethics committees of 
the University of Cape Town, Walter Sisulu University, and UNITRA. Approval was 
also obtained from the Western Cape Provincial Reproductive Health Programme, the 
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City of Cape Town, the KSD health district in the Eastern Cape, and provincial and 
local Departments of Health in the Western and Eastern Cape Provinces. 
Consent procedures 
Study personnel obtained individual written infmmed consent from both clients and 
health care providers prior to their involvement in data collection. The informed 
consent explained: 
• the purpose of the study; 
• the voluntary nature of participation; 
• what was involved in participation, including the duration of the interview; 
• the risks and benefits of participation; 
• protection of participant privacy (ie: that all information provided will be 
completely confidential and will only be viewed and used by the researchers on 
this project, and that participants' names will not be recorded to ensure 
anonymity); and, 
• the participant's right to decide not to participate. to refuse to answer any question. 
or to withdraw from the interview at any time without any penalty. 
These informed consent documents were also translated into isiXhosa (with back-
translations to ensure appropriate phrasing) prior to the initiation of research (See 
Appendix 3A and 3B for consent forms). 
Data Collection/Inten·iew procedure 
Data was obtained from clients and health care providers via an anonymous 
interviewer-administered structured questionnaire and semi-structured interviews. 
Protection of priYacy and confidentialit)1 
All data was identified only by a unique participant number and kept in confidential 
files. No individual identifying information is or will be disclosed in reports, 
publications, or presentations. 
Risks and benefits of participation 
The only risk of participation was some risk of loss of privacy; however, procedures 
for the protection of confidentiality were observed to minimize this possibility. There 
were no guaranteed benefits to individual participants from participation, but 
pai1icipation in this study may help to improve family planning services in the 
Wes tern and Eastern Cape provinces. 
TIMEFRAME 
The project took place over a 7-month period. A timeline for project activities can be 
found in the appendix (Appendix 4). 
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RESULTS - CLIENT DA TA 
Client Characteristics 
A total of 205 clients at four clinics (two in the Western and two in the Eastern Cape) 
were interviewed (Table 5.1 in Appendix 5). There were 105 participants in the 
Western Cape and 100 participants in the Eastern Cape. 
• Socio Demographic Characteristics 
The mean age of participants was 25.9 years. Participants were older in the Western 
Cape (mean: 27.8 years) than in the Eastern Cape (mean: 24.0 years) (Table 1.1 below 
or summary table 5.2 in Appendix 5). Most participants (50.7%) were between the 
ages of 20 and 29 years. Most participants (82.0%) had at least some secondary 
school education. Only about half of the participants (42.1 %) were employed and 
about one-quarter of participants were school children (24.9%). Almost all (99.5%) 
participants spoke isiXhosa as their main language. 
T bl 1 1 S . d 1. h a e ocJo- emograp.1Jc c t t f r t arac ens JCS o c Jen s. 
Western Cape Eastern Cape Total 
Characteristic Total Total /1'=205 
N=l05 N=JOO 
Mean age in years (SD) 27 .8 (8.0) 24.0 (7.6) 25.9 (8.0) 
Age categories, n (%) 
15-19 15 (14.3) 32 (32.0) 47 (22.9) 
20-29 56 (53 .3) 48 (48.0) 104 (50.7) 
30-39 22(2 1.0) 12(12 .0) 34(16.6) 
40-49 12(11.4) 8 (8.0) 20 (9.8) 
Employment status - currently ·working, n (%) 47 (44 .8) 38 (39.2) 85 (42.1) 
Type of work 
Scholar 21 (20.0) 30.0 (30.0) 51 (24.9) 
Homemaker 4 (3.8) 9 (9 .0) 13 (6.3) 
Unemployed or seeking work 22 (20.1) 24 (24.0) 46 (22.4) 
Employed 19 (18.1) 3 (3 .0) 22 (10.7) 
Main language spoken, n (%) 
Xhosa 105 (100.U) 99 (99 .0) 204 (99.5) 
Level of education, n (%) 
Grade I -Grade 7 (primary) 14 (13.3) 12 (12.0) 26 (12.7) 
Grade 8-Grade 12 (secondary) 82(78.1) 86 (86.0) 168 (82.0) 
Tertiary 9 (8 .6) 2 (2.0) 11 (5.4) 
• Reproductive and Sexual History 
The mean number of biological children was 1.9. Women in the Western Cape had a 
lower mean number of children (1.7) than women in the Eastern Cape (2.2). The 
mean age at first pregnancy was 19.3 years with the age at first pregnancy being older 
for women in the Western Cape (20.1) as compared to the Eastern Cape (18.4). The 
mean time since last pregnancy was 3 .8 years for the whole sample but Western Cape 
participants reported a longer duration since last pregnancy (4.6 years) than women 
from the Eastern Cape (2.9 years). Fifty-seven percent of participants reported having 
ever had an unplanned pregnancy. Overall, about 35% reported that their most recent 
pregnancy was mistimed (33% in the Western Cape and 36% in the Eastern Cape) 
and 16% said their most recent pregnancy was not wanted al all (14% in the Western 
Cape and 18% in the Eastern Cape). 
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Most women reported that they were in a current sexual relationship (95.1 %) (Table 
1.2 below or summary Table 5.3 in Appendix 5). Just more than half (52.7%) were in 
a stable non-cohabitating relationship. Eighteen percent were currently married and 
cohabitating. The mean number of sexual partners within the last year was 1.2 with 
most (94.6%) reporting 2 or fewer partners in the last year. 
Table 1 2 Reproductive and sexual history characteristics of clients. 
Western Cape Eastern Cape 
Characteristic Total Total 
Mean number of biological children among those 
reporting children - mean (SD) 
Currently in a sexual relationship, n (%) 
Relationship Status, n (%) 
Married cohabiting 
Single: in stable relationship, cohabiting 
Single: in stable relationship, not cohabiting 
Single: casual relationship 
Mean number of sexual partners in last 12 months 
(SD) 
0-2 sexual partners 
>2 sexual partners 
Mean number of total pregnancies (SD) 
Mean age at first pregnancy (SD) 
Mean time elapsed since last pregnancy - in 
months (SD) 
Feelings towards last pregnancy - timing, n (%) 
Wanted child then 
Wanted child later 
Did not want more children 
Ever had unplanned pregnancy, n (%) 
• Contraceptive use and knowledge 
N=/05 N=/00 
I. 7 (0.8) 
97 (92.4) 
21 (20.0) 
13 (12.4) 
52 (49.5) 
9 (8 .6) 
1.2 (0.6) 
10 I (96.2) 
4 (3 .8) 
1.9 (1.2) 
20.1 (3 .7) 
55.2 (59.6) 
33 (33.3) 
33 (33 .3) 
14 (14.1) 
58 (55 .2) 
2.2 (1.7) 
98 (98 .0) 
16 (16.0) 
6 (6.0) 
56 (56.0) 
14 (14.0) 
I .25 (0.6) 
93 (93 .0) 
7 (7.0) 
2.4 (2 .0) 
18.4 (2 .8) 
35 .6(34.1) 
20 (20.0) 
36 (36.0) 
18 (18.0) 
59 (59.0) 
Total 
N=205 
1.9(1.3) 
195(95.1) 
37 (18 . I) 
19 (9.3) 
108 (52 .7) 
23(11.2) 
I .2 (0.6) 
194 (94.6) 
I I (5.4) 
2. 1 (1.6) 
I 9.3 (3.4) 
45 .7 (49.7) 
53 (26.6) 
69 (34.7) 
32 (16. I) 
117(57.1) 
Almost all (98.5%) of the respondents had ever used a contraceptive method (Table 
1.3 below or summary Table 5.4 in Appendix 5). The most commonly ever used 
methods were the 2-month injectable (76.1 %), male condom (63.9%), the 3-month 
injectable (63.4%), and the pill (41.0%). At the time of the interview, 92.7% of clients 
were using a modern method of contraception. The most commonly used method was 
the injectable (81.5%). A greater proportion of women in the Western Cape were 
using a method of contraception than in the Eastern Cape (97% vs. 88%). Twenty-six 
percent of women had heard of emergency contraception (EC) but only 2% had ever 
used EC. Twenty-eight percent had intercourse in the last twelve months without 
using any method of contraception and 63.4% had sex without using a condom within 
the last twelve months. 
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Table 1 3· Contraceptive characteristics of clients . . . Western Cape Eastern Cape Total 
Characteristic % Total 
Total N=205 
N=/05 N=/00 
Currently using contraception, n (%) I 02 (97 .1
) 88 (88 .0) 190 (92 .7) 
Type of Method, n (%) 
Oral contraceptive pill 
9 (8 .6) 6 (6.0) 15 (7.3) 
Injectable 93 (88.6) 
74 (74.0) 167 (81.5) 
Male condom 
65 (61.9) 41 (41.0) I 06 (51.7) 
Ever used a contraceptive method, n (%) 105 (I 00.0) 
97 (97 .0) 202 (98 .5) 
Oral contraceptive pill 
48 (45.7) 36 (36.0) 84 (41.0) 
Injectable 
3-month 79 
(75 .2) 51 (51.0) 130 (63.4) 
2-month 85 
(81 .0) 71 (71.0) 156 (76. 1) 
Male condom 
79 (75.2) 52 (52 .0) 131(63 .9) 
IUD 5
 ( 4.8) 0 5 (2.4) 
Ever heard of emergency contraception, n (%) 43(41.0) 
lt(lt.O) 54 (26.3) 
Sex in last 12 months without a contraceptive 
26 (24.8) 31 (31.0) 57 (27 .8) 
method, n (%) 
Sex in last 12 months without a condom, n (%) 63 (60.0) 
65 (67.0) 128 (63.4) 
Awareness, Knowledge, and Use of the IUD 
About 26% of pa1iicipants had ever heard of the IUD met
hod. More women in the 
Western Cape (36.2%) than in the Eastern Cape (15%) had heard of the IU
D. 
Of the 53 (25.8%) women who had heard of the IUD, most said they had 
heard of the 
method through a friend (34%), through their school (26.4%), or throu
gh a family 
member (11.3%). Of those who had heard of the IUD, 20.8% said that a
 health care 
provider had ever discussed the method with them and 11.
3% reported that a health 
care provider had ever recommended the IUD as an 
appropriate contraceptive 
method. Thus 5.4% of the total sample had ever discussed th
e IUD with a health care 
provider and 2.9% had ever had an IUD recommended 
to them by a healthcare 
provider. 
Among women who had heard of the IUD, specific knowled
ge about the method was 
poor. Only 8% reported that they knew how the IUD w
orked. When asked to 
describe an IUD, only 22% were able to give any correc
t information (ie: correct 
information about how the IUD works to prevent pregnancy
, its duration of use, what 
it looks like, etc). In regards to the length of time that an IUD can be used 
for, none of 
the study participants knew that the IUD could be used for 
over 5 years (Table 5.5 in 
Appendix 5). 
No respondent had seen information about the IUD m 
the clinic on the day of 
interview 
Only 3 women (6%) had ever used an IUD. All three were in the Western 
Cape. None 
were using it currently. 
Only 10.2% of women reported knowing a woman who h
ad ever used an IUD and 
96.1 % think that most women do not know about the IUD m
ethod. 
Attitudes towards and Perceptions of the IUD method 
After questions regarding IUD awareness and knowledge w
ere asked, all participants 
were given a brief, standardised description of the IU
D method (see Client 
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Questionnaire, Appendix 1 for description). Overall, 72.7% of women said that they 
would consider using the IUD. Most women (89.7%) reported that they thought there 
were advantages to using the IUD. More women in the Western Cape (94.3%) than in 
the Eastern Cape (84.9%) reported that they thought there were advantages. 
Participants could mention multiple advantages. The most commonly mentioned 
advantage was that the IUD could be used for a long time (63.9%). Other commonly 
mentioned advantages were that the IUD is effective at preventing pregnancy (47.8%) 
and that once the IUD is removed, fertility returns quickly (39%). 
Only 14% of respondents said they thought there may be disadvantages to using the 
IUD, with more women from the Eastern Cape (21 %) reporting disadvantages than 
women from the Western Cape (7.6%). The main disadvantages cited were that the 
IUD might cause unspecified health problems (7.8%), that the method was not 
familiar to women yet (6.3%), and that it might be painful to use (5.4%). 
Eighty-six percent reported that they thought the IUD was safe and 87.8% reported 
that they thought the IUD was effective at preventing pregnancy. Forty-two percent 
believed that their partners would think that the IUD was an acceptable contraceptive 
method. Slightly more women in the Western Cape (45.2%) compared to the Eastern 
Cape (38%) thought the method would be acceptable to their partners. 
Women were asked their opinions about how the IUD compared to other methods of 
contraception with respect to ease of use. Eighty-seven percent of women thought that 
the IUD was easier to use than oral contraceptive pills; 84.9% thought that it was 
easier to use than female sterilization; 78.5% thought it was easier to use than the 
injectable; and 58.5% and 47.3% thought it was easier to use than the male and 
female condom, respectively. Importantly, many women said that male (26.3%) and 
female condoms (14.2%) were easier to use than the IUD because condoms would 
protect women from both pregnancy and STis, while the IUD would only stop 
pregnancy. 
Participants were asked if they thought various categories of women were appropriate 
candidates for IUD use. Almost all (95.1 %) women said that they believed women 
who already had a child could use an IUD, but only 53.7% thought a nulliparous 
woman could use an IUD. Almost 73% said that teenagers could use an IUD; 31.9% 
said that women with HIV could use the IUD; and 29.8% said women with STis 
could use the IUD. 
Overall, women seemed to have generally positive attitudes and perceptions about the 
IUD. A little less than one-quarter thought having an IUD could increase a woman's 
chance of contracting STis, and only 2% thought the IUD could causes infertility. 
After having the method explained to them, almost all participants (87.3%) thought 
that women would be interested in the IUD, and 74.5% said that they would consider 
using the IUD if it was offered to them. (See summary Table 5.6 in Appendix 5). 
Factors associated with awareness of the IUD method 
Overall, less than one-quarter of women in this sample had heard of the IUD. (See 
Table 2 below for factors associated with awareness of the IUD or summary Table 5. 8 
in Appendix 5). 
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Women in the Western Cape were significantly more likely to know about the IUD 
method (36%) than women in the Eastern Cape (15%) (p=0.001). Older women 
(women 30 to 39 at 47.1 % and women 40 to 49 at 60.0%) were more likely than 
younger women to know about the IUD (women aged 20 to 29 at 19% and women 15 
to 19 at 10.6%, p=0.000. Although it was not statistically significant, more women 
with a higher level of education (45% tertiary level) know about the IUD than women 
who only had a secondary or primary level education (25% secondary and 23% 
primary). Single women or women in a casual relationship were more likely to know 
about the IUD (18.5%) than married women and women in stable relationships 
(6.8%), p=0.02. Women who had ever heard of emergency contraception were 
significantly more likely to have heard of the IUD than women who had never heard 
of EC (50 vs. 17.2%, p=0.000). 
Table 2: Characteristics associated with awareness of the IUD. 
Characteristic 
Aware of JUD Not Aware of IUD P-value 
N(%) N(%) 
Overall, n (%) 53 (25.9) 152 (74.1) 
Province, n (%) 
Wes tern Cape 38 (36.2) 67 (63.8) 0.001 
Eastern Cape 15 (15 .0) 85 (85 .0) 
Age in years, n (%) 
15-19 5 (10.6) 42 (89.4) 
20-29 20(19.2) 84 (80.8) 0.000 
30-39 16(47.1) 18(52.9) 
40-49 12 (60.0) 8 (40.0) 
Education, n (%) 
Primary school only 6 (23.1) 20 (76.9) 0.3 
Secondary school only 42 (25 .0) 126 (75 .0) 
Tertiary 5 (45.5) 6 (54.6) 
Relationship Status, n (%) 
Married / Stable relationship 14 (6.8) 31 (15 .1) 0.02 
Single/ Casual relationship 38 (18.5) 115 (56.1) 
Ever heard of emergency contraception, n (%) 0.000 
Yes 27 (50.0) 27 (50.0) 
No 26 (17.2) 125 (82.8) 
Factors associated with ever using the IUD 
Only three women in our sample of 205 had ever used the IUD. Due to this very small 
number, bivariate analysis to identify factors associated with IUD use was 
inappropriate and, thus, not conducted. 
Factors associated with positive attitudes towards the IUD 
After being read a standardised description of the IUD, participants were asked what 
they thought about the method. Interviewers probed to see whether respondents 
thought the method was generally good or bad and all responses were recorded. These 
responses were then post coded and broken up into what were considered to be 
positive responses about the IUD (such as "Needs less routine maintenance" or "You 
won't get pregnant even if you are raped") and negative ones (such as "It might be 
painful to inse1i" or " It might cause health problems"). Overall, most (91 % ) of the 
participants expressed positive attitudes towards the IUD. 
Bivariate analysis showed that ever use of a contraceptive method was the only 
variable significantly associated with having positive attitudes about the IUD. 
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However, given that there was no significant variation with respect to ever use of a 
contraceptive in the sample, this finding is not meaningful. 
Factors associated with considering use of the IUD 
The characteristics associated with considering use of the IUD, should women require 
contraception in the future, were living in the Western Cape and currently using 
contraception (see Table 3 below or summary Table 5.11 in Appendix 5). Women in 
the Western Cape (83%) were significantly more likely to consider use of the IUD in 
the future than women in the Eastern Cape (62%) (p=0.000). Almost three-quarters of 
women who were currently using contraception said that they would consider the IUD 
in the future compared to 41. 7% of those who were not currently using contraception 
(p=0.02). Again there are several factors that while not statistically significant are 
worth mentioning with respect to considering IUD use: being single or in a casual 
relationship (76.5%) vs. being married or in a stable relationship (20%) (p=0.2) and 
higher level of education (women with tertiary level education (91 %) were far more 
likely to consider use of the IUD than women with only secondary (73%) or primary 
(65.4%) level education, p=0.4). 
Table 3: Characteristics associated with considering use of the IUD in the future. 
Considering Use Not Considering 
Characteristic a/IUD Use a/IUD ?-value 
n (%) n (%) 
Overall, n (%) 149 (72.7) 41 (20.0) 
Province, n (%) 
Western Cape 87 (82 .9) 9 (8.6) 0.000 
Eastern Cape 62 (62.0) 32 (32.0) 
Age (years), n (%) 
15-19 30 (63 .8) 11 (23.4) 
20-29 79 (76.0) 20(19.2) 0.4 
30-39 24 (70.6) 6(17.7) 
40-49 16 (80.0) 4 (20.0) 
Education, n (%) 
Primary school only 17 (65.4) 8 (30.8) 0.4 
Secondary school only 122 (72.6) 32 (19.1) 
Tertiary 10 (90.9) I (9.1) 
Relationship Status, n (%) 
Married / Stable relationship 30(20.1) 13 (31.7) 0.2 
Single/ Casual relationship 114 (76 .5) 27(65.9) 
Currently using contraception, n (%) 
Yes 142 (74.7) 37(19.5) 0.02 
No 5 (41.7) 4 (33.3) 
Current Method, n (%) 
Oral contraceptive pill 4 (66.7) 2 (33.3) 
Injectable 56 (73.7) 16 (21.1) 
3-month 36 (78 .3) 8(17.4) 
2-month 20 (66.7) 8 (26.7) 0.13 
Female sterilization 0 0 
Male sterilization 2 (100.0) 0 
Condom (Male+ Female) 5 (62.5) 2 (25.0) 
Dual Method 77 (77.0) 17(17.0) 
Ever used a contraceptive method, n (%) 
Yes 149 (73.8) 40 (20 .0) 0.000 
No 0 I (33.3) 
Ever used emer_gency contraception, n (%) 
Yes 3 (75.0) I (25.0) 0.13 
No 66 (82.5) 11 ( 13.8) 
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Logistic Regression Models 
• Awareness of the IUD method 
After adjusting for level of education, being from the Western Cape, one ' s age, and 
having heard of emergency contraception (EC) all independently predicted awareness 
of the IUD method. Women from the Western Cape were two times more likely to 
have heard of the IUD than women from the Eastern Cape (OR=2.13; 95% CI 0.99 -
4.58). Women who were between the ages of 30 to 39 years were three times more 
likely to have heard of the IUD than women between the ages of 15 to 29 years 
(OR=3.05; 95% CI 1.29 - 7.20) and women who were between the ages of 40 to 49 
years were almost eight times more likely to have heard of the IUD than women 
between the ages of 15 to 29 years (OR=7.75; 95% CI 2.68 - 22.42). Also, women 
who had heard of EC were 3 times more likely to have heard of the IUD than women 
who had not heard of EC (OR =3 .22; 95% CI 1.46 - 7 .11 ). The difference in 
awareness of the IUD between women who had a tertiary education and those who 
did not was non-significant (OR= l.23; 95% CI 0.32 - 4.79). (See summary Table 5.13 
in Appendix 5). 
• Considering use of the IUD in the future 
After adjusting for age and level of education, being from the Western Cape was the 
only characteristic that independently predicted whether a woman would consider use 
of the IUD in the future. Women from the Western Cape were four times more likely 
to consider the IUD use than women from the Eastern Cape (OR=4.76; 95% CI 2.07 -
10.91). (See summary Table 5.15 in Appendix 5). 
RESULTS-PROVIDER DATA 
Thirty-two providers were interviewed in total; fifteen from the Western Cape and 17 
from the Eastern Cape. 
Provider Characteristics 
Although a total of 32 providers took part in the survey, background characteristics 
were only available for 27 providers because that section of the questionnaire was 
added after 5 interviews had been completed. Of those, 55.6% were professional 
nurses, 33% were chief or senior professional nurses, and 4% were enrolled or staff 
nurses. Fourteen of the providers (52%) were the manager or supervisor of the 
facility. The mean number of years that the providers had been working at the facility 
was 4.3 and the mean number of years since completion of basic training was 13. 
Fifty-nine percent of providers had completed a family planning course. In the last six 
months, 96.3% of providers had provided family plaiming, but all were expected to 
provide family planning in the future (See Table 4 below or summary Table 5.16 in 
Appendix 5). 
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Table 4: Characteristics of providers. 
Western Cape Eastern Cape Total 
Characteristic n (%) 
n (%) n (%) 
n=Jl n=/6 n=27 
Rank 
Chief I Senior professional nurse 2 (18 .2) 7 (43 .8) 
9 (33 .3) 
Professional nurse 7(63 .6) 8 (50.0) 
15 (55.6) 
Enrolled nurse/staff nurse I (9.1) 0 
1 (3 .7) 
Other I (9 .1 )) 1 (6.3) 
2 (7.4) 
Manager or supervi sor for the facility 4 (36.4) IO (
62 .5) 14 (51.9) 
Years working at the facility - mean (SD) 4.2 (2 .0) 4.2 (4
.3) 4.3 (3. I) 
Years since finishing basic training - mean 15 .9 (7 .7) 11 .3 (6
.2) 13.2 (7 . l) 
(SD) 
Completed a family planning course 10 (90 .9) 6 (37
.5) 16(59.3) 
Trained to provide HIV care services 11 (100.0) 16(10
0.0) 27 (100.0) 
Trained to provide ST! care services 9 (81.8) 13(81
.3) 22 (81.5) 
Has provided family planning in last 6 mo. 11 (100.0) 15 (93.8)
 26 (96.3) 
Has provided HIV care services in last 6 mo. 10(90.9) 14 (87
.5) 24 (88.9) 
Has provided STI diagnosis and treatment in 10 (90.9) 16 (100 .0
) 26 (96.3) 
last 6 mo. 
IUD Knowledge 
• Method Specifications 
Overall, provider knowledge of the IUD method was inadequate (see summary Table
 
5.17 in Appendix 5). All providers had heard of the IUD. However, when asked to 
describe the IUD, only 78.1 % described the method correctly with reg
ards to insertion 
and removal issues, who can insert an IUD, its proper duration of use, 
how it works to 
prevent pregnancy, and what the device looks like. Only 53.3% knew 
that there were 
different types oflUDs. When asked about the correct duration of use
, only 12.5% of 
providers said that the IUD could be used for up to ten years, and alth
ough the IUD is 
over 99% effective at preventing pregnancy, only 18.8% of providers 
thought that the 
IUD was very effective at preventing pregnancy. However, 84.4%
 could correctly 
explain how the IUD works to prevent pregnancy, meaning they sai
d it that the IUD 
works by creating a spermicidal endometrium or that it inhibits s
perm transport, 
mobility, and viability. 
• Knowledge and Perceptions of Efficacy, Safety, Contraindications, and Side 
Effects 
Providers were asked basic questions about the effectiveness, safety, c
ontraindications 
to use, side effects, and risks of the IUD. Providers were asked 
to compare the 
effectiveness and safety of the IUD to other contraceptive methods. 
With respect to 
IUD effectiveness, 87.5% of providers said that the IUD was better th
an the rhythm 
method, 87.l % said that it was better than the withdrawal method, 71
.9% said that it 
was better than the pill, 65.6% thought that it was better than spermicid
es, and 59.4% 
thought it was better than the male condom. About 63% thought tha
t the injectable 
was better than the IUD at preventing pregnancy. When asked to com
pare the safety 
of the IUD to other methods, 81.3% reported that the IUD was safer t
han the pill, but 
for most other methods only 30 to 50% reported that the IUD was
 safer. Three-
quarters of providers believed that there are contraindications to IUD
 use. The most 
commonly mentioned contraindication was cervical, endometrial, or
 ovarian cancer 
awaiting treatment (28.1 %). Other contraindications that were mentioned were having 
an active STI (22%), unexplained and/or abnormal vaginal bleeding (18.8%), being 
pregnant (12 .5%), and having PID (12.5%). About 63% of providers said the IUD 
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causes side effects and the most commonly reported side effect was increased 
menstrual blood (28.1 %). This is a correct response for copper-bearing IUDs. Finally, 
65.5% of providers believed that the IUD had health risks related to it. The most 
commonly mentioned health risk was ectopic pregnancy (28.1 %), followed by 
developing PID (22%), uterine perforation (15.6%), and developing an STI (9.4%). 
Only 31.3% said the IUD could be used as a form of emergency contraception. Fifty-
nine percent said that the IUD increases one's risk of contracting STis and 51.6% did 
not think that nulliparous women could use an IUD. 
Only 28% of providers correctly stated that the time to first check-up after IUD 
insertion was 3 to 6 weeks or after the first menstrual period and half of the providers 
believed that women needed either monthly or six-monthly follow-up visits for their 
IUD throughout the duration of use, which is incorrect as long as women are 
experiencing no problems with the method. When asked what type of information 
they would give women about the IUD, providers most commonly said that they 
would give women information about when to return for follow-up visits (40.6%), 
side effects (37.5%), the duration of use for the method (28.1%), and how to prevent 
STis (28.1 %). When asked whom the IUD was not appropriate for, providers said that 
the IUD was not an appropriate method for women with a history of STis (46.9%), 
HIV-positive women (28.1 %), and teenage women (25.0%). (See summary Table 
5.17 in Appendix 5). 
IUD Practices 
When providers were asked to spontaneously mention which methods of family 
planning they routinely suggested to clients, only one provider in the Western Cape 
and one in the Eastern Cape mentioned the IUD. All providers stated that they suggest 
the 3 and 2-month injectables as well as the male condom and 96.6% said they 
suggest the oral contraceptive. 
Of the 32 providers interviewed, 18.8% had ever counselled a woman about the IUD, 
and only 15 .6% had ever suggested the IUD to a potential client. 
About 22% of providers reported that they were trained to insert the IUD, and only 
13.3% had ever inserted an IUD. Of those insertions, all of them had been over a year 
ago. Only 28.1 % had ever referred a woman to another site for an IUD. (See summary 
Table 5.18 in Appendix 5). 
IUD Attitudes and Perceptions 
Most providers believed there were advantages to increasing the availability of the 
IUD. Fifty percent stated that IUDs would help reduce unplanned and unwanted 
pregnancies. However, providers also belie ed there were disadvantages to the IUD 
method. The most commonly cited disadvantage was side effects (34.4%), followed 
by concern that the IUD does not offer protection from STis (31.3%). Eight providers 
(25%) said that the IUD increases the risk of developing PID. When asked whether 
they would recommend the IUD to certain groups of women, the following responses 
were given: 78.1 % of providers said they would recommend the IUD to women who 
desired more children in the future, 75% said they would recommend the IUD to 
unmarried women, and 56% said they would recommend the IUD to women who 
have not had any children yet. The mean age below which providers said they would 
not provide the IUD was 17.5 years. Finally, when asked if they had any concerns 
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about the IUD, the most commonly cited concern (40.6%) was side effects related to 
the method. Other concerns that were cited were a concern regarding the medical 
safety of the IUD (including concern about PID) (22%), concern regarding the fact 
that a trained provider must insert the IUD (18.8%), and concern that the IUD offers 
no protection from HIV or STis (11.6%). 
When asked about the three main barriers to client access and use of the IUD, 
providers highlighted the lack of knowledge on the part of the provider (84.4%), a 
lack of trained providers to insert and remove the device (62.5%), the fact that IUDs 
are not available at facilities (56.3%), and a lack of knowledge on the part of potential 
users (46.9%). 
Eighty-one percent of providers believed that women would be interested in the IUD 
if they knew about it but only 37.5% of providers believed that women's partners 
would support the use of the IUD as a contraceptive method. 
When asked why they thought IUD use was low in South Africa, the greatest number 
of providers said that it was because of a lack of knowledge on the part of the 
provider and user (50.0%). Just over half (51.6%) believed that the IUD would be a 
good method for South Africa, 73.3% believed that IUD use should be promoted in 
South Africa. Among providers who thought that the IUD should be promoted in 
South Africa, the most commonly reported reasons for this were that it would increase 
women's contraceptive choice (25.0%) and it would help prevent unwanted 
pregnancies (21.9%). Among the 29% of providers who believed the IUD would not 
be a good method for South Africa, the most commonly cited reasons for this were 
that women are either misinformed or lack information about the IUD (55 .6%) and 
that South Africa has a high prevalence of HIV and STis (33.3%). Among the 26.7% 
of providers who believed the IUD should not be promoted in South Africa, the most 
common objection was that there is a high prevalence of STis and HIV in South 
Africa (3 7.5%). Other objections listed were that women will be afraid to use the 
IUD, women will think the IUD is too invasive, using IUDs will make women ignore 
condoms, and that people will think that their babies will be born with IUDs in their 
heads (12.5% each) (see summary Tables 5.19 and 5.20 in Appendix 5). 
Training needs 
With regards to training, providers recognized that they needed more information. 
When providers were asked if they had sufficient training with regards to nine IUD 
related issues, no more than 10 providers (32.3%) said that they had enough training 
in any given area relating to providing the IUD. Almost all (93.6%) providers 
believed that they needed more training and information about the IUD. (See 
summary Table 5 .17 in Appendix 5). The issues that providers most often cited as 
areas in which they needed more training and information were how to insert and 
remove the IUD (72.4%), general knowledge about the method (48.3%), the 
advantages and disadvantages of the method (20.7%), the types of IUDs that are 
available (17.2%), and recommendations about whom the IUD is appropriate for 
(17.2%) (See summary Table 5.20 in Appendix 5). Less than 20% of providers felt 
that they had enough knowledge to counsel a woman on the IUD and only 6.5% 
thought they could insert one. 
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DISCUSSION 
This cross-sectional knowledge, attitudes, and practices study was undertaken at the 
request of the Reproductive Health Programme of the Provincial Government of the 
Western Cape Province. The purpose of the study was to learn more about client and 
provider knowledge, attitudes and practices with respect to the IUD in order to inform 
strategies relating to the reintroduction of the IUD into the contraceptive method mix 
in South African public health services. 
Among clients, awareness and knowledge about the IUD was poor. Only about a 
quarter of women had ever heard of the IUD and very few knew how the IUD worked 
or its possible duration of use. This is not surprising considering that women reported 
that health care providers, on the whole, had never discussed the method with them, 
the method was never offered at the clinics, and information about the IUD was not 
available at health facilities. Use of the IUD was extremely low with only 3 women 
( 6% ), having ever used the method. There were also substantial regional differences 
with women in the urban Western Cape having more knowledge about the IUD 
method than women in the rural Eastern Cape. All of the past IUD users were from 
the Western Cape. 
Despite having little knowledge or exposure to the IUD in the past, women had 
positive attitudes towards the IUD once they learned more about the method. Women 
cited far more advantages than disadvantages to the IUD. Some key advantages that 
women highlighted were the IUDs long duration of use, its effectiveness at preventing 
pregnancy, and the quick return to full fertility after the removal of the device. The 
majority of women believed the IUD to be a safe and effective method and very few 
reported the common yet unfounded misconceptions and myths that tend to plague the 
IUD. For example, very few women thought that the IUD caused infertility, caused 
health problems for the women who use them, or increased one's chances of 
contracting an STI. Furthermore, when women were asked to compare the IUD to 
other contraceptive methods, women thought the IUD was an easier contraceptive 
method to use than oral contraceptive pills, injectables, male and female condoms, 
and female sterilization. An overwhelming 96% of respondents said that they believed 
that most women do not know about the IUD, 87% believed that women would be 
interested in the method, and almost 75% of the respondents said that they themselves 
would consider the method if it was offered to them. 
These results would suggest that the IUD appears to be an acceptable method of 
contraception to the women we sampled. However, hypothetical acceptability of the 
IUD does not necessarily translate into long-term use. Although our results suggest 
that women are interested in the method and had positive attitudes towards it, these 
conclusions were drawn from participants' reported feelings following the 
presentation of a short description of the IUD. We therefore have an indication that 
women might like the IUD method but a woman's decision to choose a particular 
method is complex and the glowing responses we received may not be an accurate 
representation of potential usage or acceptability. 
There were a number of factors that were most likely to dispose women towards 
awareness of the IUD method and considering use of the IUD in the future. The 
characteristics associated with awareness of the IUD were living in the Western Cape, 
older age, being single or in casual relationship, and having used emergency 
contraception. The characteristics associated with considering use of the IUD in the 
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future were living in the Western Cape and currently using contraception. Originally, 
we had hoped to report on the characteristics associated with ever using the IUD but 
unfortunately, only three women in the study had ever used the IUD, making bivariate 
analysis inappropriate. 
Our logistic regression modelling showed that after adjusting for level of education, 
being from the Western Cape, older age, and having heard of emergency 
contraception all independently predicted awareness of the IUD method. After 
adjusting for age and level of education, being from the Western Cape was the only 
characteristic that independently predicted whether a woman would consider use of 
the IUD in the future. 
The results of the logistic regression modelling showed that women from the Western 
Cape were more likely to know about the IUD method and more likely to consider 
using it in the future than women from the Eastern Cape. This is not surprising since 
women from the Western Cape are likely to have had a higher degree of reproductive 
education or access to reproductive services than women from the Eastern Cape. The 
Western Cape also has a more developed reproductive health infrastructure than the 
Eastern Cape. In addition, the Western Cape has done more than the Eastern Cape to 
provincially promote the development of contraceptive projects and there have been 
some attempts in the past to generate interest in the IUD in the Western Cape. It 
seems logical that women in older age groups would have been more likely to be 
aware of the IUD and having heard of emergency contraception would suggest that 
these women had access to a greater degree of reproductive health services or 
information. It is therefore not surprising that women who knew about EC were also 
aware of the IUD method. 
Our results differ from what the most recent SADHS found regarding the IUD. The 
SADHS found that over 75% of married and sexually active women in South Africa 
reported knowing about the IUD while only 8.5% reported ever using it, and only 
1.2% were currently using the method [58]. In contrast, in our sample, we found that 
only about 26% of women had ever heard of the IUD, that only 6% had ever used it, 
and none of the women were currently using the method. It is likely that our results 
differ from the SADHS since the SADHS is drawn from women in the general South 
African population rather than women specifically attending clinics for family 
planning services. 
The SAD HS also found that older age groups reported the highest use of the method 
with 15.2% among 35-39 year olds, 20.6% among 40-44 year olds, and 17.4% among 
45-49 year olds [58]. Since a very small number of women in our study ever used the 
IUD, it was not possible to make a meaningful breakdown of method use compared to 
age. However, when we look at the characteristics associated with awareness of the 
method, older age was a predictor of awareness with 60% of women who knew of the 
IUD being between 40-49 years and 47% being 30-39 years old. One would expect 
that women attending family planning services would have a greater knowledge of 
contraceptive methods due to their exposure to family planning. We may have found 
a much lower knowledge level in our study compared to the SADHS because our 
sample included women who were younger and not necessarily married. This could 
account for the decrease in method knowledge since younger age groups were less 
likely to know about the IUD than older age groups. Furthermore, since the SADHS 
samples from the general population, it includes women from a broader range of 
socio-economic backgrounds as compared to this study, which only sampled from 
women attending public sector clinics. It is not surprising that older women and 
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women of a higher socio-economic status than those sampled would have greater 
knowledge about the IUD. Therefore, it seems as if the difference in knowledge levels 
that we observed between this study as compared to the DHS can be explained by the 
socio-demographics of this sample. 
One would expect that the percentage of women who have ever used the IUD in the 
general population (from which the SADHS is drawn) would be fairly similar to the 
women who had ever used the IUD in this study and who were sampled from those 
attending family planning services. Indeed, the percentage of women in this study 
who had ever used the IUD (6%) was similar to the percentage (8.5%) of women that 
the SADHS reported as ever having used the IUD method [58]. 
However, the SADHS found that 1.2% of women in South Africa were currently 
using the IUD, while in this study, no women were currently using the method [58]. 
This result is not surprising since our sample was drawn from women attending · 
family planning clinics. Certainly, women who are happily using the IUD in the 
community would not be at family planning clinics unless they had a problem and so 
this can explain the lack of current IUD users in our sample. 
Providers also have poor knowledge of the IUD method. All the providers had heard 
of the IUD yet about 20% of those interviewed could not describe the method 
correctly and about 15% could not describe how the IUD works to prevent pregnancy. 
In addition, most providers were unaware of the correct duration of use for the 
method or its effectiveness at preventing pregnancy. Most providers (63%) believed 
that the injectable was better than the IUD at preventing pregnancies. This belief 
could mostly be due to the greater availability and familiarity of providers with the 
injectable and its preference as a contraceptive method in South Africa. In 1998, the 
injectable was being used by 49% of all women in South Africa between the ages of 
15 to 49 who were using contraception, making it the most commonly used method in 
the country [ 61]. 
When providers were asked about the risks of the IUD method, the most commonly 
cited risk was that of ectopic pregnancy followed by the belief that the IUD increases 
a woman's chance of contracting an STI. It is interesting to note that these perceived 
risks, which are most likely tied to a fear of PID, were mentioned by providers, but 
not by clients. Twenty-five percent of providers said that the IUD increases the risk of 
developing PID, even though this has been disproved. Providers were also lacking 
knowledge about who was an appropriate candidate for the method. Providers said 
that the IUD was not appropriate for women with a history of STis, HIV-positive 
women, and teenage women, despite the fact all of these groups of women are 
capable of successfully using the IUD [7, 35, 62]. These responses suggest a need for 
far more training about the contraindications to use and the current recommendations 
about who is eligible for the IUD. Almost all the providers (94%) recognised that they 
needed more information and training before they could either counsel women or 
insert or remove the IUD. 
When asked about the three main barriers to client access and use of the IUD, 
providers highlighted issues relating to a lack of knowledge on the part of providers 
and potential users, as well as supply and training issues. Similarly, providers 
believed that IUD use was low in South Africa because of a lack of knowledge on the 
part of the provider and user. Overall, about half of the providers believed that the 
IUD would be a good method for South Africa and the majority believed that IUD use 
should be promoted in South Africa. 
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Among women in this study, the IUD method was relatively unknown, but attitudes 
towards the IUD were positive once women were given information about the 
method. This means that in South Africa there is an opportunity to educate women 
who have not been inundated with misinformation about the IUD method. The main 
obstacle to clients ' use of the IUD in South Africa appears to be a lack of knowledge, 
not misperceptions. In contrast to other studies that have showed that a main barrier to 
the increased use of the IUD method has been due to myths and misinformation 
among potential users, this study found that South African women had very few 
misconceptions about the IUD and had very positive attitudes towards the method and 
its increased use [ 18, 52]., The data presented here suggest that if the IUD were 
introduced in South Africa, it would be well accepted [17, 18, 19, 63]. 
Providers do have some misinformation about the IUD method and this will require 
correction. The results of this study are consistent with the findings of other studies 
that show that despite evidence to the contrary, many providers still believe that a 
relationship existed between IUDs and PID [55]. Providers in our study listed 
developing PID, ectopic pregnancy, and an increased chance of developing STis as 
risks of the IUD method. Also, the results of this study are consistent with others that 
have found that a provider fear of side effects, which are often unfounded, along with 
incorrect candidate selection criteria is often a barrier to increased use. Providers in 
this study were either misinformed or not up to date on current contraindications to 
IUD use. In other recent studies, it has also been found that providers too narrowly 
defined appropriate IUD candidates and it has been suggested that unless educated 
correctly, providers could become a barrier to the increased use of the method through 
unwarranted and restrictive candidate selection [20, 55]. As others have suggested, it 
will be necessary to educate providers and emphasize the medical safety and 
acceptability of current IUDs so that provider misperceptions are not a barrier to 
increased use [20]. 
Like other studies, our study found that providers need far more trammg and 
knowledge about the IUD before they will feel competent and be able to accurately 
counsel women about the method and successfully provide it [ 18]. A 1997 systematic 
review of 18 randomised trials suggested that educational outreach programs have a 
positive impact overall on clinical practice [64]. Education and training for providers 
is critical to the increased uptake of the IUD method since providers are often the 
gatekeepers through whom women access family planning. In South Africa, providers 
are especially influential when it comes to women's contraceptive decision making. 
It is important to note however, that education of providers alone may not be enough 
to create sustained interest in increasing use of the IUD. A recent study in Nicaragua 
found that while medical education about the IUD was indispensable for health care 
providers, it was not adequate to stimulate interest on the part of the potential users 
[56]. Therefore, it will be necessary to simultaneously educate both providers and 
potential users of the method. Knowledge and training for providers will need to 
focus on areas of misinformation and building clinical competence. Results from 
other studies have showed that once countries make the decision to include the IUD in 
the method mix, they need to do more than just train providers to insert it [18, 56]. 
Having health department commitment helps facilitate IUD reintroduction and 
overcomes barriers, as does training for providers and education for women, strong 
partnerships with NGOs, and systematic monitoring and evaluation of programmes 
[65]. 
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In South Africa, there is a need for long-term family planning methods among many 
different groups of women due to high levels of unintended and teenage pregnancy, a 
high prevalence of HIV, and high levels of antiretroviral treatment which can have 
potentially teratogenic effects on a developing embryo [58, 66] . The IUD could fill an 
important role and provide a good option for women who would prefer not to be 
sterilized or for women who want family planning for spacing births. The IUD is also 
a good method for young women who want a trustworthy contraceptive method and 
who are not ready to have children. In light of South Africa's HIV epidemic, the IUD 
is even a good method for HIV-positive women. The IUD has not been shown to 
increase transmission of the virus or to increase the amount of the virus in vaginal 
secretions [32, 45]. The IUD is a very good option for HIV-positive women and 
especially good for HIV-positive women who are taking potentially teratogenic ARV s 
since the method is extremely effective at preventing pregnancy. 
The IUD may be a method that suits the needs of South African women better than 
what is currently available. The most commonly used contraceptive method in South 
Africa, the injectable, is fast and easy to provide and minimal counselling is 
necessary, but the method is not the best choice for all women. Many women 
complain about the side effects of the injectable, particularly sporadic menstruation or 
amenorrhoea and the delay in return to full fertility [67]. These are common side 
effects of hormonal methods. As a non-hormonal method, the IUD offers women 
another contraceptive choice without the common hormonal side effects. For 
example, with the copper IUD, women continue to have normal periods. This is 
especially attractive to many African women [59]. Also, the return to fertility with 
hormonal methods may take a number of months while return to fertility with the IUD 
is more rapid because it is non-hormonal. Another attractive aspect of the IUD is that 
it has few compliance issues. Unlike the injectable, where women have to return for 
injections every two or three months, the IUD will work and will continue to work as 
long as it is inserted. Women in our study echoed this issue when they said that the 
IUD was an easier contraceptive method to use than the injectable. 
It has been argued that the IUD may be too time consuming for some clinicians to 
provide and that the necessary sterile environment and lack of basic materials and 
equipment for insertion in some developing country settings leads to poor uptake of 
the method [56, 65]. Although the IUD may be more time consuming to provide, it 
decreases the number of visits by women to the health service in the long run and 
reduces the stress on health centres. Since the IUD can be used safely and effectively 
for a long time, this also means that clients do not need to return for visits unless there 
is a problem or they want their IUD to be removed. This also puts less financial strain 
on women in terms of saving transport costs, taking fewer days off from work, and 
not having to find child care. Overall, the IUD is an incredibly cost effective option 
that can be provided so as to benefit both health care systems and clients [13]. 
Our findings have important implications and can help the provincial and national 
health services in planning for the reintroduction of the IUD. It is clear that there is a 
need for awareness campaigns among women seeking contraception. Study 
participants overwhelmingly did not know about the IUD method and 96% of 
respondents believed that women did not know about the IUD. This shows that in 
South Africa, public education programs about the method would be necessary for 
building public support and interest in the IUD. Also, the results showed that there are 
regional differences between the Western and Eastern Capes and that women have 
had more exposure to the IUD in the Western Cape. Therefore, education approaches 
need to recognize these regional differences. The advantages of the method that 
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women mentioned most often were the efficacy of the IUD, its long duration of use, 
and the quick return to fertility after its removal. Education campaigns could focus on 
these key advantages with only minimal attention given to dispelling the myths that 
were not especially prevalent among those surveyed. Some opponents of the IUD say 
that the method is not practical because it does not protect women from STis but that 
is no different from many other methods. Even the injectable, which is the most 
commonly used contraceptive method in South Africa, needs to be used with a 
condom to prevent the spread of STis. Therefore, like other methods, any IUD 
education program would need to highlight the method within a dual protection 
framework and still promote cqndoms as the key way to prevent STis. 
If the IUD is to be promoted as part of the contraceptive method mix in South Africa, 
it will also be necessary to train providers. Training and education among providers 
will need to focus on up to date information, dispelling myths, and proper insertion 
and removal techniques. Providers will need to be regularly updated with accurate 
IUD information and guidelines and checklists, such as recent guides from the 
Provincial Government of the Western Cape Reproductive Health Programme, are 
helpful aides in determining who is eligible for an IUD [62, 68]. With a concerted 
effort from government along with education and training for providers and clients, 
the IUD could be successfully reintroduced into the contraceptive method mix. 
This study had several limitations. This was a sample of women attending clinics in 
two areas of South Africa. Since the study was focused in the Western and Eastern 
Capes, the results may not be generalisable to the general South African population 
but the sites that were chosen were in both urban and rural settings so as to decrease 
this possibility. Also, 84% of women get their contraception in public sector clinics so 
the findings should be fairly generalisable to the overall population of women 
accessing contraceptive services [58]. Given that our participants were women 
attending family planning and STI care services, it seems logical that their level of 
knowledge about the IUD might be higher than the general population. However, 
most of the women that we sampled did not know about the IUD method and none of 
the study participants was currently using an IUD. It can be argued then that our 
results are not generalisable to all women in South Africa but may be specific to 
women attending public sector family planning services. Conversely, these are the 
women who would potentially become users of the IUD, since these women are 
seeking or using contraception. Therefore, documenting their level of knowledge and 
attitudes is important since they are the group of South African women we are most 
interested in. 
In addition, the 32 providers we interviewed may not be have been a representative 
sample of providers in the Western and Eastern Capes but they were drawn from 12 
clinics in 2 provinces. However, these providers have undergone similar family 
planning training to all other public sector providers. 
Our results suggest that the IUD appears to be an acceptable method of contraception 
to the women we sampled. However, these women were only read a short description 
about the method before they were asked about their feelings. Although most of the 
women had positive responses, hypothetical acceptability of the IUD does not 
necessarily translate into long term use. A woman's decision to choose a particular 
method is complex and the glowing responses we received may not be an accurate 
representation of potential usage. Also, after being read the short description of the 
IUD method, women may have given more positive responses about the method in 
order to please the interviewers. This would have created a bias within the study. 
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However, it seems that women felt comfortable with giving negative responses about 
the IUD since 30% of the women interviewed noted disadvantages about the IUD, 
22% said they thought IUDs increased one's chance of acquiring an STI, and 27% 
said that they would not consider using an IUD. 
Lastly, the small sample size of 205 participants may have limited our ability to find 
statistically significant associations between IUD knowledge and attitudes and various 
client factors. However, since we were most concerned with description, this was not 
the main objective of the study. Further research could be conducted with a larger 
sample size so as to be able to detect potentially significant associations. 
This study was meant as a starting point for gathering further information about the 
possible re-introduction of the IUD into the contraceptive method mix in South Africa 
and is the first of its kind in South Africa. The research was requested by the 
Reproductive Health Director of the Provincial Government of the Western Cape so 
as to inform decisions relating to health services and family planning. This work is a 
valuable tool for understanding the current knowledge, attitudes, and practices 
surrounding the IUD among both clients and providers. These results can be used to 
identify possible interventions for promoting the use of the IUD. With these results, 
we are now better equipped to plan for a rollout of the IUD and address issues such as 
the need for provider training and education and awareness campaigns among women 
seeking contraception. The results of this research will be presented to policy makers 
in provincial and local health departments, in both the Western and Easter Cape, in 
the form of a research brief to help educate and raise awareness about the IUD. The 
specific outputs of the project will also be tailored to meet the needs of Government, 
and may include technical reports, policy briefs, and/or scientific publications. 
Intrauterine contraception is a safe, effective, reliable method that has few risks, many 
advantages and is particularly suited to a wide range of women. The method itself is 
cost-effective and is an especially useful addition to the contraceptive method mix 
where medical resources are scarce. Many women desire to use long acting, non-
hormonal methods of contraception to either stop or space births and the IUD can 
help stop unintended pregnancies which are expensive to both women and society. 
IUD use is low in South Africa because women are unaware of the method and 
providers lack skill and training to insert and remove it and lack knowledge to 
correctly counsel women about the IUD. However, despite these gaps, South African 
women are interested in learning more about the IUD and possibly using the method. 
South Africa could easily re-introduce the IUD into the contraceptive method mix, 
thereby increasing women's choice and adding a valuable and viable option to the 
contraceptive method mix. 
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Appendix 1 - Client Questionnaire 
Client Questionnaire: Increasing the Contraceptive Method Mix in South Africa: 
Knowledge, Attitudes, and Practices Surrounding the Intrauterine Device (IUD) 
Qs. # Item Responses Code for DE 
Interviewer Initials 
Date of Interview DD/MM/YYYY 
Participant ID Number 
Has the Participant completed the informed Yes=1 
consent process? No=2 
If No, complete consent before proceedina 
Demo,iraphic & socioeconomic characteristics 
100 How old are you? Age in years 
101 Are you currently working? 1=Yes 
2=No (Proceed to Qs.#103) 
102 What work do you do? 1= Scholar 
2= Student 
3= Homemaker 
4= Unemployed or seeking work 
5= Employed 
6= Government grant/pension 
?=Other, Specify: 
103 What language do you speak at home? 1=isiXhosa 
2=isiZulu 
3=Afrikaans 
4=English 
5=0ther, Specify: 
104 What is the highest level of O= No formal schooling 
schooling/education that you have 1 = Grade 1/Sub A 
completed? 2= Grade 2/Sub 2 3= Grade 3/Std 1 
4= Grade 4/Std 2 
5= Grade 5/Std 3 
6= Grade 6/Std 4 
7= Grade 7/Std 5 
8= Grade 8/Std 6 
9= Grade 9/Std 7 
1 O=Grade 10/Std 8 
11 =Grade 11 /Std 9 
12=Grade 12/Std 10 without matric 
13=Grade 12/Std 1 O with matric 
14=Some tertiary 
(Univ/Technikon/College, degree , 
dioloma, or certificate) 
105 A How many biological children of your own Enter number 
do vou have? 
B. How many boys do you have? How many Enter number 
girls do you have? Boys: 
Girls: 
106 How many children in total are you financially Enter number 
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responsible for? 
107 Are you currently in a sexual relat ionship with 1=Yes 
someone? 2=No 
If No, skip to Contraceptive Qs 
108 A. What is your current relationship status? 1 =Married cohabiting 
• Are you married? 2=Married , not cohabiting 
• Are you staying with your 3=Single: in stable relationship, 
husband now? cohabiting 
• If you are not married, are you 4=Single: in stable relationship, not 
in a relationship with a man cohabiting 
now? 5=Single: casual relationship 
• If you are in a relationship, do 
6=Single: no relationship now 
you see it as a long- ?=Client chose not to answer 
term/stable/permanent 8=0ther, specify: 
relationship or short-term/casual 
relationship? 
8 . If long-term/stable, are you staying with 1=Yes 
your partner now? 2=No 
3=0ther, specify: 
Contraceptives 
109 Are you currently using any form of 1=Yes 
contraception/ anything to prevent pregnancy 2=No (Proceed to Qs.# 112) 
when you have sex? 
110 If yes, which of the following methods of contraception/methods to prevent 
pregnancy are you (or your partner) using currently? 
(Interviewer read each one) 
A Oral contraceptive pill 1=Yes 
Women take a pill everyday 2=No 
9=Not Sure 
B 3-month injectable ('depo') 1=Yes 
Women have an injection every 3 2=No 
months, by a nurse or a doctor which 9=Not Sure 
stops them from qettinq preqnant 
C 2-month injectable ('nuristerate') 1=Yes 
Women have an injection every 2 2=No 
months, by a nurse or a doctor which 9=Not Sure 
stops them from aettina oreanant 
D Female sterilization 1=Yes 
Women have an operation that stops 2=No 
them from having any more children. In 9=Not Sure 
this operation, women have their tubes 
tied 
E Male steril ization 1=Yes 
Men have an operation that stops them 2=No 
from havinq any more children 9=Not Sure 
F Male condom 1=Yes 
Men put a rubber sheath on their 2=No 
penis before sexual intercourse 9=Not Sure 
G Female condom 1=Yes 
Women put a rubber sheath inside 2=No 
themselves/their vagina before sexual 9=Not Sure 
intercourse 
H Any other methods that we have not 1=Yes 
talked about? 2=No 
If Yes, specify: 
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11 1 Please tell me why you have chosen the method(s) that you are currently using? 
INTERVIEWER: Probe for all reasons!!! 
Method #1 (type: ) duration (Interviewer: For type, enter type# from 
above) 
Method #2 (type: ) duration (Interviewer: For type, enter type# from 
above) 
112 If no contraception is currently being used , why are you not using any contraception? 
(INTERVIEWER: PROBE FOR ALL REASONS) 
113 Please tell me all of the methods of contraception you have ever used in your life: 
A Oral contraceptive pill 1=Yes 
Women take a pill everyday 2=No 
9=Not Sure 
B 3-month injectable ('depo') 1=Yes 
Women have an injection every 3 months, by a 2=No 
nurse or a doctor which stops them from 9=Not Sure 
qettinq preqnant 
C 2-month injectable ('nuristerate') 1=Yes 
Women have an injection every 2 months, by a 2=No 
nurse or a doctor which stops them from 9=Not Sure 
aettina preanant 
D Male condom 1=Yes 
Men put a rubber sheath on their penis 2=No 
before sexual intercourse 9=Not Sure 
E Female condom 1=Yes 
Women put a rubber sheath inside 2=No 
themselves/their vagina before sexual 9=Not Sure 
intercourse 
F Emergency Contraception 1=Yes 
Also known as the morning after pill. Women 2=No 
can take these pills up to 72 hours after 9=Not Sure 
unprotected intercourse to prevent preqnancv 
G IUD (Intrauterine Device) 1=Yes 
Women have an IUD (copper Tor Loop) 2=No 
inserted by a health care provider and it 9=Not Sure 
prevents pregnancy 
H Any other methods that we have not talked 1=Yes 
about? 2=No 
3= Never have used any 
method of contraception 
If Yes, specify: 
114 Have you ever heard of Emergency 1=Yes 
L Contraception (EC / Morning after pill) 
2=No (Proceed to Qs.# 115) 
before? 3=Not sure 
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Have you ever used EC? 1=Yes 
2=No 
3=Not sure 
115 In the last 12 months have you had sex 1=Yes 
without using any: method of contraceQtion at 2=No (Proceed to Qs.# 117) 
.ell? 7=1NAP (no sex in 12 months) -Proceed to Qs.# 124 
116 If so, why? Why did you not use any contraception? 
117 In the last 12 months have you had sex Yes=1 
without using a condom? No=O (Proceed to Qs.# 118) INAP (no sex in 12 months)=?- Proceed to 
Qs.# 124 
118 If so, why? Why did you not use a condom? 
119 In the last 12 months, have you ever used Yes=1 
emergency contraception (the 'morning after No=O Never heard of emergency contraception=2 
pill ')? INAP (no sex in 12 months)=? 
Don't know=9 
120 In the last 12 months, have you ever had an 1=Yes 
abortion provided by a doctor or nurse? 2=No 
9=Not Sure 
121 In the last 12 months, have you ever had an 1=Yes 
abortion provided by someone who was not a 2=No 
doctor or nurse? 9=Not Sure 
Sexual Activity and Pregnancies 
122 How many different sexual partners have you Enter number 
had in the last 12 months? 
123 In the past month, about how many times 1 =About 1 time 
have you had sex? 2=About 2-10 times (about 1 time per 
week) 
3=About 11-20 times 
4=More than 20-30 times (about 1 time 
per day) 
124 A How many pregnancies have you had in Enter Number (if answer is 0, proceed to 
total? Qs.# 126) 
B. How old were you when you first got Enter number 
preqnant? 
125 When was your last pregnancy? Enter months or years 
126 Do you plan to have children/more children in 1=Yes 
the future? 2=No (Proceed to Qs.# 128) 
9=Not Sure 
127 If yes , when? 
128 The last time y:ou became 12regnant, did you O=Never been pregnant 
want to become pregnant then, did you want 1=Then 2=Later 
to wait until later, or did you want no (more) 3=No (more) 
children at all? 4=Don't know 
129 Have you ever had an unplanned O=Never been pregnant 
pregnancy? 1=Yes 
2=No 
130 How would you feel if you became pregnant 1 =Very happy 
in the next few months? (read all options) 2=Somewhat happy 
3=Mixed feelings 
4=Somewhat sad 
5=Verv sad/upset 
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6=0on't know 
-
131 How would your partner feel if you became 1 =Very happy 
pregnant in the next few months? (read all 2=Somewhat happy 
options) 3=Mixed feelings 4=Somewhat sad 
5=Very sad/upset 
6=0on't know 
?=No partner 
Client Questions 
1. Have you ever heard of the intrauterine 1 =Yes (if yes, proceed to next question) 
device, which is also called the IUD or the 2=No (if no, proceed to Qs.#21 -
Loop, and which is something that is inserted Explanation of IUD) 
by a nurse or doctor and sits in your womb to 
3=Not sure 
prevent preonancv? 
2. What do you think the IUD is? Can you 
please tell me about it? 
3. Where did you first hear about the IUD? 1 =Health service provider at this facility 
2=Health service provider at another 
facility 
3=PamphleUposter at health facility 
4=GP/Private doctor 
5=Newspaper/radio/television 
6=Husband/partner 
?=Mother 
8=0ther family member 
9=Friend 
10=School 
11 =Church 
12=0ther - specify 
13=Unsure 
4 . Has a health care provider ever discussed 1=Yes 
the possibility of using an IUD with you? 2=No 
3=Don't think so/ Not sure 
5. Has a health care provider ever suggested 1=Yes 
the IUD as an appropriate method of 2=No 
pregnancy prevention for vou? 3=Don 't think so/ Not sure 
6. Before this interview, did you hear or see 1=Yes 
anything about IUDs while you were here 2=No 
todav? 3=Can't remember /Unsure 
7. Do you think you could get an IUD at this 1=Yes 
clinic if you wanted one? 2=No 
3=Not sure 
8. Do you know how an IUD works? 1=Yes (if yes, 
explain) 
2=No 
3=1 think so 
4=Not really 
9. How long can a woman keep an IUD in for? 1=1 month 
2= 1-3 months 
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3=1 year 
4=1-5 years 
5=10 years 
10 Have you ever used an IUD? 1=Yes (Go on to next question) 
2=No (Go to Qs.# 21-Explanation of 
IUD) 
11 When did you last use an IUD? 1 =Using currently 
2=Used within the last year 
3=Used within last 5 years 
4=Used more than 5 years aqo 
12 How long have you been using/did you use 
the IUD for? How long was the IUD inserted 
for? (Answer in number of months) 
13 Where was your IUD inserted? 1 =At a clinic in South Africa 
2=At a private doctor in South Africa 
3=1n another country 
14 When your IUD was inserted, had you 1 =Client requested method 
requested it or did a health care provider 2=Health care provider suggested 
suggest the method? method 
3=Do not remember I Unsure 
15 When you started using the IUD, were you 1=Yes (Proceed to next question) 
given information about this method? 2=No (Proceed to Qs.# 17) 
3=Do not remember/ Unsure 
16 What information were you given? (probe) 
17 Do you know which type of IUD you 1 =Yes (if yes, please describe) 
use/used? 
2=Don't know 
18 What kind of experience did you have with 1=Very good 
the IUD? Was your experience ... (read all 2=Somewhat good 
choices) 3=Somewhat bad 
4=Verv bad 
19 Why did you start using the IUD? (probe) 
20 If you have stopped using the IUD, why did 1 =Wanted to get pregnant 
you stop? 2=Experienced side effects 
3=No longer wanted it 
4=Partner did not like it 
5=0ther 
(specify) 
21 Explanation of IUD: Just to make sure we are all on the same meaning of the IUD, I would like to now give 
you a short summary of the IUD method. IUD stands for intrauterine device. It is a small device wh ich is 
usually made of plastic and copper and which is inserted into a woman's womb (uterus) to prevent 
preqnancy. A trained provider uses a special tube to insert an IUD into the womb. When the IUD is in 
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place, it sits in the womb and short strings hang out of the cervix. These strings do not irritate the woman 
but rather they help the woman to make sure that the IUD is still in place in the womb. Also, the strings 
make it possible for health providers to remove the IUD at a later time. It is only possible for a health 
provider to remove an IUD. Women cannot remove them on their own. The IUD works by making it harder 
for sperm to fertilize an egg and by making it hard for a fertilized egg to implant in the womb. The IUD is 
99% effective at preventing pregnancy and some IUDs can stay in place and prevent pregnancy for up to 
ten years. The IUD is a very good method for women who want to prevent pregnancy for a number of 
years. Once the IUD is in place, it does not require routine maintenance to work correctly. Once the IUD is 
removed, it is possible to become pregnant again very quickly. Some common side effects of the IUD are 
pain or discomfort upon insertion, heavier periods and cramps. IUDs do not offer any protection from HIV 
and other STls. Although IUDs are used a great deal in other countries around the world , they are not used 
very frequently in South Africa. 
Tha IUD prevents the egg 
from implan ting in the womb l _ lall~n tu,,. 
ov.uy 
~vagina 
22 What do you think about this method? (Probe 
for whether respondent thinks the method is 
generally good or generally bad, any 
concerns the respondent may have about the 
IUD and wh . Record exact res onse! 
23 Do you see any advantages to using this 
method? 
24 What do you think the advantages are? 
25 Would you see any problems with this 
method? 
26 If you see problems, what are they? (Probe 
and write details) 
1=Yes (Proceed to Qs.# 24) 
2=No (Proceed to Qs.# 25) 
3=Ma be Proceed to Qs.#24 
1 =It is not yet familiar to me/I don't know 
enough 
2=1t is a safe method 
3=1t is an effective methodNery good at 
preventing pregnancy 
4=1t can be used for a long time 
5=0nce inserted, the IUD does not 
require routine maintenance 
6=The side effects are not serious 
?=Once the IUD is removed, fertility 
quickly returns 
8=Partner does not have to know about 
it 
9=1t cannot be felt during intercourse 
1 O=Men will approve of this method 
11=0ther 
1 =Yes (Proceed to Qs.# 26) 
2=No (Proceed to Qs.# 27) 
3=Ma be Proceed to Qs.#26 
1 =It is not yet familiar to me/I don't know 
enough 
2=1t might cause health problems 
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3=1t will harm the baby if it does not work 
4=Women might not be able to have 
babies properly later 
5=1t is abortion 
6=1t is immoral/against my religion 
?=It will cause women to get more STDs 
and maybe HIV 
8=Men may not approve of the method 
9=1t will make women 
promiscuous/women will misbehave 
1 O=Women will become lazy and forget 
they have an IUD if they do not have to 
worry about contraception for a long time 
11 =My partner won't allow me to use it 
12=1t could be painful 
13=1t could move to another place 
14=Don't know/ Unsure 
15=0ther / Specify 
27 Based on what you know, do you think you 1=Yes 
would consider using an IUD? 2=No 
3=Not sure/maybe 
28 Why or why not? (Record response) 
29 Do you think that IUDs are safe to use? 1=Yes 
2=No 
3=Don't know/ Unsure 
30 Do you think that IUDs are a good method to 1=Yes 
use for preventing pregnancy? 2=No 
3=Don't know/ Unsure 
31 Do you think the IUD is an easier or harder A. Pill / oral contraceptives, why? 
method to use than the .... (list all that apply) 1. Easier 2. Harder 
3. Not sure 
B. Injectable, why? 
1. Easier 
2. Harder 
3. Not sure 
C. Male condom, why? 
1. Easier 
2. Harder 
3. Not sure 
D. Female condom, why? 
1. Easier 
2. Harder 
3. Not sure 
61 
Os. # Item Responses Code for DE 
E. Female sterilization, why? 
1. Easier 
2. Harder 
3. Not sure 
32 Do you think that the following women could A. A teenage woman 
use an IUD? 1. Yes 
2. No 
3. Maybe/ Unsure 
8. A woman who has never had children 
1. Yes 
2. No 
3. Maybe/ Unsure 
C. A woman who has had a baby 
1. Yes 
2. No 
3. Maybe/ Unsure 
D. A woman who is breastfeeding 
1. Yes 
2. No 
3. Maybe/ Unsure 
E. A woman who has an STI currently 
1. Yes 
2. No 
3. Maybe/ Unsure 
F. A woman who has had an STI in the 
past 
1. Yes 
2. No 
3. Maybe/ Unsure 
G. A woman who has AIDS 
1. Yes 
2. No 
3. Mavbe/ Unsure 
33 Do you think that IUDs cause problems for 1 =Yes, explain : 
the women who use them? 
2=No 
3=Don't know/ Unsure 
34 Do you think that IUDs cause infertility/ a 1=Yes 
woman to be unable to get pregnant after 2=No 
using the method? 3=Don 't know/ Unsure 
35 Do you think that using an IUD increases a 1=Yes 
woman's chance of getting an STI? 2=No 
3=Don't know/ Unsure 
36 Do you think that using an IUD protects 1=Yes 
against STls? 2=No 
3=Don't know/ Unsure 
37 If a woman was using an IUD, do you think 1=Yes -why? 
that her sexual partner (your partner) would 
think it was an acceptable method? 
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2=No-Why? 
3=Unsure 
38 Do you think that the woman can feel the IUD 1=Yes 
during intercourse? 2=No 
3=Maybe/Unsure 
39 Do you think that the man can feel his 1=Yes 
partners' IUD during intercourse? 2=No 
3=Maybe/Unsure 
40 Do you know anyone who is using or has 1 =Yes (Proceed to Qs.# 41) 
used an IUD in the past? 2=No (Proceed to Qs.# 43) 
3=Maybe/Unsure (Proceed to Qs.# 
43) 
41 If yes, who? (Probe for relationship) 
42 What kind of experience did that person have 1=Very good 
using the IUD? 2=Somewhat good 
3=Somewhat bad 
4=Verv bad 
43 Do you think that most people know about 1=Yes 
IUDs? 2=No 
3=Unsure 
44 Do you think that more people would be 1=Yes 
interested in using the IUD if they had more 2=No 
information about it and it was offered more 3=Unsure 
reqularlv at family planninq services? 
45 Would you consider using the IUD if it was 1=Yes 
offered to you? 2=No 
3=Unsure/Mavbe 
46 Is there anything else you would like to know 
about the IUD? 
Thank you for your time. 
63 
Appendix 2 - Provider Questionnaire 
Provider Questionnaire: Increasing the Contraceptive Method Mix in South Africa: 
Knowledge, Attitudes, and Practices Surrounding the Intrauterine Device (IUD) 
Qs. # Item Responses Code for DE 
Interviewer Initials 
Date of Interview 
Participant ID Number 
Has the Participant completed the informed 
consent process? 
Knowledge 
1. Please name all of the methods of family 1 =The pill 
planning you suggest to clients at this clinic. 2=The IUD 3=3 month injection 
4=2 month injection 
5=Male condom 
6=Female condom 
?=Spermicide 
8=Diaphragm 
9=Female sterilization 
1 O=Male sterilization 
11 =Rhythm, calendar method 
12=Withdrawal 
13=Herbs 
14=0ther (specify) 
2. Have you ever heard of the IUD? 1 =Yes (Proceed to Qs.# 3) 
2=No (Proceed to explanation of the 
IUD and read . Then go to Qs.# 36) 
3=Maybe / Unsure (Proceed to 
explanation of IUD and read . Then go 
to Qs.# 36). 
3. Please tell me what you know about the IUD. 
(probe) 
4. A. Do you know about different types of IUDs? 1=Yes (Proceed to Qs.# 48) 
2=No (Proceed to Qs.# 4E) 
B. If yes , what types? (probe for types) 1. 
2. 
C. How does the first type that you mentioned 1 =It creates a spermicidal endometrium 
work to prevent pregnancy? 2=1t inhibits sperm transport, mobil ity and 
viability 
3=1t contains hormones that make getting 
pregnant difficult 
4=As an abortifacient 
5=Unsure 
6= Other (explain) 
64 
Qs. # Item Responses Code for DE 
D. How does the second type that you 1 =It creates a spermicidal endometrium 
mentioned work to prevent pregnancy? (list all 2=1t inhibits sperm transport, mobility and 
that are said) viability 
3=1t contains hormones that make getting 
pregnant difficult 
4=As an abortifacient 
5=Unsure 
6= Other (explain) 
E. (Only read if the provider did not know 1 =It creates a spermicidal endometrium 
about different types of IUDs) 2=1t inhibits sperm transport, mobility and 
viabil ity 
How does an IUD work to prevent 3=1t contains hormones that make getting 
pregnancy? (list all that are said) pregnant difficult 4=As an abortifacient 
5=Unsure 
6= Other (explain) 
5. If respondent knows about different types of IUDs, ask this question for each type, if not, ask it 
qeneral/y! 
A How long can an IUD be used for/ kept 1 =A few months 
in for? (type 1) 2=A year 
3=1-5 years 
4=10 years 
5= Unsure 
6= Other (specifv) 
B. How long can an IUD be used for/ kept 1 =A few months 
in for? (type 2) 2=A year 
3=1-5 years 
4=10 years 
5= Unsure 
6= Other (specifv) 
6. How well do you think the IUD works to 1 =Almost 100% 
prevent pregnancy? (read option) 2=0ver 75%, but less than 95% 
3=75% 
4=50%-74% 
5=25%-49% 
6=Less than 25% 
?=Unsure 
7. Do you think the IUD is better than or worse A. Pill / oral contraceptives 
than the following methods at preventing 1. Better 
pregnancy? 2 . Worse 3. Not sure 
B. Injectable 
1. Better 
2. Worse 
3. Not sure 
C. Male condom 
1. Better 
2. Worse 
3. Not sure 
D. Female condom 
1. Better 
2. Worse 
3. Not sure 
E. Spermicide 
1. Better 
2. Worse 
3. Not sure 
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F. Diaphragm 
I. Better 
2. Worse 
3. Not sure 
G. Female sterilization 
1. Better 
2. Worse 
3. Not sure 
H. Male steri lization 
1. Better 
2. Worse 
3. Not sure 
I. Rhythm , calendar method 
1. Better 
2. Worse 
3. Not sure 
J . Withdrawal 
1. Better 
2. Worse 
3. Not sure 
8. Do you think the IUD is safer or less safe A. Pill / oral contraceptives 
than the following methods? a. Safer b. Less safe 
C. Unsure 
B. Injectable 
1. Safer 
2. Less safe 
3. Unsure 
C. Male condom 
1. Safer 
2. Less safe 
3. Unsure 
D. Female condom 
1. Safer 
2. Less safe 
3. Unsure 
E. Spermicide 
1. Safer 
2. Less safe 
3. Unsure 
F. Diaphragm 
1. Safer 
2. Less safe 
3. Unsure 
G. Female sterilization 
1. Safer 
2. Less safe 
3. Unsure 
H. Male steril ization 
1. Safer 
2. Less safe 
3. Unsure 
9. Are there any medical reasons why women 1 =Yes (Proceed to Qs.# 10) 
shouldn 't use the IUD? 2=No (Proceed to Qs.# 11) 
3=Unsure (Proceed to Qs.# 11 ) 
10 What are those reasons? (list all that are 1 =Pregnancy 
mentioned) 2=Having PIO 
3=Having PIO wi thin the last three months 
4=Having an active STI 
5=Having an STI within the last three 
months 
6=Unexplained and/or abnormal vaginal 
bleeding 
7=A severely distorted uterine cavity 
8=Cervical , endometrial , or ovarian 
cancer that is awai ting treatment 
9=Allergy to any component of the IUD 
(ie. Cooner) 
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1 O=Pelvic tuberculosis 
11 =Unsure 
12=0ther (specify) 
11 Are there any side effects associated with 1 =Yes (Proceed to Qs.# 12) 
IUD use? 2=No (Proceed to Qs.# 13) 
3=Unsure ((Proceed to Qs.# 13) 
12 What are the common side effects? 1=Nausea 
2=Vomiting 
3=Headaches 
4=Cramping / abdominal pain 
5=Change in menstrual cycle 
6=More menstrual blood 
?=Less menstrual blood 
8=Pain during insertion 
9=Breast tenderness 
1 O=Depression 
11 = Pelvic Inflammatory Disease (PIO) 
12=Unsure 
13= Other (specify) 
13 Do you think there are any risks or problems 1=Yes (Proceed to Qs.# 14) 
associated with IUD use for the woman? 2=No (Proceed to Os.# 15) 
3=Not sure (Proceed to Qs.# 15) 
14 What are the risks? 1 =Developing PIO 
2=1nfertility 
3=Ectopic pregnancy 
4=Developing STls 
5=Uterine perforation 
6=0ther (specify) 
15 Can the IUD be used as a form of 1=Yes 
emergency contraception after unprotected 2=No 
intercourse? 3=Unsure 
16 Do IUDs offer any protection from STls? 1=Yes 
2=No 
3=Unsure 
17 Do IUDs increase ones risk of getting an 1=Yes 
STI? 2=No 
3=Unsure 
18 Can the IUD be used by a woman who has 1=Yes 
never given birth before? 2=No 
3=Unsure 
19 Do you feel that you have received A. Length of use 
sufficient training/ have sufficient knowledge 1. Yes 
about the IUD with respect to 2. No 
B. How it works to prevent pregnancy 
d. Yes 
e. No 
C. Medical reasons why certain women 
shouldn't use it 
1. Yes 
2. No 
D. Side effects 
1. Yes 
2. No 
E. Types of IUDs 
1. Yes 
2. No 
F. Safety 
1. Yes 
2. No 
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G. Efficacy/ How well is works 
1. Yes 
2. No 
H. How to insert it 
1. Yes 
2. No 
I. How to remove it 
1. Yes 
2. No 
J. Other (specify) 
Practices 
20 Does this clinic offer the IUD? 1=Yes 
2=No 
3=Unsure 
21 Are there guidelines for IUD usage in this 1=Yes 
clinic? 2=No 
3=Unsure 
22 Have you ever counselled a woman about 1=Yes 
the IUD method? 2=No 
3=Unsure 
23 Have you ever suggested that a client use 1=Yes (Proceed to Qs.# 24) 
an IUD? 2=No (Proceed to Qs.#25) 
3=Unsure 
24 How often do you suggest the IUD to 1 =At least once a week 
clients? 2=At least once a month 
3=At least once a year 
4=Never 
25 Have you ever been trained to insert the 1=Yes 
IUD? 2=No 
26 Have you ever inserted an IUD before? 1=Yes (Proceed to Qs.# 27) 
2=No (Proceed to Qs.# 28) 
27 If yes, when did you last insert an IUD? 1=This week 
2=This month 
3=Within the last six months 
4=Within the last year 
5=More than a year ago 
28 Have you ever referred a woman to another 1=Yes (Proceed to Qs.# 29) 
site for an IUD? 2=No (Proceed to Qs.# 30) 
3=Unsure (Proceed to Qs.# 30) 
29 Where or to whom did you refer her? 1 =Another provider in this facility 
2=Another facility 
3=GP/Private doctor 
4=0ther (specify) 
30 If you were to insert an IUD, how long after 1=0ne week 
insertion would you tell a client to come 2=Three to six weeks 
back for their first check-up? 3=Six months 
4=0ne year 
5=0ther (specify) 
31 If a client has an IUD, how often should they 1=Monthly 
return for check-ups? 2=Every six months 
3=Yearly 
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4=0ther 
32 If you had a client that was starting the IUD 1=How long IUD can be used for 
method, what information would you give to 2=Safety 
her about the method? 3=Efficacy - how well it works 4=Side effects - such as cramps or 
heavier periods 
5=When to return for follow up visits 
6=Preventing STls 
7=How to make sure the IUD is in place 
8=0ther (specify) 
33 Who is the IUD appropriate for? (list all that 1 =Women who desire to have more 
apply) children in the future 
2=Women who have never had children 
before 
3=Women who are done having children 
4=Women who are married 
5=Women who are not married 
6=Teenage women 
7=Women who are breastfeeding 
8=Women who are HIV-positive 
9=Women with a history of STls 
1 O=Women with no history of STls 
11 =Other (specify) 
34 Who is the IUD NOT appropriate for? (Circle 1 =Women who desire to have more 
all the are mentioned) children in the future 
2=Women who have never had children 
before 
3=Women who are done having children 
4=Women who are married 
5=Women who are not married 
6=Women who are breastfeeding 
7=Women who are HIV-positive 
8=Women with a history of STls 
9=Women with no history of STls 
1 O=Teenage women 
11 =Other (specify) 
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35 
ONLY READ THIS EXPLANATION TO PROVIDERS WHO DON'T 
KNOW ABOUT THE IUD!!! 
Explanation of IUD: Just to make sure we are all on the same meaning of the IUD, I would like to now give 
you a short summary of the IUD method . IUD stands for intrauterine device. It is a small device which is 
usually made of plastic and copper and which is inserted into a woman's womb (uterus) to prevent 
pregnancy. A trained provider uses a special tube to insert an IUD into the womb. When the IUD is in 
place, it sits in the womb and short strings hang out of the cervix. The strings help the woman to make sure 
that the IUD is still in place in the womb and make it possible for health providers to remove the IUD at a 
later time. The IUD works by making it harder for sperm to fertilize an egg and by making it hard for a 
fertilized egg to implant in the womb. The IUD is 99% effective at preventing pregnancy and some IUDs 
can stay in place and prevent pregnancy for up to ten years. The IUD is a very good method for women 
who want to prevent pregnancy for a number of years. Once the IUD is in place, it does not require routine 
maintenance to work correctly. Once the IUD is removed , it is possible to become pregnant again very 
quickly. Some common side effects of the IUD are pain or discomfort upon insertion, heavier periods and 
cramps. IUDs do not offer any protection from HIV and other STls. 
= -c·.:::;:-:-:_:=-_= 
Attitudes About the IUD 
36 Do you feel like you know enough about the 
IUD to counsel women about this method? 
37 Do you feel like you know enough about the 
IUD to be able to insert one? 
38 What do you see as the advantages of IUD 
use? (Do not read . Probe and record all 
options mentioned . If option not supplied in 
list, record under Other) 
1=Yes 
2=No 
3=Maybe/Unsure 
1=Yes 
2=No 
3=Need more training 
4=Unsure 
1 =Reduce unplanned/unwanted 
pregnancy 
2=Reduce teenage pregnancy 
3=Can be used as a form of emergency 
contraception (EC) 
4=Expand's women's choice 
5=Effective 
6=Safe 
?=Private 
8=Can be used by all women 
9=Can be used by HIV-positive women 
1 O=Cost-effective 
11 =Quick return to fertility upon removal 
12=The copper IUD is a non-hormonal 
method 
13=Don't see any advantages 
14=Unsure 
15=0ther (soeciM 
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39 What do you see as the disadvantages of 1 =Doesn't protect against STls / HIV 
the IUD? (Do not read . Probe and record all 2=1t is an abortifacient 
options mentioned. If option not supplied in 3=1t increases the risk of developing PID 
list, record under Other) 4=1t has side effects 5=Women may forget they have it 
6=1nitial costs for the device are high 
?=It requires training for insertion 
8=Don't see any disadvantages 
9=Unsure 
1 O=Other (specify) 
40 As a health care provider, would you A woman who desires to have more 
personally recommend the IUD to . .. children in the future? 
1. Yes 
2. No 
3. Unsure 
An unmarried woman? 
1. Yes 
2. No 
3. Unsure 
A woman who has never had a child? 
1. Yes 
2. No 
3. Unsure 
A woman who is HIV-positive? 
1. Yes 
2. No 
3. Unsure 
A woman who has AIDS? 
1. Yes 
2. No 
3. Unsure 
A woman who has had an STI in the past? 
1. Yes 
2. No 
3. Unsure 
A woman who has a current STI? 
1. Yes 
2. No 
3. Unsure 
A woman who doesn't use condoms? 
1. Yes 
2. No 
3. Unsure 
A teenage woman? 
f. Yes 
g. No 
h. Unsure 
41 Is there a minimum age below which you 
yourself would not provide an IUD to a 
woman? In other words , is there an age that 
you consider too young for a girl or woman 
to be qiven an IUD? (list aoe in vears) 
42 Do you have any concerns about the IUD? 1-Concern regarding medical safety 
Explain . (Do not read . Probe and record all (including risk of PID) 
options mentioned . If option not supplied in 2=Risk of infertility 
list, record under Other) 3=Concerns about side effects (such as 
excessive bleeding and uterine cramping) 
4=0ffers no protection from STls and HIV 
5=Concern regarding efficacy 
6=Cost of the method 
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?=Requires trained provider to insert 
8=0ther (specify) 
Provider Perceotions 
43 What do you see as the three main 1 =Lack of knowledge on the part of the 
obstacles or barriers to clients' access to provider 
and use of the IUD? 2=Lack of knowledge on the part of the potential user 
3=Lack of trained providers to insert or 
remove the device 
4=Moral/religious worries of potential 
users 
5=Moral/religious worries of potential 
providers 
6=Providers belief that IUD is an 
abortifacient 
?=IUD is never available at this facility 
8=1UD is often out of stock 
9=1UD does not offer protection from STls 
1 O=Many myths and misperceptions 
11 =Other (specify) 
44 Do you think that women would use the IUD 
method if they knew about it? 
Why or why not? 
45 Do you think that women's partners would 1=Yes 
support their use of the IUD as a method for 2=No 
preventing pregnancy? 3=Unsure/Maybe 
4=0ther (specify) 
46 Why do you think use of the IUD is low in 
South Africa? 
47 Do you th ink the IUD is a good family 1 =Yes, 
planning method for South Africa? Why or 
why not? Explain . 
2=No, 
3=Maybe/unsure 
48 Do you think that greater IUD use should be 1 =Yes, 
promoted in South Africa? Why or why not? 
2=No, 
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General Information / Moving Forward 
49 Do you th ink you need to know more about 1=Yes 
the IUD in order to counsel women on this 2=No 
method? 
50 What aspect of the IUD would you like to 
know more about? (Record response) 
Thank you for your time. 
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Appendix 3A - Participant consent form 
University of Cape Town 
Women's Health Research Unit 
School of Public Health and Family Medicine 
PARTICIPANT CONSENT FORM 
Increasing the Contraceptive Method Mix in South Africa: Knowledge, Attitudes, and 
Practices Surrounding the Intrauterine Device (IUD) 
We are from the Women's Health Research Unit at the University of Cape Town and 
the Department of Obstetrics & Gynaecology at Walter Sisulu University. We are 
gathering some information on what women know about a contraceptive method 
called the intrauterine device, also known as the IUD. Your participation in this 
interview is completely voluntary. Whether or not you decide to participate in this 
interview will not affect your health care at this or any other clinic now or in the 
future. 
If you decide to participate: 
• This will involve you answering short questions for about 20 minutes. 
• All of the information that you provide will be completely confidential and will 
only be viewed and used by the researchers on this project. The health care 
providers at this clinic will not see this information. 
• We will record the information on a form so that we know what you have said, but 
we will never record your name or anything that could be used to identify you 
anywhere on the study form so your participation is completely anonymous. 
• You have the right to decide not to participate in the study, to refuse to answer any 
question, or to withdraw from the study at any time without any penalty. 
• All information gathered will be identified only by a clinic and unique participant 
number and kept in confidential files. No individual identifying information will 
be obtained and no identifying information will be disclosed in reports, 
publications, or presentations. 
• The information you provide may help us to improve reproductive health services 
for all women in the Western Cape Province. 
• If there is anything that is unclear or if you need further information, please ask us 
and we will provide it. Do you have any questions? 
Participant Volunteer Declaration: 
I have read the above information, or it has been read to me. I have had the 
opportunity to ask questions about it and any questions that I have asked have been 
answered to my satisfaction. I consent voluntarily to participate as a subject in this 
study and understand that I have the right to withdraw from the study at any time 
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without in any way affecting my medical care at this or any other clinic now or in the 
future . 
Please indicate your consent with your name. 
Thank you. 
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Appendix 3B - Provider consent form 
University of Cape Town 
Women' s Health Research Unit 
School of Public Health and Family Medicine 
PROVIDER CONSENT FORM 
Increasing the Contraceptive Method Mix in South Africa: Knowledge, 
Attitudes, and Practices Surrounding the Intrauterine Device (IUD) 
We are from the Women's Health Research Unit at the University of Cape Town and 
the Depa1iment of Obstetrics & Gynaecology at Walter Sisulu University. We are 
gathering some information on what women know about a contraceptive method 
called the intrauterine device, also known as the IUD. Specifically we are going to ask 
you for information about the services that you provide, your experience with the 
IUD, and your experiences as a provider of health care services in this clinic. Your 
participation in this interview is completely voluntary. 
If you decide to participate: 
• This will involve you answering short questions for about 20 minutes. 
• All of the information that you provide will be completely confidential and will 
only be viewed and used by the researchers on this project. 
• We will record the information you give us on a form so that we know what you 
have said, but we will never record your name or anything that could be used to 
identify you anywhere on the study form. Your participation is completely 
anonymous. 
• You have the right to decide not to participate in the study, to refuse to answer any 
question, or to withdraw from the study at any time without any penalty. 
• All information gathered will be identified only by a clinic and unique participant 
number and kept in confidential files. No individual identifying information will 
be obtained and no identifying information will be disclosed in reports, 
publications, or presentations. 
• The information you provide may help us to improve reproductive health services 
for all women in the Western Cape Province. 
• If there is anything that is unclear or if you need further information, please ask us 
and we will provide it. Do you have any questions? 
Provider declaration 
• I have understood that the purpose of the study is to gain information on what 
women know about the intrauterine device, as well as the contraceptive services 
that I provide, my experiences as a provider of the IUD, and my experiences as a 
provider of health care services in this clinic. 
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• I have read the above information. I have had the opportunity to ask questions 
about it and any questions that I have asked have been answered to my 
satisfaction. I consent voluntari ly to participate in this study and understand that I 
have the right to withdraw from the study at any time without penalty. 
Please indicate your consent with your signature. 
Signature of Volunteer Date 
Signature of Investigator Date 
Thank you. 
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Appendix 4 - Project Timeline 
Project timeline of activities over 7 months . 
Month 
1 2 3 4 5 6 7 
Sta1t-u12 
Finalise study instruments xx 
Insti tutional approvals * xx 
Cage Town fieldwork 
Site set-up xx 
Client interviews xxxx xx 
Provider interviews xx X 
Umtata fieldwork 
Site set-up xx 
Client interviews xx xxxx 
Provider interviews X xx 
Data analysis xxxx 
Regorting xxxx 
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Appendix 5 - Tables of Results 
Table 5.1: Total number of clinics and patiicipants 
A total of 205 women from 4 clinics participated in this survey. The number of 
women surveyed at each clinic is presented in Table 5.1. 
Table 5.1. Number of participants per clinic 
Province Facility Name Number of participants Number of participants 
oer facilitv, n (%) Total 
Langa Clinic 52 (25.4) n=205 
Wes tern Cape Weltevreden Clinic 53 (25.9) 
Mhlakulo Clinic 50 (24.4) 
Eastern Cape Mbekweni Clinic 50 (24.4) 
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Table 5.2: Client Socio-demographic characteristics 
The socio-demographic characteristics of participants in the Western and Eastern 
Cape and at each of the four clinics surveyed are summarized in Table 5.2. The mean 
age of women participating in this survey was 25.9 years and the mean age of 
participants was a bit older in the Western Cape (27.8) as opposed to the Eastern Cape 
(24.0). Most of the participants (50.7%) were between the ages of 20 and 29 years. 
Most participants (82.0%) had at least some secondary school education. Only about 
half of the participants (42.1%) said that they were employed at the time of the 
interview and about one-quarter of participants were scholars (24.9%). Almost 100% 
(99.5%) of participants spoke isiXhosa as their main language. 
Table 5.2. Socio-demographic characteristics of clients 
Western Cape 
w.c. 
Eastern Cape 
Characteristic Langa Weltevreden Total Mhlakulo Mbekweni E.C. Total 
Clinic Clinic n=53 n=/05 Clinic Clinic n=JOO 
n=52 n=50 n=50 
Mean age in years (SD) 28.9(9.1) 26.6 (6.7) 27.8 24.8 (8.3) 23.1 (6.7) 24.0 (7.6) (8.0) 
Age categories, n (%) 
15-19 7 (13.5) 8 ( 15.1) 15 16 (32.0) 16 (32.0) 32 (32.0) ( 14.3) 
20-29 28 (53.9) 28 (52.8) 56 21 (42.0) 27 (54.0) 48 (48.0) (53.3) 
30-39 8 (15.4) 14(26.4) 22 9 (18.0) 3 (6.0) 12 (12.0) (21.0) 
40-49 9 (17.3) 3 (5.7) 12 4 (8.0) 4 (8.0) 8 (8.0) (11.4) 
Employment status- 23 (44.2) 24(45.3) 47 20 (40.0) 18 (38.3) 38 (39.2) currently working, n (%) (44.8) 
Type of work, n (%) 
Scholar 14(26.9) 7(13.2) 21 14 (28.0) 16 (32.0) 30.0 (20.0) (30.0) 
Student 0 0 0 I (2.0) I (2.0) 2 (2.0) 
Homemaker 4 (7.7) 0 4 (3.8) 0 9 (18.0) 9 (9.0) 
Unemployed or seeking 22 (42.3) 0 22 0 24 (48.0) 24 (24.0) work (20.1) 
Employed 9(17.3) 10 (18.9) 19 3 (6.0) 0 3 (3 .0) (18.1) 
Government I (1.9) 0 I ( 1.0) 0 0 0 grant/pension 
Other 0 6(11.3) 6 (5.7) 2 (4.0) 0 2 (2.0) 
Main language spoken, n 
(%) 
Xhosa 52 53 (100.0) 105 49 (98.0) 50 (100.0) (100.0) (100.0) 99 (99.0) 
Zulu 0 0 0 I (2.0) 0 1 ( 1.0) 
Level of education, n (%) 
No formal schooling 0 0 0 0 0 0 
Grade I -Grade 7 6 (11.5) 8 ( 15 . I) 14 2(4.0) IO (20.0) 
(primary) ( I 3.3) 12(12.0) 
Grade 8-Grade 12 41 (78.9) 41 (77.4) 82 46 (92.0) 40 (80.0) 86 (86.0) (secondary) (78.1) 
Tertiary 5 (9.62) 4 (7.6) 9 (8.6) 2 (4.0) 0 2 (2.0) 
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Total 
n=205 
25.9 
(8.0) 
47 
(22.9) 
104 
(50. 7) 
34 
(16.6) 
20 (9.8) 
85 
(42.1) 
51 
(24.9) 
2 ( 1.0) 
13 (6.3) 
46 
(22.4) 
22 
(10.7) 
I (0.5) 
8 (3.9) 
204 
(99.5) 
1 (0.5) 
0 
26 
(12.7) 
168 
(82.0) 
11 (5.4) 
Table 5.3 : Sexual and Reproductive characteristics of Clients 
The sexual and reproductive characteristics of clients are presented in table 5.3. The 
mean number of biological children was 1.9 with the average being higher in the 
Eastern Cape with 2.2 children compared with 1.7 in the Western Cape. Most women 
reported that they were in a current sexual relationship (95.1 %) and just more than 
half (52.7%) stated that they were single but in a stable non-cohabitating relationship. 
Only 18% reported being married and cohabitating. The mean number of sexual 
partners within the last year was 1.2 with the overwhelming majority (94.6%) 
reporting O to2 partners in the last year. Of those reporting sexual intercourse within 
the last month, 60% said they had sex 2 to 10 times (about once a week) in the last 
month with women in the Western Cape more frequently reporting 2 to 10 sexual 
encounters (73.3%) as compared to women from the Eastern Cape (46.0%). The mean 
age at first pregnancy was 19.3 years with the age at first pregnancy being older for 
women in the Western Cape (20.1) as compared to the Eastern Cape (18.4) . The mean 
number of pregnancies was 2.1 with women in the Western Cape having a lower 
mean number of pregnancies (1.9) than women in the Eastern Cape (2.4). Also, the 
mean number of time since last pregnancy was 3.8 years for the whole sample but 
again, the Western Cape participants reported a larger space ( 4. 6 years) than women 
from the Eastern Cape (2.9 years). Fifty-seven percent of participants reported having 
had an unplanned pregnancy (with the amount being similar between the Western and 
Eastern Capes - 55.2% vs. 59.0%) and 34.7% reported that their pregnancy was 
mistimed while another 16.1 % said their most recent pregnancies were not wanted at 
all. In addition, although 45.9% said they planned to have children in the future, 78% 
said that they would be somewhat sad or very sad if they became pregnant within the 
next few months. Participants were also asked about how they believed their partners 
would feel about a pregnancy in the next few months. Women were split in their 
responses and 34.1 % said that their partners would be happy or somewhat happy if 
they became pregnant, 35.6% said their partners would be somewhat sad or very upset 
if they became pregnant, and 20% said they did not know how their partners would 
react. 
Table 5.3. Sexual and reproductive history of clients 
Western Cape Eastern Cape 
w.c. E.C. 
Characteristic Langa Weltevreden Total Mhlaku/o Mbekweni Total 
Clinic Clinic n=l05 Clinic= 8 Clinic= 8 n=JOO 
n=52 n=53 n=50 n=50 
Mean number of biological 
children in total sample- mean 1.2 (0.9) 1.4 (1.0) l.3 ( 1.0) 1.8 (1.8) 1.4 (1.7) 1.6 (l .8) 
(SD) 
Mean number of biologica l 
children among those with I .6 (0.7) 1.8 (0.8) I .7 (0.8) 2.3 ( 1.8) 2.0 (1.7) 2.2 (1 .7) 
children- mean (SO) 
Sex breakdown of children -
mean (SD) 
Boys 1.2 (0.4) I .5 (0 .6) 1.3 (0.6) I .6 (0.0 .8) I .5 (0.5) I .6 (0.7) 
Female I .3 (0.6) 1.3 (0.5) I .3 (0.5) I .6 (1.0) 1.7 ((1.4) 1.6 (1 .2) 
Mean number of children 
for whom financially I .2 (0.9) 1.9(1.8) l.6 ( 1.5) 2.2 (2. 1) 1.5 (l.5) 1.8 (2. 1) 
responsible (SD) 
Currently in a sexual 48 (92.3) 49 (92.5) 97 49 (98 .0) 49 (98.0) 98 
relationship, n (%) (92.4) (98.0) 
Relationship Status, n (%) 
Married cohabiting 4 (7 .7) I 7 (32. 1) 2 1 11 (22.0) 5 ( 10.0) 16 (20.0) ( 16.0) 
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Total 
n=205 
1.4 ( l .4) 
l .9(1.3) 
1.4 (0 .6) 
I .5 (0.9) 
1.7 ( 1. 8) 
195 
(95. I) 
37 (18. 1) 
Married, not cohabiting 2 (3 .9) 0 2 ( 1.9) 2 (4.0) 4 (8.0) 6 (6.0) 8 (3 .9) 
Single: in stable 8 (15.4) 5 (9.4) 13 3 (6.0) 3 (6.0) 6 (6.0) 19 (9.3) 
relationship, cohabiting (12.4) 
Single : in stab le 52 56 108 
relationship, not 34 (65.4) 18 (34 .0) (49.5) 19 (38.0) 37 (74 .0) (56.0) (52.7) 
cohabiting 
0 9(17.0) 9 (8.6) 14 (28 .0) 0 14 23 (11.2) Single: casual relationship (14.0) 
Single: no relationship 3 (5.8) 0 3 (2.9) 0 0 0 3 ( 1.5) 
now 
Living with current partner, n 12(23.1) 20 (37.7) 32 9(18 .0) 8 (16 .0) 17 49 (23.9) (%) (30.5) (17.0) 
Mean number of sexual 1.25 partners in last 12 months 1.1(0.4) 1.2 (0.6) 1.2 (0.6) 1.3 (0 .6) 1.2 (0.5) (0.6) 1.2 (0 .6) (SD) 
0-2 sexual pa11ners 52 (100.0) 49 (92 .5) 101 43 (86.0) 50 (100.0) 93 194 (96.2) (93.0) (94.6) 
>2 sexual partners 0 4 (7 .6) 4 (3.8) 7 (14.0) 0 7 (7 .0) 11 (5.4) 
Amount of intercourse in last 
month, n (%) 
1 time 2 (3.9) 8 (15.1) 10 (9 .5) 2(4.0) 6 (12.0) 8 (8.0) 18 (8 .8) 
2-10 times 38(73.1) 39 (73.6) 77 24 (48.0) 22 (44.0) 46 123 (73.3) (46.0) (60 .0) 
11-20 times 2 (3.9) 0 2 ( 1.9) 9(18 .0) 5(10.0) 14 16(7.8) (14.0) 
Mean number of total 1.8 ( 1.0) 2.0 (1.4) 1.9 (1.2) 2.6(2.1) 2.2 (1.9) 2.4 (2.0) 2.1 (1.6) pregnancies (SD) 
Mean age at first pregnancy, 20.1 (3.2) 20.1(4.1) 20.1 18.4 (3.1) 18.5 (2.4) 18.4 19.3 (3.4) (SD) (3.7) (2.8) 
Mean time elapsed since last 69.3 42.4 (44.9) 55.2 35.3 36.0 35.6 45.7 pregnancy - in months (SD) (70.5) (59.6) (31 .0) (37.9) (34.1) (49.7) 
Planning to have children in 25 (48.1) 20(37.7) 45 16 (32.0) 33 (66.0) 49 94 (45 .9) the future, n (%) - Yes (42.9) (49.0) 
Timing of future children, n 
(%) 
When employed 12 (23 . 1) 1 ( 1.9) 13 2 (4.0) 4 (8.0) 5 (4.8) 19 (9 .3) (12.4) 
When older / in the future 1 ( 1.9) 12(22.6) 13 13 (26.0) 19 (38.0) 32 45 (22.0) (12.4) (32.0) 
When married I (1.9) 4 (7 .6) 5 (4.8) 3 (6.0) 8 (16.0) 11 16(7.8) (I I .0) 
Feelings towards last 
pregnancy - timing, n (%) 
Wanted child then 14(29.8) 19 (36.5) 33 11 (22.0) 9(18.0) 20 53 (26.6) (33.3) (20.0) 
Wanted child later 22(46.8) 11 (21.2) 33 14 (28 .0) 22 (44.0) 36 69 (34.7) (33.3) (36.0) 
Did not want more 3 (6.4) I I (21.2) 14 I 5 (30.0) 3 (6 .0) 18 32(16. 1) 
children ( 14.1) (18.0) 
Ever had unplanned 30 (57.7) 28 (52.8) 58 30 (60.0) 29 (58.0) 59 117 pregnancy, n (%) (55.2) (59.0) (57 .1) 
Feelings towards a pregnancy 
in next few months, n (%) 
Very haooy 0 I ( 1.9) I ( 1.0) 0 I (2.0) I ( 1.0) 2 ( 1.0) 
Somewhat happy II (21.2) 3 (5.7) 14 0 7 (14.0) 7 (7.0) 21(10.2) (13 .3) 
Mixed feelings 2 (3.9) 8 (15 . 1) 10(9.5) 3 (6.0) I (2 .0) 4 (4.0) 14 (6 .8) 
Somewhat sad 2 (3.9) 4 (7 .6) 6 (5 .7) 7 (14.0) 12 (24.0) 19 25 (12.2) (19.0) 
Very sad/upset 37 (71.2) 34 (64.2) 71 35 (70.0) 29 (58 .0) 64 135 (67.6) (64.0) (65 .9) 
Don't know 0 3 (5.7) 3 (2.9) 5 (10.0) 0 5 (5.0) 8 (3.9) 
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Feelings of partner towards a 
pregnancy in next few months , 
n (%) 
Very happy l I (21.2) 18 (34.0) 29 10 (20.0) 4 (8.0) 14 43 (21.0) (27.6) (14.0) 
Somewhat happy 7 (13.5) l (2.0) 8 (7.6) 4 (8.0) 15 (30.0) 19 27 (13.2) (19.0) 
Mixed feelings 5 (9.6) 6 (11.3) 11 2 (4.0) 0 2 (2.0) 13 (6.3) ( I 0.5) 
Somewhat sad 6(11.5) 3 (5.7) 9 (8.6) 5(10.0) 8 (16.0) 13 22 (10.7) ( 13.0) 
Very sad/upset 17 (32.7) 8 (15. l) 25 14 (28.0) l2 (24 .0) 26 51 (24.9) (23.8) (26.0) 
Don't know 4 (7 .7) 13 (24.5) 17 13 (26.0) 11 (22.0) 24 4 l (20 .0) (16.2) (24.0) 
No partner 2 (3.9) 4 (7.6) 6 (5.7) 2 (4.0) 0 2 (2.0) 8 (3.9) 
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Table 5.4: Contraceptive characteristics of Clients 
The contraceptive practices of study participants are presented in Table 5.4. At the 
time of interview, 92.7% were using a method of contraception. The most commonly 
used method was the injectable (81.5%) with 46.8% using the three-month and 34.6% 
using the two-month injectable, and was followed by the male condom (51.7%). A 
greater proportion of women in the Western Cape were using injectables and male 
condoms as opposed to women in the Eastern Cape. 98 .5% of all respondents had 
ever used a contraceptive method and the most commonly ever used methods were 
the 2-month injectable (76.1 %), male condom (63.9%), the 3-month injectable 
(63.4%) and the pill (41.0%). 26 .3% of women had heard of emergency contraception 
but only 2% had ever used EC. Far more women in the Western Cape as opposed to 
the Eastern Cape had heard of EC (41.0% vs. 11.0%) and all of the women who had 
ever used EC lived in the Western Cape. 27.8% had intercourse in the last 12 months 
without using any method of contraception and 63 .4% had sex without using a 
condom within the last 12 months. 
Table 5.4. Contraceptive characteristics, among ever sexually active clients 
Western CaJJe WC. Total Eastern CaJJe E.C. Total Characteristic langa Weltevreden 
n=l05 Mhlakulo Mbekweni Total n=205 
n=52 n=53 n=50 n=50 n=lOO 
Currently using 88 (88.0) 190 (92.7) 
contraception, n 49 (94.2) 53 (100.0) 102(97.1) 39 (78.0) 49 (98.0) 
(%) 
Type of Method, n 
(%) 
Oral 5 (9.6) 4 (7.6) 9 (8.6) I (2.0) 5 (10.0) 6 (6.0) 15 (7.3) 
contraceptive pill 
Injectable 47 (90.4) 46 (86.8) 93 (88 .6) 32 (64.0) 42 (84 .0) 74 (74.0) 167 (81.5) 
3-month 34 (65.4) 34 (64.2) 68 (64.8) 13 (26.0) 15 (30 .0) 28 (28.0) 96 (46.8) 
2-month 13 (25.0) 12 (22.6) 25 (23.8) 19 (38.0) 27 (54.0) 46 (46.0) 71 (34 .6) 
Female 0 0 0 1 (2.0) 0 I (1.0) I (0.5) 
sterilization 
Male sterilization 1 (1.9) 1 ( 1.9) 2 (1.0) 0 0 0 2 ( 1.0) 
Male condom 37 (71.1) 28 (52.8) 65 (61 .9) 18 (36.0) 23 (46.0) 41 (41.0) 106(51.7) 
Female condom 4 (7.7) 0 4 (3.8) 0 0 0 4 (2.0) 
Ever used a 52 (100 .0) 53 (100.0) 105 48 (96.0) 49 (98.0) 97 (97.0) 202 (98.5) 
contraceptive (100.0) 
method, n (%) 
Oral 22 (42.3) 26(49.1) 48 (45.7) 22 (44.0) 14 (28.0) 36 (36 .0) 84 (41.0) 
contraceptive pill 
Injectable 
3-month 39 (75.0) 40 (75.5) 79 (75.2) 28 (56.0) 23 (46.0) 51 (51.0) 130 (63.4) 
2-month 40 (77.0) 45 (84.9) 85 (8 I .0) 35 (70.0) 36 (72.0) 71(71.0) 156(76.1) 
Male condom 41 (78.9) 38 (71.7) 79 (75.2) 26 (52.0) 26 (52.0) 52 (52 .0) 131 (63.9) 
Female condom 4 (7 .7) 0 4(3.8) 0 0 0 4 (2 .0) 
Emergency 2 (3.9) 0 2 (2.0) 0 0 0 2 ( 1.0) 
contraception 
IUD 3 (5 .8) 2(3.8) 5 (4.8) 0 0 0 5 (2.4) 
Ever heard of 33 (63.5) 10 (18.9) 43 (41.0) 7 (14.0) 4 (8 .0) 11(11.0) 54 (26.3) 
emergency 
contraception, n (%) 
Ever used 4 (7.7) 0 4 (3.8) 0 0 0 4 (2.0) 
emergency 
contraception, n (%) 
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Sex in last 12 16(30.8) 10 (18 .9) 26 (24 .8) 10 (20.0) 21 (42.0) 3 I (31.0) 57 (27.8) 
months without a 
contraceptive 
method, n (%) 
Sex in last 12 27 (5 1.9) 36 (67.9) 63 (60.0) 3 I (64.6) 34 (69.4) 65 (67.0) 128 (63.4) 
months without a 
condom, n (%) 
Use of emergency 0 0 0 0 0 0 0 
contraception in last 
12 months, n (%) 
Abortion in last 12 0 0 0 0 0 0 0 
months provided by 
doctor or nurse, n 
(%) 
Abortion in last 12 0 0 0 2 ( 4.4) 0 2 (2.1) 2 ( 1.0) 
months not provided 
by doctor or nurse, n 
(%) 
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Table 5.5: Client Awareness, Knowledge and Use of the IUD 
Participant's awareness, knowledge and use of the IUD are presented in Table 5.5. 
Only 25.8% of women had ever heard of the IUD. Of this small number, more women 
in the Western Cape (36.2%) as opposed to the Eastern Cape (15%) had heard of the 
IUD. In cases where women reported that they had heard of the IUD, most said they 
had heard of the method through a friend (34%), through their school (26.4%), or 
through a family member other than their mothers (11.3%). Only 3 women (6%) had 
ever used an IUD and all three of those women were in the more urban Western Cape. 
Of those who had heard of the IUD, only 20.8% of respondents said that a health care 
provider had ever discussed the method with them. Of that same number, only 11.3% 
reported that a health care provider had ever recommended the IUD as an appropriate 
contraceptive method. No respondent had seen information about the IUD prior to 
their interview. 
Not surprisingly then, overall knowledge about the IUD was poor. Only 8% believed 
that they knew how the IUD worked. When asked to describe an IUD, only 45 
women (22%) were able to give any correct information. When discussing the length 
of time that the IUD could be used for, no respondent said 10 years, the maximum 
limit for a copper IUD, while the majority (10.2%) said that the IUD could be used 
for 1 to 5 years. This suggests a lack of understanding of the IUD as a long-term 
contraceptive method. 
Table 5.5. Client Awareness, Knowledge and Use of the IUD 
Western Cape WC. Eastern Cape E.C. Total Total Characteristic l =langa 2= Weltevreden Total 7=Mhlakulo 8=Mbekweni n(%)= /00 N(%)= 
n(%)=52 n(%) =53 n(%)=105 n(%) =50 n(%)=50 205 
Ever heard of the IUD 30 (57.7) 8(15.1) 38 (36.2) 7(14.0) 8(16.0) 15(15.0) 53 
(25.8) 
Women who can correctly 24 (46.2) 8 ( 15 . 1) 32 (30.5) 6 (12.0) 7 (14.0) 13 (13.0) 45 ' 
describe what an IUD is (22.0) 
Where heard of the N=JO N=8 N=38 N=7 N=8 N=/5 N=53 
IUD 
Health service provider 2 (6.7) 0 2 (5.3) 0 1 (12.5) 1 (6 .7) 3 (5.7) 
at this facility 
Health service provider I (3 .3) 2 (25.0) 3 (7.9) 1 (14.3) I (12.5) 2(13.3) 5 (9.4) 
at another facility 
Pamphlet/poster at 0 1 (12.5) I (2.6) 0 0 0 I ( I. 9) 
health facility 
Newspaper/ radio/ 0 0 0 0 1 (12.5) I (6.7) I (1.9) 
television 
Mother 0 1 (12.5) I (2 .6) 0 0 0 I (1.9) 
Other family member I (3 .3) 3 (37.5) 4 (10.5) 2 (28.6) 0 2(13.3) 6(11.3) 
Friend 13(43 .3) I ( 12.5) 14 (36.8) I (14.3) 3 (37.5) 4 (26.7) 18 
(34.0) 
School 10 (33.3) 0 IO (26.3) 2 (28.6) 2 (25.0) 4 (26.7) 14 
(26.4) 
Other 2 (6.7) 0 2 (5 .3) I ( 14.3) 0 I (6.7) 3 (5.7) 
Unsure 1 (3 .3) 0 I (2.6) 0 0 0 I (1.9) 
Health care provider has 6 (20.0) 2 (25.0) 8 (21.1) 2 (28.6) I ( 12.5) 3 (20.0) 11 
ever discussed the IUD with (20.8) 
them 
86 
Health care provider ever 4 (13.3) I ( 12.5) 5 (13.2) 1 (14.3) 0 I (6.7) 6 (11.3) 
suggested the IUD as an 
appropriate contraceptive 
method 
Ever heard or seen 0 0 0 0 0 0 0 information about IUD 
prior to interview 
Women who believe they 2 (6.7) 3 (37.5) 5 (13.2) 0 4 (50.0) 4 (26.7) 9 (17.0) I 
could get an IUD at the 
clinic if they wanted one 
Women who believe they 2 (7.1) I ( 12 .5) 3 (8.3) I (16.7) 0 I (7.1) 4 (8.0) know how an IUD works 
How long women believe N=/8 N=7 N=25 N=6 N=5 N=ll N=36 
an IUD can be used for 
Less than a year 9 (17.3) 2 (3.8) II (10.5) 2 (400) 2 (4.0) 4 (4 .0) 15 
(7.32) I - 5 years 9(17.3) 5 (9.4) 14 (13.3) 4 (8.0) 3 (6.0) 7 (7.0) 21 
(10.2) IO years 0 0 0 0 0 0 0 Women who have ever used 2 (7 .1) I (14.3) 3 (8.6) 0 0 0 3 (6.1) 
an IUD 
Most recent IUD use N=2 N=l N=3 N=O N=O N=O N=3 
Using currently 0 0 0 0 0 0 3 Used within the last year 0 0 0 0 0 0 ( I 00.0) Used within last 5 years 0 0 0 0 0 0 Used more than 5 years 2 (100.0) I (100.0) 3 (100.0) 0 0 0 
ago 
Mean amount of time (in 3 (2-4) 48 (48-48) 18 (2-48) 0 0 0 
months) that women used 
the IUD 
Location of IUD N=2 N=l N=3 N=O N=O N=O N=3 
insertion 
At a clinic in South I (50.0) I ( I 00.0) 2 (66.7) 0 0 0 3 Africa (I 00 .0) At a private doctor in 1 (50.0) 0 1 (33.3) 0 0 0 South Africa 
Reason for IUD N=2 N=l N=3 N=O N=O N=O N=3 
insertion 
Client requested method 1 (50.0) I (100 .0) 2 (66.7) 0 0 0 3 (%) ( I 00.0) Health care provider I (50.0) 0 I (33.3) 0 0 0 
suggested method (%) 
Women given information 2 (100.0) 0 2 (66.7) 0 0 0 2 (66.7) about IUD when starting 
the method 
Women who knew what I (50.0) 0 1 (33.3) 0 0 0 1 (33.3) type of IUD they used 
Experiences using the IUD 
Good 1 ( 1.9) 0 1 ( 1.0) 0 0 0 1 (0.5) Bad I (1.9) 0 1 ( 1.0) 0 0 0 I (0.5) Reasons for stopping use of N=O N=l N=I N=O N=O N=O N=I the IUD 
Wanted to get pregnant 0 I (100.0) I (100.0) 0 0 0 I 
(I 00.0) 
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Table 5.6: Client's attitudes towards the IUD method 
Participant's attitudes towards the IUD method are presented in Table 5.6. Overall, 72 .7% of women said that they would consider using the IUD. After hearing a brief description of the IUD method, most women (89.7%) reported that they thought there 
were advantages to using the IUD. More women in the Western Cape (94.3%) than in the Eastern Cape (84.9%) reported such advantages. The most commonly cited 
advantage was that the IUD can be used for a long time (63.9%). Other commonly 
mentioned advantages were that the IUD is effective at preventing pregnancy (47.8%) 
and that once the IUD is removed, fertility returns quickly (39%). 14.2% of 
respondents said that they saw disadvantages to using the IUD, with more women from the Eastern Cape (21%) than the Western Cape (7.6%). Very few women believed that the IUD caused health problems for the women who use them (7.8%) 
while 86.3% reported that they think the IUD is safe (91.4% in the Western Cape and 81 % in the Eastern Cape) and 87.8% reported that they think the IUD is effective at preventing pregnancy. 
When the IUD was compared to other contraceptive methods, it fared well. Women 
said that the IUD was easier to use than oral contraceptive pills (87.3%), female 
sterilization (84.9%), the injectable (78.5%), the male condom (58.5%), and the female condom (47.3%). Impressively, many women said that male and female 
condoms were easier to use than the IUD because condoms would protect from both pregnancy and STis while the IUD would only stop pregnancy. 
When asked whom they believed were correct candidates for IUD use, 95.1 % of 
women said that they believed that women who had already had a child could use an IUD while only 53.7% thought a nulliparous woman could use an IUD. For other groups, 72 .7% said that teenagers, 31.9% said that women with HIV, and 29.8% said 
women with STis could use the IUD. 
Overall , women seemed to have positive attitudes about the IUD. Only 10.3% said they thought the IUD caused problems for the women who used them while only 2% believed the IUD causes infertility and 22.6% thought the IUD increases a woman's 
chance of contracting STis. Most of the negative press surrounding the IUD and PID 
appears to not have had a great impact on this population. Only 10.2% of women 
reported knowing a woman who had ever used an IUD and 96.1 % think that most 
women do not know about the IUD method. However, a promising 87.3% think that 
women would be interested in the IUD and at the end of the interview, 74.5% said that they would consider using the IUD if it was offered to them. 
Table 5.6. Client's attitudes towards the IUD method 
Western Cape WC. Eastern Cape 
E.C. Total Characteristic Langa Weltevreden Total Mhlakulo Mbekweni N= /00 N =52 N=53 N= /05 N=50 N=50 Women who see an advantage to 52 (100.0) 47 (88.7) 99 (94.3) 37 (74.0) 47 (95.9) 84 (84.9) using the IUD, n (%) 
Types of advantages of the N=52 N=47 N=99 N=37 N=47 N=84 IUD*, n ( % ) 
It is not yet fam iliar to me/ I 0 4 (7.6) 4 (3 .8) 5 (10.0) 0 5 (5 .0) don't know enough 
It is a safe method 24 (46.2) 17(32.1) 41(39.1) 3 (6.0) 2 (4.0) 5 (5.0) It is an effective method / 35 (67 .3) 29 (54 .7) 64(61.0) 20 (40.0) 14 (28.0) 34 (34.0) Very good at preventing 
pregnancy 
It can be used for a long time 42 (87 .8) 3 1 (58 .5) 73 (69.5) 27 (54 .0) 3 1 (62.0) 58 (58.0) 
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Total 
N=205 
183 (89.7) 
N=/83 
9 ( 4.4) 
46 (?2.4) 
98 (47.8) 
13 1 (63.9) 
Once inserted, the IUD does 5 (9.6) 14(26.4) 19(18.1) 11 (22.0) 2 (4.0) 13 ( 13.0) 32(15.6) 
not require routine 
maintenance 
The side effects are not 35 (67 .3) 6(11.3) 41 (39.1) 3 (6.0) 24 (48.0) 27 (27.0) 68 (33.2) 
senous 
Once the IUD is removed, 28 (53.9) 14 (26.4) 42 (40.0) 15 (30.0) 23 (46.0) 38 (38.0) 80 (39 .0) 
fert ility quickly returns 
Partner does not have to I ( I. 9) 8 ( 15. 1) 9 (8.6) 5 ( 10.0) I (2.0) 6 (6.0) 15 (7.3) 
know about it 
It cannot be felt during 6 ( 11 .5) 0 6 (5.7) 0 2 (4.0) 2 (2 .0) 8 (3.9) 
intercourse 
Men will approve of this 0 0 0 0 I (2 .0) I ( 1.0) I (0.5) 
method 
Other 8(15.4) 4 (7.6) 12 ( 11 .4) I (2.0) 0 1 (1 .0) 13 (6.3) 
Women who see a disadvantage 5 (9.6) 3 (5.7) 8 (7.6) 9(18 .0) 12 (24.0) 2 1 (21.0) 29 (14.2) 
to using the IUD *, n (%) 
It is not yet familiar / don ' t 3 (5 .8) 4 ( 1.6) 7 (6.7) 2(4.0) 4 (8.0) 6 (6 .0) 13 (6.3) 
know enough 
It might cause health 2 (3.9) 3 (5.7) 5 (4.8) IO (20.0) I (2.0) II (11.0) 16 (7.8) 
prob lems 
It wi ll cause women to get 0 0 0 2 (4 .0) 0 2 (2 .0) 2 ( 1.0) 
more STDs and maybe HIV 
It could be painful 1 ( 1.9) 2 (3 .8) 3 (2 .9) 5 (10.0) 3 (6.0) 8 (8 .0) 11 (5.4) 
It could move to another 3 (5 .8) 0 3 (2.9) 2 (4.0) 3 (6 .0) 5 (5.0) 8 (4.0) 
place 
Other I Specify 0 1 ( 1.9) I (1.0) 0 4 (8 .0) 4 (4.0) 5 (2.4) 
Women who would consider 45 (86.5) 42 (79.3) 87 (82 .9) 29 (58.0) 33 (66.0) 62 (62.0) 149 (72.7) 
using the IUD, n (%) 
Women who think the IUD is 52 ( 100.0) 44 (83.0) 96 (91.4) 36 (72.0) 45 (90.0) 81 (81.0) 177(86.3) 
safe, n (%) 
Women who think the IUD is a 50 (96.2) 45 (84.9) 95 (90.5) 38 (76.0) 47 (94.0) 85 (85.0) 180 (87 .8) 
good method for preventing 
pregnancy 
Methods the IUD is easier or N=50 N=49 N=99 N=46 N=47 N=93 N=/92 
harder to use than, n (%): 
A. Pill / oral contraceptives 
Easier 50 (96 .2) 43 (8 1.1) 93 (88.6) 44 (88.0) 42 (84.0) 86 (86.0) 179 (87.3) 
Harder 2 (3 .9) 0 2 ( 1.9) 0 8 (16.0) 8 (8.0) 10 (4.9) 
B. Injectable 
Easier 45 (86.5) 46 (86.8) 91 (86.7) 36 (72.0) 34 (68.0) 70 (70.0) 161 (78.5) 
Harder 4 (7 .7) 1 ( 1.9) 5 (4 .8) 5 (10.0) 14 (28 .0) 19 (19.0) 24 ( 11.7) 
C. Male condom 
Easier 43 (82 .7) 28 (52.8) 71 (67.6) 27 (54.0) 22 (44.0) 49 (49.0) 120 (58.5) 
Harder 5 (9.6) 16 (30.2) 21 (20.0) 14 (28.0) 25 (50.0) 39 (39.0) 60 (29 .3 ) 
D. Female condom 
Easier 43 (82 .7) 15 (28 .3) 58 (55.2) 17 (34.0) 22 (44.0) 13 (12.4) 97 (47.3) 
Harder 5 (9.6) 8(15 .1) 39 (39.0) 9 ( 18.0) 24 (48.0) 33 (33.0) 46 (22.4) 
E. Female sterilization 
Easier 45 (86 .5) 46 (86.8) 91 (86.7) 43 (86.0) 40 (80.0) 83 (83.0) 174 (84.9) 
Harder 7 (13 .5) 1 ( 1.9) 8 (7 .6) 0 8 (16.0) 8 (8.0) 16 (7.8) 
Perceptions of which women can N =52 N=51 N=/03 N=47 N= 50 N=97 N=200 
use the IUD, n (%) 
A. A teenage woman 37 (71.2) 37 (69.8) 74 (70.5) 34 (68.0) 41 (82.0) 75 (75.0) 149 (72.7) 
B. A woman who has never 30 (57.7) 31 (58.5) 61 (58.1) 19 (38.0) 30 (60.0) 49 (49 .0) 11 0 (53.7) 
had children 
C. A woman who has had a 51 (98.1) 51 (96.2) I 02 (97.1) 43 (86.0) 50 (100.0) 93 (93 .0) 195(95 .1) 
baby 
D. A woman who is 52 (100.0) 50 (94.3) I 02 (97.1) 38 (76.0) 48 (96 .0) 86 (86.0) 188 (91.7) 
breastfeeding 
E. A woman who has an ST! 34 (65.4) 4 (7.6) 38 (36.2) 8(16.0) 15 (30.0) 23 (23.0) 61 (29.8) 
currently 
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F. A woman who has had an 41 (78.9) 38 (71.7) 79 (75.2) 31 (62.0) 28 (56.0) 59 (59.0) 138 (67.3) STI in the past 
G. A woman who has AIDS 37 (72.6) 12 (22 .6) 49 (47.1) 7(14.0) 9 (18.0) 16 (16.0) 65(31 .9) 
Women who think the IUD 5 (9.6) I ( I. 9) 6 (5.7) 5 ( I 0.2) IO (20.0) 15 (15.2) 21 (10.3) 
causes problems for the women 
who use them, n (%) 
Women who think the IUD 1 ( I. 9) 0 I ( 1.0) I (2.0) 2 (4.1) 3 (3.0) 4 (2.0) 
causes infertility, n (%) 
Women who think having an 2 (3.9) 7 (13.2) 9 (8.7) 20 (40.0) 17 (34.0) 37(37.0) 46 (22.6) IUD increases a woman's 
chance of getting an STI, n (%) 
Women who think using an IUD 8(15.4) 0 8 (7.8) 0 I (2 .0) I ( 1.0) 9 ( 4.4) protects against STis, n (%) 
Women who think the IUD 30 (57.7) 17 (32.7) 47 (45.2) 16 (32.0) 22 (44.0) 38 (38.0) 85(41.7) 
would be an acceptable method 
to the woman's sexual partner, n 
(%) 
Women who think the woman 6 ( I 1.5) 2 (3.8) 8 (7.6) 2(4.0) 8(16.0) 10 (10.0) 18 (8 .8) 
can feel the IUD during 
intercourse, n (%) 
Women who believe a sexual 2 (3.9) 0 2 ( 1.9) 0 6 (12.0) 6 (6 .0) 8 (3.9) partner will be able to feel the 
IUD during intercourse, n (%) 
Women who know someone 14 (26.9) 5 (9.4) 19 (18.1) 2 (4.0) 0 2 (2.0) 21 (10.2) 
who has used an IUD in the past, 
n (%) 
Experience of the person who N= /3 N=5 N=/8 N=2 N=I N=3 N=21 had that IUD, n (%) 
Good 9 (17.3) 3 (5.7) 12 (11.4) 2 (4.0) I (2.0) 3 (3.0) 15 (7.3) Bad 4 (7.7) 2 (3.8) 6 (5.7) 0 0 0 6 (2.9) Women who think most people 3 (5.8) 1 ( 1.9) 4 (3.8) 0 4 (8.0) 4(4.0) 8 (3.9) know about the IUD, n (%) 
Women who think more women 51 (98.1) 46 (86.8) 97 (92.4) 37 (74.0) 45 (90.0) 82 (82.0) 179 (87.3) would be interested in the IUD 
method, n (%) 
Women who would consider 45 (86.5) 42 (80.78) 87 (83.7) 32 (64.0) 33 (66.0) 65 (65.0) 152 (74.5) using the IUD if it was offered to 
them, n (%) 
* Women could have answered more than once in this section of questions. 
Table 5.7: Awareness ofIUD by clinic 
Respondent's awareness of the IUD by clinic is presented in Table 5.7. The most 
respondents had heard of the IUD at the urban Langa clinic (14.6% of the total). 
Table 5.7. Awareness ofIUD by clinic 
Awareness of Awareness of 
Clinic JUD, n (%) by JUD, % of Total 
Cape 
Western Cape 
Langa ( N=52) 30 (57.7) 14.6 
Weltevreden (N=53) 8(15.1) 3.9 
Eastern Cape 
Mhlakulo (N=50) 7 (14.0) 3.4 
Mbekweni (N=50) 8 (16.0) 3.9 
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Table 5.8: Client Characteristics Associated with Awareness ofIUD 
Respondent characteristics associated with awareness of the IUD are presented in Table 5.8. The characteristics associated with awareness of the IUD were living in the Western Cape, older age, being single or in casual relationship, and having used 
emergency contraception. Women in the Western Cape were significantly more likely to know about the IUD method (36%) than women in the Eastern Cape (15%) (p=0.001). Older age was also associated with awareness of the IUD method with 
older women (women 30 to 39 at 47.1 % and women 40 to 49 at 60.0%) reporting higher awareness of the method than younger women (women aged 20 to 29 at 19% 
and women 15 to 19 at 89.4%), p=0.000. Although it was not significant, women with 
a higher level of education ( 45% tertiary level) were more likely to know about the IUD than women who only had a secondary or primary level education (25% 
secondary and 23% primary). Single women or women in a casual relationship were 
more likely to know about the IUD (18.5%) than married women and women in stable 
relationships (6.8%), p=0.02. Women who had ever heard of emergency 
contraception were significantly more likely to have heard of the IUD than women 
who had never heard of EC (50 vs. 17.2%, p=0.000). 
Table 5.8. Client Characteristics Associated with Awareness ofIUD 
Characteristic Aware of IUD Not Aware of IUD ?-value n(%) n(%) Overall 53 (25.9) 152(74.1) Province 
Western Cape 38 (36.2) 67 (63.8) 0.001 Eastern Cape 15 (15.0) 85 (85.0) Age (years) 
15-19 5 (I 0.6) 42 (89.4) 20-29 20 (19.2) 84 (80.8) 0.000 30-39 16 (47.1) 18(52.9) 40-49 12 (60.0) 8 (40.0) Employment status 
Yes 21 (24.7) 64 (75 .3) 0.7 No 32 (27.4) 85 (72.7) Education 
Primary school only 6 (23.1) 20 (76.9) 
0.3 Secondary school only 42 (25.0) 126 (75.0) Tertiary 5 ( 45 .5) 6 (54.6) Currently in a sexual relationship 
Yes 50 (25.6) 145 (74.4) 0.8 No 3 (30.0) 7 (70.0) Relationship Status 
Married / Stable relationship 14 (6.8) 31 (15.1) 0.02 Single/ Casual relationship 38 (18.5) 115(56.1) Ever had unplanned pregnancy 
Yes 31 (26.5) 86 (73.5) 0.2 No 14 (33.3) 28 (66.7) Currently using contraception 
Yes 49 (25.8) 141 (74.2) 1.0 No 3 (25.0) 9 (75.0) Current Method 
0.8 Oral contraceptive pill I (16.7) 5 (83.3) Injectable 21 (27.6) 55 (72.4) 3-month 14(30.4) 32 (69 .6) 2-month 7 (23.3) 23 (76.7) Female sterilization 0 0 Male sterilization 1 (50.0) l (50.0) Condom Only (male + female) I (12.5) 7 (87.5) 
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Dual Methods 27 (27.0) I 73 (73.0) Ever used a contraceptive method 
Yes 53 (26.2) I 149 (73 .8) 0.3 No 0 I 3 (2.0) Ever heard of emergency contraception, n (%) 0.000 Yes 27 (50.0) I 27 (50.0) No 26 (17.2) I 125 (82.8) 
Table 5.9: Client Characteristics Associated with Ever Use of IUD 
We had hoped to report on the characteristics associated with ever using the IUD. Unfortunately, only three (3) women in our sample of 205 had ever used the IUD, 
making bivariate analysis inappropriate. 
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Table 5.10: Client Characteristics Associated with Positive Attitudes about IUD 
The respondent characteristics associated with positive attitudes about the IUD are presented in Table 5.10. The only statistically significant characteristic associated with having positive attitudes about the IUD method was having ever used a contraceptive method. Ever use of a contraceptive method is significantly associated with having positive attitudes about the IUD (92%) as opposed to those who have never used a contraceptive (33.3%, 1 person) who had positive attitudes about the IUD (p=0.000). However, this is not a meaningful test since almost every person sampled had used a contraceptive method (almost 99%), suggesting no significant variation in the sample population. This is not surprising considering we recruited our sampled from women attending family planning services. 
There are other characteristics that seem associated with positive attitudes towards the IUD but these were not significant. Those currently using a contraceptive method were more likely to have positive attitudes about the IUD (92%) compared to those not using a method (83.3%). Although this association was not significant, it can be said that it was approaching significance with p=0.2. Those who were single or in a casual relationship were more likely to have positive attitudes about the IUD (67.8%) than women who were married or in a stable relationship (20%). This was not significant with the current sample size (p=0.3) . Lastly, age, although not significant (p=0.4), was a predictor of attitudes towards the IUD with older women (40-49) being more likely to have positive attitudes towards the IUD (95%) than younger women (14-19) who only had positive attitudes towards the IUD 85% of the time. 
Table 5.10. Client Characteristics Associated with Positive Attitudes about IUD 
Positive Attitudes Negative Attitudes Characteristic about JUD about IUD P-value 
n (%) n (%) Overall 187 (91.2) 18 (8.8) 
Province 
Western Cape 97 (92.4) 8 (7.6) 0.5 Eastern Cape 90 (90.0) 10(10.0) Age (years) 
15-19 40(85.1) 7 (14.9) 20-29 97(93 .3) 7 (6.7) 0.4 30-39 31 (91.2) 3 (8.8) 40-49 19 (95.0) I (5.0) Employment status 
Yes 77 (90.6) 8 (9.4) 0.7 No I 08 (92.3) 9 (7.7) Education 
Primary school only 24 (92.3) 2 (7.7) 
0.5 Secondary school only 152 (90.5) 16(9.5) Tertiary 11 (100.0) 0 Currently in a sexual relationship 
Yes 178 (91.3) 17 (8.7) 0.9 No 9 (90.0) I (10.Q) Relationship Status (%) 
Married/ Stable relationship 4 l (20.0) 4 (2.0) 0.3 Single/ Casual relationship 139 (67.8) 14 (6.8) Ever had unplanned pregnancy 
Yes I 07 (91.5) IO (8.6) 0.4 No 40 (95.2) 2 ( 4.8) Currently using contraception 
Yes 175 (92.1) 15 (7.9) 0.2 No 10 (83.3) 2 (16.7) 
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Current Method 
Oral contraceptive pill 6 (100.0) 0 Injectable 67 (88.2) 9 ( I I. 8) 3-month 40 (87.0) 6(13.0) 2-month 27 (90.0) 3 ( I 0.0) 0.3 Female sterilization 0 0 Male sterilization 2 (100 .0) 0 Condom (male+ female) 7 (87.5) I (12.5) Dual Method 95 (95.00) 5 (5.0) Ever used a contraceptive method 
Yes 186 (92.1) 16 (7.9) 0.000 No l (33.3) 2 (66.7) Ever used emergency contraception 0.2 Yes 3 (75.0) I (25.0) No 76 (95.0) 4 (5.0) 
94 
Table 5.11: Client Characteristics Associated with Considering IUD use in the Future 
The respondent characteristics associated with considering IUD use in the future are presented in Table 5.11. Women in the Western Cape (83%) are significantly more likely to consider use of the IUD in the future than women in the Eastern Cape (62%), p=0.000. Currently using contraception was associated with considering use of the IUD (74.7%) compared to those who were not currently using contraception (41.7%) and the association was statistically significant, p=0.02. Those currently using the 3-month injectable (78.3%) and those using dual protection (77%) were more likely to consider IUD use in the future. This association was approaching significance (p=0.13). Also, being single or in a casual relationship was associated with considering use of the IUD (76.5%) as compared to being married or in a stable relationship (20%). This association was approaching significance (p=0.2). Age, although not significant (p=0.4), was a predictor of future IUD use with women over the age of twenty being more likely to consider use of the IUD (70-80%) than women who are 15 to 19 years old (64%). Increasing education was also associated with considering IUD use in the future although the association was not significant (p=0.4). Women with tertiary level education (91 %) were far more likely to consider use of the IUD than women with only secondary (73%) or primary (65.4%) level education. 
Table 5.11. Client Characteristics Associated with Considering IUD use in Future 
Considering Use Not Considering Characteristic of JUD Use of!UD P-value 
n (%) n (%) Overall 149 (72.7) 41 (20.0) Province 
Western Cape 87 (82.9) 9 (8.6) 0.000 Eastern Cape 62 (62.0) 32 (32.0) Age (years) 
15-19 30 (63.8) 11 (23.4) 20-29 79 (76.0) 20 (19.2) 0.4 30-39 24 (70 .6) 6(17.7) 40-49 16 (80.0) 4 (20.0) Employment status 
Yes 62 (72.9) 13 (15.3) 0.08 No 86 (73.5) 26 (22.2) Education 
Primary school only 17 (65.4) 8 (30.8) 
0.4 Secondary school only 122 (72.6) 32(19.1) Tertiary 10(90.9) I (9.1) Currently in a sexual relationship 
Yes 142 (72.8) 39 (20.0) 0.9 No 7 (70.0) 2 (20.0) Relationship Status (%) 
Married / Stable relationship 30 (20.1) 13 (31. 7) 0.2 Sin_gle / Casual relationship 114 (76.5) 27 (65.9) Feelings towards last pre_gnancy - timing 
Wanted child then 39 (73.6) 10(18.9) 
0.4 Wanted child later 54 (78.3) 13 (18.8) Did not want more children 2 1 (65.6) 9 (28.1) Ever had unplanned pregnancy 
Yes 87 (74.4) 24 (20.5) 0.7 No 29(69.1) 9(21.4) Currently using contraception 
Yes 142 (74.7) 37(19.5) 0.02 No 5 ( 41.7) 4 (33.3) 
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Current Method 
Oral contraceptive pill 4 (66.7) 2 (33.3) Injectable 56(73.7) 16 (21.1) 3-month 36 (78.3) 8 ( 17.4) 2-month 20 (66.7) 8 (26.7) 0.13 Female sterilization 0 0 Male sterilization 2 ( 100.0) 0 Condom (Male + Female) 5 (62.5) 2 (25 .0) Dual Method 77 (77.0) 17(17.0) Ever used a contraceptive method 
Yes 149 (73 .8) 40 (20 .0) 0.000 No 0 I (33.3) Ever used emergency contraception 
Yes 3 (75.0) I (25.0) 0.13 No 66 (82.5) 11 ( 13.8) 
Table 5.12: Res12ondent's feelings about whether the IUD is easier or harder to use than other contraceptive methods 
Respondent's feelings about whether the IUD is easier or harder to use than other contraceptive methods are presented in Table 5 .12. In total, participants believed that the IUD was an easier contraceptive method to use than the oral contraceptive pill, the injectable, the male and female condoms, and female sterilization. The only methods that were closer in ease to the IUD were the male and female condoms and most people listed that these were easier to use because they protected a woman from both pregnancy and STis where as the IUD would only protect a woman from pregnancy. 
Table 5 .12. IUD easier/harder to use than other methods Characteristic Western Cape WC Eastern Cape E.C. Total Total 
Langa Weltevreden Total Mhlakulo Mbekweni n=/00 n=205 n=/05 IUD vs Pill / oral 
contraceptives 
Easier 50 (96.2) 43(81.13) 93 (88.6) 44 (88.0) 42 (84.0) 86 (86.0) 179(87.3) Harder 2 (3.9) 0 2 (1.9) 0 8(16.0) 8 (8.0) 10 (4.9) IUD vs Injectable 
Easier 45 (86.5) 46 (86.8) 91 (86.7) 36 (72.0) 34 (68.0) 70 (70.0) 161 (78.5) Harder 4 (7 .7) 1 ( 1.9) 5 (4.8) 5 (10.0) 14 (28.0) 19 (19.0) 24 (11. 7) IUD vs Male condom 
Easier 43 (82.7) 28 (52.8) 71 (67.6) 27 (54.0) 22 (44.0) 49 (49.0) 120 (58.5) Harder 5 (9.6) 16 (30 .2) 21 (20.0) 14 (28.0) 25 (50.0) 39 (39.0) 60 (29.3) IUD vs Female condom 
Easier 43 (82.7) 15 (28.3) 58 (55 .2) 17 (34.0) 22 (44.0) 39 (39.0) 97 (47.3) Harder 5 (9.6) 8 (15.1) 13 (12.4) 9 (18.0) 24 (48.0) 33 (33.0) 46 (22.4) IUD vs Female sterilization 
Easier 45 (86.5) 46 (86.8) 91 (86.7) 43 (86.0) 40 (40 .0) 83 (83 .0) 174 (84.9) Harder 7 ( 13 .5) I ( 1.9) 8 (7.6) 0 8 (16.0) 8 (8.0) 16 (7.8) 
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Table 5.13: Logistic regression model for factors associated with awareness of IUD 
After adjusting for level of education, being from the Western Cape, one's age, and having heard of EC all independently predicted awareness of the IUD method. Women from the Western Cape were two times more likely to have heard of the IUD than women from the Eastern Cape (OR=2.13; 95% CI 0.99 - 4.58). Women who 
were between the ages of 30 to 39 years were three times more likely to have heard of the IUD than women between the ages of 15 to 29 years (OR=3.05; 95% CI 1.29 -7.20) and women who were between the ages of 40 to 49 years were almost eight times more likely to have heard of the IUD than women between the ages of 15 to 29 years (OR=7.75; 95% CI 2.68 - 22.42). Also, women who had heard of EC were 3 times more likely to have heard of the IUD than women who had not heard of EC (OR=3.22; 95% CI 1.46 - 7.11). The difference in awareness of the IUD between 
women who had a tertiary education and those who did not was non-significant (OR=l.23; 95% CI 0.32 - 4.79) . 
. xi: logistic qlheardIUDrecode cape2 i.agecat2 i.educcat2 q114heardec2 i.agecat2 Iagecat2_1-4 (naturally coded; _Iagecat2_1 omitted) i.educcat2 Ieduccat2 1 - 3 (naturally coded; Ieduccat2_1 omitted) 
Logistic regression 
Log likelihood= -95.508153 
qlheardIUD-e I Odds Ratio Std. Err. z 
Number of obs 
LR chi2(5) 
Prob> chi2 
Pseudo R2 
205 
43.31 
0.0000 
0.1848 
[95% Conf. Interval] 
- ------------+------ ---------------------- ------------ ------ ----- ------- · -- ---cape2 2.127865 .8312252 1.93 0.053 .9895373 4.575682 
_Iagecat2_3 3.045217 1. 336513 2.54 0. 011 1.288354 7.197829 
_Iagecat2_4 7 . 745867 4.200579 3.77 0.000 2.675864 22.42209 Ieduccat2 3 1.230858 .853901 0.30 0.765 .316003 4. 794291 - -q114heardec2 3.217701 1.301154 2.89 0.004 1.456606 7.10803 
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Table 5.14: Logistic regression model for factors associated with positive attitudes towards the IUD 
Only one factor, having ever used contraception, was significantly associated with having positive attitudes about the IUD. However, 18 women did not have positive attitudes about the IUD and only 3 women had never used contraception. These numbers were too small for modeling . 
. tab q22feelingstoIUD 
q22feelings I 
toIUD I Freq. Percent Cum. 
- - - - - - - - - - - -+- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
o I 
1 I 
18 
187 
8.78 
91. 22 
8.78 
100.00 
- -- - - - - -- -- -+- - - - - - - - - - -- - - - - - - - - - - - - - - - - --- - -- -
Total I 205 
tab qll3contraevertotal 
qll3contrae I 
vertotal I Freq. 
100.00 
Percent Cum. 
-- - -- - - -- - - -+- - - - - - - - - - - - -- - - - - - - - - - - - -- - - - -- - - -
o I 
1 I 
3 
202 
1. 46 
98.54 
1. 46 
100.00 
-- - - - - - --- --+- - - - - - - - - - -- - - - - - - - - - - - - - --- -- - - - - -Total I 205 100.00 
xi: logistic q22feelingstoIUD qll3contraevertotal 
Logistic regression 
Log likelihood= -57 . 829317 
q22feeling-D I Odds Ratio Std. Err. z 
Number of obs 
LR chi2{1) 
Prob> chi2 
Pseudo R2 
205 
6.29 
0 . 0122 
0.0516 
P>jzj [95% Conf. Interval) 
-------------+----------------------------------------------------------------qll3contra-l I 23.25 29.11246 2.51 0.012 1.997984 270.5539 
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Table 5.15: Logistic regression model for factors associated with considering IUD use in the future. 
After adjusting for age and level of education, being from the Western Cape was the only characteristic that independently predicted whether a woman would consider use of the IUD in the future. Women from the Western Cape were four times more likely to consider the IUD use than women from the Eastern Cape (OR=4.76; 95% CI 2.07 -10.91). 
. xi: logistic 
i.agecat2 
i.educcat2 
considerIUDfut cape2 
_Iagecat2_1-4 
Ieduccat2 1-3 
Logistic regression 
Log likelihood= -93.063969 
considerIU-t I Odds Ratio Std. Err. 
i.agecat2 i.educcat2 q109current (naturally coded; _Iagecat2_1 omitted) (naturally coded; Ieduccat2_1 omitted) 
z 
Number of obs 
LR chi2(5) 
Prob> chi2 
Pseudo R2 
205 
19.04 
0.0019 
0.0928 
P>lzl [95% Conf. Interval) 
-------------+--------- --------------- ----------------- - ----------------------cape2 4.760794 2.016699 3.68 0.000 2.075419 10.92077 
_Iagecat2_3 .8657564 .4552099 -0.27 0.784 .3089148 2.426346 
_Iagecat2_4 .8498155 .5344546 
-0.26 0. 796 .2477412 2.915083 Ieduccat2 3 1.751239 1.976356 0.50 0.620 .1917452 15.99435 -q109current .6767525 .4204086 -0.63 0.530 .2002862 2.286698 
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Table 5 .16: Provider Characteristics 
The characteristics of providers in the Western and Eastern Cape are summarized in 
Table 5.16. Although a total of 32 providers took part in the survey, background 
characteristics were only available for 27 providers. Of those 55.6% were professional 
nurses, 33.3% were chief or senior professional nurses, and 3.7% were enrolled or 
staff nurses. Fourieen of the providers (52%) were the manager or supervisor of the 
facility. The mean number of years that a provider had been working at the facility 
was 4.3 and the mean number of years since the provider had finished their basic 
training was 13 years. 59.3% of providers had completed a family planning course, 
l 00% of the providers had been trained to provide HIV care services, and 81.5% had 
been trained to provide STI care services. In the last six months, 96.3% of providers 
had provided family planning, 88.9% had provided HIV care services, and 96.3% had 
provided STI diagnosis and treatment. 
Table 5 .16. Provider characteristics 
Western Cape Eastern Cape Total 
Characteristic n (%) n (%) n (%) 
n=II n=16 n=27 
Rank 
Chief I Senior professional nurse 2(18 .2) 7 (43.8) 9 (33.3) 
Professional nurse 7 (63.6) 8 (50.0) 15(55.6) 
Enrolled nurse/staff nurse 1 (9.1) 0 I (3.7) 
Other 1 (9.1)) l (6.3) 2 (7.4) 
Manager or supervisor for the facility 4 (36.4) 10 (62.5) 14(51.9) 
Years working at the fa1.:ility - mean (SD) 4.2 (2 .0) 4.2 (4 .3) 4.3 (3 .1) 
Years since finishing basic training- mean 15.9 (7.7) 11.3 (6.2) 13 .2 (7.1) 
(SD) 
Completed a family planning course 10(90.9) 6(37.5) 16 (59.3) 
Trained to provide HIV care services 11 (100.0) 16 (100.0) 27 (100.0) 
Trained to provide STI care services 9 (81.8) 13 (81.3) 22 (81.5) 
Has provided family planning in last 6 mo. 11 (100.0) 15 (93.8) 26 (96.3) 
Has provided HIV care services in last 6 mo. 10 (90.9) 14(87 .5) 24 (88 .9) 
Has provided STI diagnosis and treatment in 10 (90.9) 16(100.0) 26 (96.3) 
last 6 mo. 
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Table 5.17: Provider Knowledge about the IUD 
Provider knowledge about the IUD is presented in Table 5 .17. Overall provider 
knowledge of the IUD method is poor. When asked which methods of family 
planning providers routinely suggested to clients, only 1 provider in the Western Cape 
and 1 in the Eastern Cape mentioned the IUD. After the rhythm or calendar method (3.1 %), the IUD was the least suggested method (6.3%). The most commonly 
suggested methods were the 3 and 2-month injectables (100% each), the male condom (100%), and oral contraceptive pills (96.6%). However, despite the fact that most 
providers did not suggest the IUD as a family planning option, all providers had heard 
of the IUD. However, when asked to describe the IUD, only 78.1 % described the 
method correctly. Only 53.3% had heard that there were different types of IUDs, 
when asked about the correct duration of use, only 12.5% of providers said that the 
IUD could be used for up to ten years. However, 84.4% could correctly explain how 
the IUD works to prevent pregnancy by saying that it either creates a spermicidal 
endometrium or that it inhibits sperm transport, mobility, and viability. 
Providers were asked a number of basic questions about the effectiveness, safety, 
contraindications to use, side effects and risks of the IUD. Only 18.8% of providers 
knew that the IUD is over 99% effective at preventing pregnancy. When providers 
were asked to compare the effectiveness of the IUD to other contraceptive methods, 
providers notably said that the IUD was better than the rhythm method (87.5%), the 
withdrawal method (87.1 %), the pill (71.9%), spermicides (65.6%), the male condom (59.4%). However, only 16.1 % reported the IUD to be better than female sterilization. 
A surprising 62.5% thought that the injectable was better than the IUD at preventing 
pregnancy. When asked if the IUD was safer than other methods, 81. 3 % reported that 
the IUD was safer than the pill but for most other methods only 30 to 50% reported 
that the IUD was safer. 75% of providers said there was some contraindications to 
IUD use and the most commonly cited was reported cervical, endometrial, or ovarian 
cancer awaiting treatment (28.1 %). 62.5% of providers said the IUD causes side 
effects and the most commonly reported side effect was increased menstrual blood (28.1 %). Finally, 65.5% of providers believed that the IUD had risks related to it and 
the most commonly reported risk was ectopic pregnancy (28.1 %). Only 31.3% said 
the IUD could be used as a form of emergency contraception. 59.4% said that the IUD 
increases one's risk of contracting STis and 51 .6% did not think that nulliparous 
women could use an IUD. 
With regards to training, providers recognized that they needed more information. 
When providers were asked if they had sufficient training with regards to 9 IUD 
related issues, no more than 10 providers (32.3%) said that they had enough training 
in any given area relating to providing the IUD. 93 .6% of providers believed that they 
needed more training and information about the IUD. 
Table 5.17. Provider Knowledge about the IUD 
Characteristic 
Methods of family planning suggested to 
clients at clinic * 
The pill 
The IUD 
Western Cape 
n (%) 
n=l5 
N=/5 
14 (93.3) 
I (6.7) 
Eastern Cape 
n (%) 
n= / 7 
N=l7 
17(100.0) 
I (5.9) 
Total 
n (%) 
n=32 
N=32 
31 (96.9) 
2 (6.3) 3 month injection 15(!00.0) 17 (!00.0) 32 (100.0) 2 month injection 15 (100.0) 17(100.0) 32 (!00.0) 
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' 
Male condom 15(100.0) 17(100.0) 32 (100.0) 
Female condom 13 (86.7) 12 (70.6) 25 (78.1) 
Female sterilization 4 (26.7) 0 4 (12.5) 
Male sterilization 3 (20.0) 0 3 (9.4) 
Rhvthm , calendar method 0 I (5.9) I (3.1) 
Heard of the IUD 15 (100.0) 17 (100.0) 32 (100.0) 
Can describe the IUD method correctly 12 (80.0) 13 (76.5) 25 (78.1) 
Know about different types of IUDs 11 (84.6) 5 (29.4) 16 (53.3) 
Understanding of how IUD prevents 13 (86.7) 14(82.4) 27 (84.4) 
pregnancy - Correct response 
Length of use for IUD 
Those who said 1-5 years 6 (40.0) 4 (23 .5) 10 (31.3) 
Those who said IO years I (6.7) 3 (17.7) 4 (12.5) 
Efficacy of IUD- Correct response 3 (20.0) 3 (17.7) 6 (18.8) 
Effectiveness of IUD at preventing pregnancy N= /5 N=/7 N =32 
compared to other methods * 
Pill / oral contraceptives - Better 8 (53.3) 15 (88.2) 23 (71.9) 
Injectable - Better 4 (26.7) 8(47.l) 12 (37.5) 
Male condom - Better 9 (60.0) IO (58.8) 19 (59.4) 
Female condom - Better 7 (46.7) 6 (35.3) 13(40.6) 
Soermicide - Better 10(66.7) 11 (64.7) 21 (65.6) 
Diaphragm - Better 6 (40.0) 11 (64.7) 17 (53.1) 1, Female sterilization - Better I (6.7) 4 (25.0) 5 ( 16.1) 
Male sterilization - Better I (6.7) 5 (29.4) 6(18.8) 
Rhythm, calendar method - Better 13 (86.7) 15 (88.2) 28 (87.5) 
Withdrawal- Better 12 (85 .7) 15 (88.2) 27(87.1) 
% who believe IUD is safer than other N=/5 N=/7 N=32 
contraceptive methods * 
Pill / oral contraceptives - Safer 11 (73.3) 15 (88.2) 26 (81.3) 
Injectable - Safer 7 (46.7) 8(47.1) 15(46.9) 
Male condom - Safer 7(46.7) 10 (58.8) 17(53 .1) 
Female condom - Safer 7 (46.7) 9 (52.9) 16 (50.0) 
Spermicide - Safer 9 (60.0) 11 (64.7) 20 (62.5) 
Diaphragm - Safer 6 (40.0) 12 (70.6) 18(56.3) 
Female sterilization - Safer 3 (20.0) 7 (41.2) 10(31.3) 
Male sterilization - Safer 3 (20.0) 7 (41.2) 10 (31.3) 
Providers who believe there are medical 12 (80.0) 12 (70.6) 24 (75.0) 
contraindications to IUD use 
Distribution of contraindications indicated * 
Pregnancy 4 (26.7) 0 4 (12.5) 
Having PID 3 (20.0) I (5.9) 4 (12.5) 
Having PIO within the last three months 2 (13.3) 0 2 (6.3) 
Having an active ST! 5 (33.3) 2(11.8) 7 (21.9) 
Having an ST! within the last three 2 (13.3) 0 2 (6.3) 
months 
Unexplained and/or abnormal vaginal 3 (20.0) 3 (17.7) 6 (18.8) 
bleeding 
A severely distorted uterine cavity 2 (13.3) I (5.9) 3 (9.4) 
Cervical, endometrial, or ovarian cancer 6 (40.0) 3 (17.7) 9 (28.1) 
that is awaiting treatment 
Allergy to any component of the IUD 0 2(11.8) 2 (6.3) (ie. Copper) 
Pelvic tuberculosis 0 0 0 
Unsure 0 0 0 
Other I (6.7) 3 (17.7) 4(12.5) 
Providers who believe there are side effects 11 (73.3) 9 (52.9) 20 (62.5) 
associated with IUD use 
Noted side effects * 
Nausea I (6.7) 0 I (3. I) 
Vomiting I (6.7) 2(11.8) 3 (9.4) 
Headaches 0 I (5.9) 1 (3.1) 
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Cramping / abdominal pain 3 (20.0) 2(11.8) 5 (15.6) 
Change in menstrual cycle 3 (20.0) 0 3 (9.4) 
More menstrual blood 4 (26.7) 5 (29.4) 9 (28.1) 
Less menstrual blood 0 0 0 
Pain during insertion 2 (13.3) 1 (5.9) 3 (9.38) 
Breast tenderness 0 0 0 
Depression 0 0 0 
Pelvic Inflammatory Disease (PIO) 6 (40.0) I (5.9) 7(21.9) 
Unsure 3 (20.0) 1 (5 .9) 4 (12.5) 
Other 4 (26.7) 4 (23.5) 8 (25.0) 
Providers who believe there are risks 13 (86.7) 8 (47.1) 21 (65.6) 
associated with IUD use 
Noted risks * N=J3 N=B N=21 
Developing PIO 4 (26.7) 3 (17.7) 7 (21.9) 
lnferti I ity I (6.7) l (5.9) 2 (6.3) 
Ectopic pregnancy 7 (46.7) 2 (l 1.8) 9(28.1) 
Developing STis 2 (13 .3) l (5.9) 3 (9.4) 
Uterine perforation 5 (33.3) 0 5(15.6) 
Other 3 (20.0) 3 (l 7.7) 6(18.8) 
Providers who believe the IUD can be used as 5 (33.3) 5 (29.4) 10(31.3) 
a form of EC 
Providers who believe the IUD offers 0 0 0 
protection from ST!s 
Providers who believe the IUD increases 6 (40.0) 13 (76.5) 19 (59.4) 
one's risk of contracting STis 
Providers who believe the IUD cannot be used 4 (26.7) 12 (75.0) 16(51.6) 
by a nulliparous woman 
Sufficient training related to the IUD in N= 14 N=l7 N=31 
regards to the following factors: * 
Length of use - Yes 7 (50.0) I (5 .9) 8 (25.8) 
How it works to prevent pregnancy - Yes 6 (42.9) 2(11.8) 8 (25.8) 
Medical reasons why certain women 5 (35. 7) 2(11.8) 7 (22.6) 
shouldn't use it - Yes 
Side effects - Yes 6 (42.9) I (5.9) 7 (22.6) 
Types of IUDs - Yes 6 (42.9) I (5.9) 7 (22.6) 
Safety- Yes 6(42.9) 4 (23 .5) IO (32.3) 
Efficacy/ How well is works - Yes 7 (50.0) 2 (11.8) 9 (29.0) 
How to insert it - Yes 3 (21.4) 0 3 (9.7) 
How to remove it - Yes 4 (28.6) I (5.9) 5 (16.1) 
Think they need to know more about the IUD 14(93.3) 15 (93.8) 29 (93.6) 
in order to counsel women on this method 
* Health care providers could have answered more than once in this section of 
questions. 
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Table 5.18 : Provider practices related to the IUD method 
Provider practices relating to the IUD are presented in Table 5.18. Of the 32 providers 
interviewed, only 18.8% had ever counseled a woman about the IUD, only 15.6% had 
ever suggested the IUD to a potential client, only 21.9% of providers reported that 
they were trained to insert the IUD, only 13.3% had ever inserted an IUD, and of 
those insertions, all of them had been over a year ago. Only 28.1 % had ever referred a 
woman to another site for an IUD and of those referrals, most (77.8%) referred 
women to another facility. It is worth noting that in the Western Cape, women were 
referred to another facility 100% of the time while in the Eastern Cape, women were 
far more likely to be referred to a GP or private doctor (66.7). Only 28% gave a 
correct answer about the time to first check- up after IUD insertion and half of the 
providers believed that women needed routine follow-up visits for their IUD. When 
asked what type of information they would give women about the IUD, providers 
mostly commonly said that they would give women information about when to return 
for follow-up visits (40.65), side effects (37.5%), the duration of use for the method (28.1 %) and preventing STis (28.1 %). When asked who the IUD was appropriate for, 
providers believed the method was most appropriate for those who want children in 
the future ( 46. 9% ), those who have never had children (31. 3 % ), and those who are 
married (25.0%). When asked whom the IUD was not appropriate for, providers said 
that the IUD was not an appropriate method for women with a history of STis ( 46.9%), HIV-positive women (28.1 %), and teenage women (25.0%). 
Table 5.18. Provider practices related to the IUD method 
Western Cape Eastern Cape Total 
Characteristic n (%) n (%) n (%) 
N=l5 N=l7 N=32 
Clinics offering the IUD 0 0 0 
Guidelines for IUD usage at clinic 5 (33.3) 4 (23.5) 9 (28.1) 
Providers who have ever counseled a woman 3 (20.0) 3 (17.7) 6 (18 .8) 
about an IUD 
Ever su2:2:ested use of IUD 3 (20.0) 2(11.8) 5(15.6) 
Amount of times provider suggests IUD to 
client 
Once a week 0 0 0 
Once a month I (14.3) 1 (33.3) 2 (20.0) 
Once a vear 2 (28.6) 1 (33 .3) 3 (30.0) 
Never 4 (57.14) l (33.3) 5 (50.0) 
Providers trained to insert IUD 7 (46.7) 0 7(21.9) 
Providers who have ever inserted IUD 4 (26.7) 0 4(13 .3) 
Time to last insertion 
Within the last year 0 0 0 
Over a year ago 4 (26.7) 0 4 (12.5) 
Referred a woman to another site for IUD 6 (40.0) 3 (17.7) 9 (28.1) 
Where referred * 
Another provider in this facility 0 0 0 
Another facilitv 6(100.0) 1 (33.3) 7 (77.8) 
GP/Private doctor 0 2 (66.7) 2 (22 .2) 
Other (soecifv) 0 0 0 
Time to first check-up after IUD insertion 
One week 2 (13.3) 2 ( 11 .8) 4 ( 12.5) 
Three to six weeks 3 (20.0) 5 (29.4) 8 (25.0) 
Six months 1 (6.7) 2(11.8) 3 (9.4) 
One year 2(13.3) 0 2 (6.3) 
Other 7 (46.7) 8 (47.1) 15 (46.9) 
Other-Correct 0 1 (5.9) I (3.1) 
Timing of routine check-uos 
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Monthly 2 (13.3) 2(11.8) 4 (12.5) 
Every six months 3 (20.0) 9 (52. 9) 12 (37.5) 
Yearly 4 (26.7) 3 (17.7) 7 (212) 
Other 6 (40.0) 3 (l 7.7) 9 (28 .1) 
Information given to client starting IUD * 
How long IUD can be used for 5 (33 .3) 4 (23.5) 9 (28.1) 
Safety 0 I (5.9) I (3. I) 
Efficacy 0 0 0 
Side effects 8 (53.3) 4 (23.5) 12 (37.5) 
When to return for follow up visits 5 (33.3) 8(47.1) 13 (40.6) 
Preventing STls I (6.7) I (5.9) 2 (6.3) 
Making sure the IUD is in place 6 (40.0) 3 (17.7) 9(28.1) 
Other 6 (40.0) 10(58.8) 16 (50.0) 
Other - correct responses 2(13.3) 3 (17.7) 5(15.6) 
Types of women the IUD is appropriate for * 
Women who desire to have more 7 (46.7) 8(47.1) 15 (46.9) 
children in the future 
Women who have never had 5 (33.3) 5 (29.4) 10 (31.3) 
children before 
Women who are done having 3 (20.0) 2(11.8) 5 (15.6) 
children 
Women who are married 6 (40.0) 2 (11.8) 8 (25.0) 
Women who are not married 3 (20.0) 2 (11.8) 5(15.6) 
Teenage women 4 (26.7) 3 (17 .7) 7 (21.9) 
Women who are breastfeeding 3 (20.0) 0 3 (9.4) 
Women who are HIV-positive 1 (6.7) 0 I (3.1) 
Women with a history ofST!s 0 0 0 
Women with no history ofSTls 6(40.0) I (5.9) 7 (21.9) 
Other 5 (33.3) 7 (41.2) 12(37.5) 
Who is the IUD NOT appropriate for * 
Women who desire to have more I (6.7) 0 I (3.1) 
children in the future 
Women who have never had 4 (26.7) 3 (17.7) 7 (21.9) 
children before 
Women who are done having 5 (33.3) 2 (11.8) 7 (21.9) 
children 
Women who are married 0 0 0 
Women who are not married I (6.7) 0 I (3. I) 
Women who are breastfeeding 0 0 0 
Women who are HIV-positive 4 (26.7) 5 (29.4) 9 (28.1) 
Women with a history ofST!s 6 (40.0) 9 (52.9) 15 (46.9) 
Women with no history of ST!s 0 2 (11.8) 2 (6.3) 
Teenage women 4 (26.7) 4 (23.5) 8 (25.0) 
Other 3 (20.0) 6 (35.3) 9 (28.1) 
* Health care providers could have answered more than once in this section of 
questions. 
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Table 5 .19: Provider attitudes related to the IUD method 
Provider attitudes related to the IUD method are presented in Table 5.19. Overall, 
providers did not feel confident about their IUD-related knowledge. Not even 20% of 
providers felt that they had enough knowledge to counsel a woman on the IUD and 
only 6.5% felt as if they would be able to insert one. Most providers believed there 
was an advantage to having an IUD and 50% stated that IUDs could help reduce 
unplanned and unwanted pregnancies. However, providers also believed there were 
disadvantages to the IUD method. The most commonly cited disadvantage was side 
effects (34.4%), followed by concern that the IUD does not offer protection from STis (31.3%). Eight providers (25%) said that the IUD increases the risk of developing 
PID. When asked what type of women they would recommend the IUD to, 78.1 % of 
providers said they would recommend the IUD to women who desired more children 
in the future, 7 5% said they would recommend the IUD to unmarried women, and 
56% said they would recommend the IUD to women who have not had any children 
yet. The mean age below which providers said they would not provide the IUD was 
17.5 years and this was similar between the Western and Eastern Capes. Finally, 
when asked if they had any concerns about the IUD, the most commonly cited 
concern ( 40. 6%) was side effects related to the method. 
Table 5.19. Provider attitudes about the IUD 
Western Cape Eastern Cape Total 
Character isl ic n (%) n (%) n (%) 
N=/5 N=l7 N=32 
Feel as if know enough to counsel women on 3 (21.4) 3 (17.7) 6(19.4) 
IUD method 
Feel as if know enough to insert an IUD 2 (14.3) 0 2 (6.5) 
Advantages ofIUD use * 
Reduce unplanned/unwanted 7 (46.7) 9 (52.9) 16 (50.0) 
pregnancy 
Reduce teenage oregnancy 2 (13.3) I (5.9) 3 (9.4) 
Can be used as a form of emergency 1 (6.7) 1 (5 .9) 2 (6.3) 
contraception (EC) 
Expand's women's choice 3 (20.0) 0 3 (9.4) 
Effective I (6.7) 4 (23.5) 5 (15.6) 
Safe 2 (13 .3) 4 (23.5) 6 (18.8) 
Private I (6 .7) 0 I (3.1) 
Can be used by all women I (6.7) 0 I (3 .1) 
Can be used by HIV-positive 0 0 0 
women 
Cost-effective 0 0 0 Quick return to fertility upon 3 (20.0) 2(11.8) 5 (15.6) 
removal 
The copper IUD is a non-hormonal I (6.7) 3(17.7) 4 (12.5) 
method 
Don't see any advantages 0 0 0 
Unsure 3 (20.0) 0 3 (9.4) 
Other 3 (20.0) 4 (23.5) 7 (21.9) 
Other-correct response 2(13.3) 4 (23.5) 6 ( 18.8) 
Disadvantages of IUD * 
Doesn't protect against STis / HIV 6(40.0) 4 (23.5) 10(31.3) 
It is an abortifacient I (6.7) 0 I (3.1) 
It increases the risk of developing 4(26.7) 4 (23.5) 8 (25.0) 
PIO 
It has side effects 8 (53.3) 3 (17.7) 11 (34.4) 
Women may forget they have it I (6.7) 0 I (3.1) 
Initial costs for the device are high 0 0 0 
It requires training for insertion 3 (20.0) 2 (11.8) 5 (15.6) 
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Don't see any disadvantages 2 (13.3) 4 (23 .5) 6 (18.8) 
Unsure I (6.7) 2(11.8) 3 (9 .4) 
Other 4 (26.7) 4 (23.5) 8 (25 .0) 
Other - Correct response 2 (13.3) I (5 .9) 3 (9 .4) 
As a hea lth care provider, wo uld personall y 
recommend the IUD to ... * 
A woman who desires to have more II (73.3) 14 (82 .4) 25 (78 .1) 
children in the future 
An unmarried woman 10 (66 .7) 14 (82.4) 24 (75.0) 
A woman who has never had a child 7 (46.7) 9 (52.9) 16 (56.0) 
A woman who is HIV-positive 3 (20.0) 2(11.8) 5 (15 .6) 
A woman who has AIDS 2 (13.3) I (5.9) 3 (9.4) 
A woman who has had an STI in the 3 (20.0) 4 (23.5) 7 (21.9) past 
A woman who has a current STI 0 0 0 A woman who doesn ' t use condoms 6 (40.0) 6 (35 .3) 12 (37 .5) A teenage woman 9 (69.2) 3 (17.7) 12 (40.0) Mean minimum age below which health 17.6 (15-20) 17 .3 (I 3-20) 17.5 (14.5-20) provider would not provide an IUD to a 
woman 
Concerns about the IUD * 
Concern regarding medical safety 4 (26.7) 3 (17.7) 7 (21.9) (including risk of PID) 
Risk of infertility 0 1 (5.9) I (3 .1) Concerns about side effects 7 (46.7) 6 (35 .3) 13 (40.6) Offers no protection from STls and 3 (20.0) 2(11.8) 5(11.6) HIV 
Concern regarding efficacy 0 I (5.9) I (3.1) Cost of the method 0 0 0 --Requires trained provider to insert 5 (33 .3) I (5.9) 6 (18.8) Other 3 (20.0) 5 (29.4) 8 (25.0) 
* Health care providers could have answered more than once in this section of 
questions. 
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Table 5.20: Provider perceptions of the IUD 
Provider perceptions of the IUD are presented in Table 5.20. Providers had some very 
interesting insights about the IUD. When asked about the three main barriers to client 
access and use of the IUD, providers highlighted the lack of knowledge on the part of 
the provider (84.4%), a lack of trained providers to insert and remove the device 
(62.5%), the fact that IUDs are not available at facilities (56.3%), and a lack of 
knowledge on the part of potential users ( 46.9%). 81.3% of providers believed that 
women would be interested in the IUD if they knew about it but only 37.5% of 
providers believed that women's partners would support the use of the IUD as a 
contraceptive method. When asked why they thought IUD use was low in South 
Africa, the greatest number of providers said that it was because of a lack of 
knowledge on the part of the provider and user (50.0%). Just over half of the 
providers surveyed (51.6%) of providers believed that the IUD would be a good 
method for South Africa, 73.3% believed that IUD use should be promoted in South 
Africa, and the most highly cited reason for why IUD use should be promoted in 
South Africa were that it would increase women's reproductive choice (25.0%) and it 
would help prevent unwanted pregnancies (21.9%). 
Table 5.20. Provider perceptions of the IUD 
Western Cape Eastern Cape Total 
Characteristic n (%) n (%) n (%) 
N=l5 N=l7 N=32 
The three main obstacles or barriers to clients' access 
to and use of the IUD 
Lack of knowledge on the part of the 13 (86.7) 14 (82.4) 27 (84.4) 
provider 
Lack of knowledge on the part of the 8 (53 .3) 7(41.2) 15 (46.9) 
potential user 
Lack of trained providers to insert or remove 9 (60.0) 11 (64.7) 20 (62.5) 
the device 
Moral/religious worries of potential users I (6.7) I (5 .9) 2 (6.3) 
Providers belief that IUD is an abortifacient I (6 .7) 0 I (3 .1) 
IUD is never available at this facility 9 (60.0) 9 (52 .9) 18 (56.3) 
IUD is often out of stock 0 I (5.9) I (3 .1) 
IUD does not offer protection from ST!s 2 (13.3) 0 2 (6 .3) 
Many myths and misperceptions I (6.7) I (5.9) 2 (6.3) 
I Other 3 (20.0) 7(41.2) IO (31.3) 
Other - IUD not promoted 0 2 (11.8) 2 (6.3) 
Think that women would use the IUD method if they 11 (73 .3) 15 (88 .2) 26(81.3) 
knew about it 
Think that women's partners would support their use of 3 (20.0) 9 (52.9) 12 (37.5) 
the IUD as a method for preventing pregnancy 
Reasons why HCP think IUD use is low in South 
Africa 
Fear of side effects 2 (13.3) I (5.9) 3 (9.4) 
Lack of knowledge on part of provider or 7 (46.7) 9 (52.9) 16 (50.0) 
user 
IUD method is not promoted / available 4 (26.7) 6 (35.3) 10 (31.3) 
Women are not comfortable with a method 3 (20.0) I (5 .9) 4(12.5) 
that stays inside the body all the time 
Women ' s partners will not agree with the 2 (13 .3) 0 2 (6.3) 
method 
Other 3 (20.0) 2 (11 .8) 5 (15.6) 
Think the IUD is a good family planning method for 8 (53.3) 8 (50.0) 16(51.6) 
South Africa 
Reasons cited for why more IUD use should be 
promoted in South Africa 
Increases women's contraceptive choices 6 (40.0) 2(11.8) 8 (25 .0) 
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-Prevents unwanted pregnancy 3 (20.0) 4 (23.5) 7 (21.9) 
It is a reliable option 3 (20.0) 0 3 (9.4) 
People currently lack knowledge about the I (6 .7) I (5 .9) 2 (6.3) 
IUD 
IUD has less side effects than other methods 0 2(11.8) 2 (6.3) 
Other 3 (20.0) 3 (17.7) 6 (18.8) 
Reasons cited for why more IUD use should not be 
promoted in South Africa 
Misinformation of lack of knowledge about I ( 11.1) 4 (44.4) 5 (55.6) 
method 
High prevalence ofHIV/STls I ( I I. I) 2 (22 .2) 3 (33 .3) 
Other I ( 11.1) 0 1(11.1) 
Think that greater IUD use should be promoted in 12 (80.0) 10 (66.7) 22 (73.3) 
South Africa 
Providers who think they need more training and 14 (93.3) 15 (93.8) 29 (93.6) 
information about the IUD method 
Areas for further training and education about the 
IUD* 
Types of IUDs that are available 2 (6.9) 3 (10 .3) 5(17.2) 
Recommendations about appropriate 4 (13.8) I (3.4) 5 (17.2) 
candidates for IUD usage 
Possible duration of use 1 (3.4) 1 (3.4) 2 (6.9) 
How to insert and remove IUD 10 (34.5) 11 (37.9) 21 (72.4) 
Advantages and disadvantages 2 (6.9) 4(13.8) 6 (20.7) 
General knowledge 7 (24.1) 7 (24.1) 14 (48 .3) 
Side effects 2 (6 .9) 2 (6.9) 4 (13.8) 
Efficacy 0 3 (10.3) 3 (10.3) 
Other I (3.4) 3 {10.3) 4(13.8) 
* Health care providers could have answered more than once in this section of 
questions. 
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